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Abstract 
 
The gram-negative bacterium Campylobacter jejuni represents a major agent causing food-
borne gastroenteritis in humans worldwide. C. jejuni infection is also an important pre-
condition for Guillain-Barrè syndrome. The cytotoxic effects of Campylobacter have been 
ascribed to the actions of several different toxins. The best characterized C. jejunir toxin is the 
cytolethal distending toxin (CDT), released by bacteria via outer membrane vesicles (OMVs). 
Many bacterial pathogens, including C. jejuni, utilize OMVs to transport virulence factors, 
such as the CDT (cytolethal distending toxin), into host cells. To date, different authors 
described the peculiar relationship among C. jejuni virulence factors and human intestinal and 
myeloid cells. It is known that resident macrophages contribute to the maintenance of tissue 
by acting as the first line of defense against pathogens and by initiating wound repair. These 
monocyte-derived cells establish (together with dendritic cells) the role of “guardian of the 
gut”. The aim of this work was to investigate the effects of C. jejuni virulence factors in 
human cells focusing the attention on cellular pathways that this bacterium activates or 
deactivates during host cell infection. Among the several virulence factors, the CDT was the 
most investigated. To do that, effects induced by three different C. jejuni wild type strains 
were compared with the effects induced by the C. jejuni cdtA mutant strain, in three different 
cell lines: monocytes isolated from donor’s human blood, tumour myeloid cells (U937) and 
human intestinal epithelial cells (T84). C. jejuni lysates, OMVs and whole cells were 
separately used for the infections. Carried out cytometric, microscopy and molecular analyses 
revealed that C. jejuni induce DNA damage, apoptosis, mitochondrial and lysosomal 
destabilization as well as intracellular lipid content alterations, ICAM-1 upregulation and 
activation of autophagic, secretory and endocytic pathways in a CDT dependent manner. 
Nevertheless, although they are important for C. jejuni infection, CDT seems not to have a 
role in ER stress and UPR activation, CD14 and CD59 upregulation. Involvement of all these 
pathways enhances C. jejuni invasion, persistence and survival, allowing the possible onset of 
post infectious sequelae such as the Guillain-Barré syndrome. 
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Introduction 
 
1. Biology of Campylobacter jejuni 
The Campylobacter genus belongs to the family Campylobacteraceae, the order 
Campylobacterales, the class Epsilonproteobacteria, and the phylum Proteobacteria. Since its 
first description, the genus has grown to include several important human and animal 
pathogens that are primarily classified through phylogenetic means. The genus 
Campylobacter consists of 26 species, 2 provisional species, and 9 subspecies (as of 
December 2014). 
Although the infections were attributed to Vibrio fetus (now known to be Campylobacter 
fetus), the first recognized case of Campylobacter infection (termed campylobacteriosis) were 
reported in the early 20
th
 century in farm animals, and during the next three decades, it was 
believed to be a rare, opportunistic, invasive pathogen that occurred principally in debilitated 
hosts. Only in the early 1980s the importance of these infections was recognized as a cause of 
human gastrointestinal illness. By the mid-to-late 1980s, Campylobacter species have been 
identified as one of the most common bacterial causes of diarrhoea worldwide. 
C. jejuni like all Campylobacter species, is a microaerophilic, non-fermentative Gram-
negative organism. Being structurally similar to other Gram-negative bacilli, C. jejuni cells 
are slender, spirally ‘curved rods’, approximately 0.2-0.8 wide and 0.5-5µm long. It is motile 
with a characteristic corkscrew like motion via a single polar unsheathed flagellum at one or 
both ends of the cell (Vandamme et al, 2015). 
For an efficient cultivation in vitro, the microaerophilic nature of C. jejuni requires an 
atmosphere with reduced oxygen and elevated carbon dioxide concentrations: gas mixtures of 
5% oxygen, 10% carbon dioxide and 85% nitrogen provide optimal cultivation conditions for 
most C. jejuni isolates (Bolton et al, 1983). 
The C. jejuni genome is small (1.6-2.0 megabases) and can establish long-term associations 
with their hosts, sometimes with pathogenic consequences (Young et al, 2007). 
The complete genome sequence of C. jejuni was characterized and hypervariable regions that 
might be important in the survival of this organism were found (Parkhill et al, 2000). Most of 
the hypervariable sequences that have been found are in regions that encode proteins that are 
involved in the biosynthesis or modification of surface-accessible carbohydrate structures, 
such as the capsule, lipooligosaccharide (LOS) and flagellum; these structures have a key role 
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in C. jejuni biology, in particular for host-bacterium interactions (Young et al, 2007). C. jejuni 
is naturally competent, meaning that it can take up DNA from the environment. This leads to 
recombination between strains, which allows the generation of even more genetic diversity. 
The horizontal transfer of both plasmid and chromosomal DNA occurs both in vitro and in 
vivo during chick colonization; this indicates that natural transformation may have a 
significant role in genome plasticity (Wilson et al, 2003) (Avrain et al, 2004). 
 
1.1 Epidemiology of C. jejuni 
To date, campylobacteriosis is one of the most widespread infectious diseases of the last 
century. Recent reports suggested that in the past decade the incidence and prevalence of 
campylobacteriosis increased globally in both developed and developing countries. In North 
America, Europe, and Australia was recorded a remarkable increase, and data from parts of 
Africa, Asia, and the Middle East indicated that campylobacteriosis was endemic in these 
areas, especially in children (Fig. 1.1) (Kaakoush et al, 2015). In developed countries, where 
waterborne infection is less likely, animals are the primary source of human infection and 
disease. By contrast, Campylobacter is hyperendemic in the developing world, because of 
poor sanitation and close human contact with animals. In these countries Campylobacter 
species are usually limited to children, with illness/infection ratios decreasing with age, 
suggesting that exposure in early life might lead to the development of protective immunity 
(Rao et al, 2001).  
Several factors have been hypothesized to influence the prevalence of Campylobacter 
infections; for example, in the last years it has been hypothesized that it might be influenced 
by population-level immunity (Havelaar et al, 2009). 
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Fig. 1.1 Incidence and prevalence of Campylobacteriosis worldwide (American Society of 
Microbiology, 2015). 
 
1.2 Transmission of C. jejuni 
C. jejuni is commonly considered to be a commensal organism of chickens and other avian 
species. Several environmental reservoirs can lead to human infection by C. jejuni. It 
colonizes the chicken gastrointestinal tract in high numbers, primarily in the mucosal layer, 
and it is passed between chicks within a flock through the faecal-oral route. C. jejuni can 
infect humans directly through consumption of contaminated food, particularly poultry 
products, unpasteurized milk, and water (Fig. 1.2) (Friedman et al, 2004) (Kapperud et al, 
1992) (Neimann et al, 2003). In humans, C. jejuni can invade the intestinal epithelial layer, 
resulting in inflammation and diarrhoea.   
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Fig. 1.2 Consumption of undercooked or contaminated food and contact with animals can 
lead to transmission of Campylobacter to humans. Depending on species, strains involved and 
the ingestion dose, gastrointestinal and/or extra-gastrointestinal manifestations can occur 
(Kaakoush et al, 2015). 
 
1.3 Pathogenesis of C. jejuni 
C. jejuni is successful in competing with the human intestinal microbiota; an infectious dose 
of few hundred bacteria is sufficient to overcome the colonization resistance of humans 
leading to campylobacteriosis (Hofreuter, 2014). More than 80% of the registered 
campylobacteriosis are caused by C. jejuni, for this reason the term ‘campylobacteriosis’ is 
frequently associated to C. jejuni infection. Campylobacteriosis typically causes 
gastroenteritis/enterocolitis, and clinical picture varies significantly in duration, severity and 
associated symptoms (Ketley, 1997). Following an incubation of ~24-72 hours, symptoms 
like cramping abdominal pain, fever, vomiting and headaches can develop (Blaser, 1997). 
Upon onset of abdominal pain, diarrhoea develops quickly. Depending on virulence of the 
infecting strain and host immune status, it varies from a mild, non-inflammatory, watery 
presentation to severe and bloody. 
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Although gastroenteritis is the major clinical condition resulting from C. jejuni infection, 
other serious conditions within the gastrointestinal tract have been associated with C. jejuni, 
including inflammatory bowel diseases (IBD), post infectious functional gastrointestinal 
disorders, such as irritable bowel syndrome and functional dyspepsia, and celiac disease 
(Kaakoush et al, 2015).  
 
1.4 Post-infectious sequelae of C. jejuni 
In addition to gastrointestinal infections, C. jejuni can trigger extra-intestinal manifestations, 
as either a local isolated infection (which is a systemic manifestation after an episode of 
enteritis) or a postinfectious immune disorder. Overall, the incidence of extra-intestinal 
manifestations associated with C. jejuni infection is low compared with gastroenteritis. Post-
infectious complications can be severe, and potentially life-threatening. These manifestations 
include Guillain-Barré syndrome (GBS), Miller Fisher Syndrome, Bell’s palsy (unilateral 
facial paralysis) and reactive arthritis. To date, the post-infectious disease most extensively 
studied is GBS. 
 
1.4.1 The Guillain-Barré syndrome  
The Guillain-Barre’ syndrome (GBS) is an acute post-infectious ascending paralysis that can 
affect peripheral and cranial nerves (particularly VII, facial nerve) and manifests as rapidly 
evolving weakness and sensory disturbance in arms, legs and, in some cases, facial, bulbar 
and respiratory muscles (Goodfellow & Willison, 2016). This disorder affects children and 
adults of all ages and both sexes, although men are more frequently affected than women. 
In most cases (60-70%), the neuropathy is preceded by a bacterial or viral illness. Usually, an 
initial respiratory tract infection or gastroenteritis is followed by an acute phase in which 
paralysis of muscles develops and reaches a plateau. After this phase, a gradual resolution of 
the paralysis follows, that lasts from weeks to months. 
Current strategies for GBS therapy include plasma exchange and intravenous immunoglobulin 
(IVIg), that have been shown to improve outcomes for patients with GBS (Hughes et al, 
2014) (van Doorn et al, 2010). 
C. jejuni, cytomegalovirus, Epstein-Barr virus, and Mycoplasma pneumonia infections are 
recognized as triggering agents of about two-third of GBS cases (Sinha et al, 2004). In 1982 
Rhodes and Tattersfield reported for the first time the link between C. jejuni infection and 
GBS development (Rhodes & Tattersfield, 1982). Several subsequent studies documented the 
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prevalence of C. jejuni infection or seropositivity in patients with GBS, confirming the 
finding to be widespread and reproducible (Rees et al, 1995). At present, C. jejuni is 
recognized as the most identifiable pathogen associated with development of GBS because 
25-40% of GBS patients suffer from C. jejuni infection 1-3 weeks prior to the illness (Mishu 
& Blaser, 1993); nevertheless, the risk of developing GBS after C. jejuni infection exposition 
is quite low, only 1 in 1000 patients develops GBS (Magira et al, 2003). The annual incidence 
of GBS is approximately between 1.2 and 2.3 cases per 100,000 persons (van Doorn et al, 
2008). 
Depending on the electrophysiological properties, GBS is classified in different subtypes: 
acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy 
(AMAN), and a severe form of AMAN that is termed acute motor sensory axonal neuropathy 
(AMSAN), which is much less common (Griffin et al, 1996). AMAN is an axonal subtype (30 
to 65% of patients) particularly widespread in Asia and Central and South America 
(Kuwabara & Yuki, 2013) (Bae et al, 2014), while AIDP is more prevalent in Europe and 
North America. Especially for the AMAN type, the pathogenesis of the disease is believed to 
involve molecular mimicry between sialylated lipooligosaccharide structures, that are 
contained on the cell envelope, and ganglioside epitopes of C. jejuni and neural gangliosides. 
This mechanism generates a cross-reactive immune response, resulting in a cascade of 
immune-mediated inflammatory responses, degeneration of the peripheral nerve and 
interruption of neurotransmission (Fig. 1.3). In serum samples from numerous patients 
affected by AMAN, subsequently to C. jejuni infection, high titres of antibodies against the 
following gangliosides were contained: GM1, GM1b, GD1a or GalNAc-GD1a (Ogawara et 
al, 2000). Basically, the LPS (lipopolysaccharide) from C. jejuni contains a terminal 
tetrasaccharide identical to that of GM1 (Yuki et al, 1993). The concept of ‘molecular 
mimicry’ is gathered from these observations, which imply the sharing of homologues 
epitopes between bacterial LPS and ganglioside surface components of peripheral nerves, 
particularly on the axolemma. It was supposed that, because of these molecular analogies, 
antibodies that are produced to attack bacteria could also attack neuronal axons, leading to 
GBS. 
The immune response is generated by a specific immune recognition which involves T-
lymphocytes, monocytes, and various cytokines responsible for causing the demyelination 
(Fig. 1.4). Recent studies also established the relevant role of macrophages in immune-
mediated nerve damage, which are essential in both the effector phase of the disease and 
initiating the repair phase (Hartung & Toyka, 1990) (Baichwal et al, 1988). Previous studies 
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also demonstrated that human monocytes can phagocytose Campylobacter species in vitro 
and that C. jejuni, ingested by human macrophages, convert to a coccal form (Kiehlbauch et 
al, 1985). 
Moreover, in the last 10 years, cell sorting investigations (Van Rhijn et al, 2002) revealed that 
Campylobacter DNA was present in CD14
+
 and CD33
+
 populations, indicating that 
myelomonocytic cells are Campylobacter DNA-carrying cells. A possible explanation was 
that although ingested bacteria could be killed by monocytes, bacterial DNA is resistant to 
degradation and persists within the cells, without causing clinical symptoms, in a viable but 
non culturable form (Hickey et al, 2005). 
 
 
Fig. 1.3: Molecular mimicry and antiganglioside antibodies are at the base of the 
immunopathogenesis of GBS.  (van den Berg et al, 2014). 
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Fig. 1.4 Monocyte functions. Monocytes and T-cells are critical to the host response to acute 
bacterial infection but monocytes are primarily viewed as amplifying the inflammatory signal. 
Although monocytes are specialized in defense against pathogens, C. jejuni elaborated CDT 
dependent and independent mechanisms to survive in human monocytic cells. (Image created 
by Gianna Di Sario) 
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1.5 Molecular basis of C. jejuni pathogenesis  
To date bacterial factors implicated in host cell invasion and disease pathogenesis are: 
lipooligosaccharides, capsule, flagellar apparatus, cytolethal distending toxin (CDT) and post-
translational glycosylation system (O-linked and N-linked glycosylation). 
 
1.5.1 Lipooligosaccharides 
In Gram-negative bacteria a main component of most outer membranes is the 
lipopolysaccharide (LPS). It has crucial roles in protection of bacteria from harsh 
environments and toxic compounds (Dong et al, 2014). LOS is analogous to the 
lipopolysaccharide (LPS) found in other Gram-negative families; LPS is made up of an O-
polysaccharide chain, core oligosaccharide and a lipid A component in the outer membrane. 
LOS, lacking an O-polysaccharide repeating structure, is a low molecular weight form of 
bacterial LPS (Gilbert et al, 2008). They have a role in adhesion, invasion and colonisation of 
host and intestinal niches, protection from complement-mediated killing and surviving in 
different non-intestinal environments (Guerry et al, 2002) (Karlyshev et al, 2005). LOS are 
highly variable structures and C. jejuni uses this variability as an expedient for avoiding host 
defences and adapting to different microenvironments. LOS are also capable of mimicking 
human antigens (Guerry & Szymanski, 2008). In particular, molecular mimicry of C. jejuni 
LOS with gangliosides in nervous tissue induces the generation of cross-reactive anti-
ganglioside antibodies resulting in GBS and Miller Fisher syndrome (see 1.4.1) (Ang et al, 
2004). Indeed, it was demonstrated that specific types of the C. jejuni LOS biosynthesis gene 
locus are clearly associated with immune-mediated neuropathy and with the presence of 
ganglioside-mimicking structures in LOS (Godschalk et al, 2004).  
It is well known that membrane CD14 molecule is involved in LPS-induced cytokine 
production in human blood cells (Alexander & Rietschel, 2001) (Landmann et al, 1996). 
CD14 is a 55-kDa glycoprotein, which is mainly expressed on mature monocytes, 
macrophages and activated granulocytes. It is a myeloid membrane glycoprotein which serves 
as a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein (LBP) 
(Heinzelmann & Bosshart, 2005). The specific cellular recognition of agonistic LPS/lipid A is 
initialized by the combined extracellular actions of LBP, the membrane-bound or soluble 
forms of CD14 and the newly identified Toll-like receptor 4 (TLR4) *MD-2 complex, leading 
to the rapid activation of an intracellular signaling network. Moreover, it is well known that 
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CD14 molecule is involved in a CD14-dependent phagocytosis that monocytes use to 
phagocytose Gram-negative bacteria (Neu et al, 2013).  
 
1.5.2 Capsule 
Capsular polysaccharides (CPSs) are commonly present on bacterial surface and play an 
important role in bacterial pathogenesis, survival and persistence (Llobet et al, 2008). 
Although capsule might be crucial for successful adhesion to epithelial cells, it does not 
provide protection against host innate defence and the potent antimicrobial action of human β-
defensins 2 or 3 (Zilbauer et al, 2005). As elucidated during sequencing of the shotgun library 
of NCTC11168 (Karlyshev et al, 1999) and in subsequent studies (Gundogdu et al, 2007) 
(Guerry et al, 2012), capsule components are codified by genes that are split in three different 
regions: the first and the last regions comprise kps genes, that encode the KpS proteins 
involved in capsular assembly and transport; whereas the central region is highly variable and 
is involved in polysaccharide synthesis. Therefore, CPSs are involved in structural variation, 
mimicry to host antigens, and resistance to phagocytosis and complement-mediated killing.  
 
1.5.3 Flagella 
Campylobacter motility is mediated by a single unsheathed flagellum that can be contained at 
one or both poles.  Flagella represent the primary adherence factor that creates contact 
between eukaryotic cell membrane and specific bacterial-invasion factors (Hu et al, 2008). 
Flagellar motility is vital to many aspects of C. jejuni biology, including motility, host 
colonization, virulence in ferret models, secretion and host-cell invasion. This apparatus 
allows C. jejuni to colonize both human and animal host cells (Wassenaar et al, 1993). A 
correlation between the presence of intact flagellum and the ability of C. jejuni to adhere and 
invade host cells was demonstrated in the last 20 years (Grant et al, 1993)  (Konkel et al, 
2004). Flagella are also involved in: secretion of virulence proteins, autoagglutination (AAG), 
microcolony formation and avoidance of the innate immune response (Guerry, 2007). 
Structurally, flagella are composed of a major flagellin, FlaA, and a minor flagellin, FlaB, that 
are both approximately 59 kDa in size and are highly homologous. flaA and flaB genes are 
respectively regulated by σ28 (encoded by fliA) and a σ54-dependent promoter (encoded by 
rpoN). Mutation of flaA results in the production of a truncated flagellar filament composed 
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of FlaB and having a severe reduction in motility. On the contrary, mutants in flaB have no 
significant changes in motility and produce a flagellar filament that appears structurally 
normal (Nuijten et al, 1990). 
 
1.5.4 The cytolethal distending toxin 
CDT is a heterotrimeric holotoxin produced by a diverse group of Gram-negative pathogenic 
bacteria, belonging to the subclass of AB2 toxin superfamily. As in the case of other AB 
toxins, CDT comprise three subunits, CdtA, CdtB, and CdtC (Ge et al, 2008).  
The A subunit of the toxin, CdtB, is an enzyme, with an average molecular size of 29 kDa, 
that exhibits cation-dependent metalloenzyme activities, in vitro, characteristic of 
endonucleases (Elwell & Dreyfus, 2000; Lara-Tejero & Galan, 2000), inositol polyphosphate 
5-phosphatases (Dlakic, 2001) and sphingomyelinases (Hofmann et al, 2000). The B 
component consist in two heterogeneous subunits, CdtA (23 kDa) and CdtC (21 kDa). CdtA 
and CdtC act as carriers to deliver the catalytic subunit, CdtB, into host cells (Smith & 
Bayles, 2006). CdtB reaches the nucleus by an endoplasmic reticulum-associated degradation 
(ERAD) or non-ERAD pathway (followed by translocation across the nuclear membrane) 
where exhibits DNase I-like activity and induces limited DNA damage such as double-strand 
damage, leading to the activation of DNA repair responses and cell cycle arrest at the G2/M 
phase (Canonico et al, 2014; Lara-Tejero & Galan, 2001)  
The importance of the CdtB is clearly demonstrated in the case of Salmonella typhi that, 
lacking the genes for CdtA and CdtC, can translate only the CdtB protein. It was proposed 
that S. typhi synthesizes and secretes CdtB once it has reached an intracellular compartment of 
the host cell (Haghjoo & Galan, 2004). To interact with the target cells, the A subunit, that 
imparts biological activity to the holotoxin, is likely translocated across the plasma membrane 
of the target cells through a receptor-mediated process. In addition, a second important 
element is thought to be important for the binding of CDT to a specific area of the host 
membrane: it is known as lipid raft (see Lipid rafts section).  
In the last 15 years different authors (Guerra et al, 2005) (DiRienzo, 2014) (Gargi et al, 2013) 
suggested a novel model system through which all CDTs are trafficked in a retrograde manner  
from the cell membrane to Golgi and endoplasmic reticulum to translocate to cytosolic targets 
and nucleus. More studies will be required to better define the nature of this process for C. 
jejuni CDT. 
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1.5.5 Glycosylation system 
C. jejuni possesses two protein-glycosylation systems: The N- linked glycosylation system, 
which modifies serine or threonine residues, and the O- linked glycosylation system, which 
modifies asparagine residues (Young et al, 2007).  
N-linked glycosylation machinery of C. jejuni is encoded by a single gene cluster of 16 kb 
named pgl cluster (protein glycosylation) (Szymanski et al, 1999). The first N-linked 
oligosaccharyltransferase identified in bacteria was PglB, a key enzyme in the pgl locus.  
Although N-linked glycosylation system is conserved in all C. jejuni strains studied to date, 
its role in C. jejuni biology is not clear and has to be better investigated.   
It was demonstrated a correlation between N-linked glycosylation system and bacterial 
virulence. Different C. jejuni glycosylation mutants, that were deficient in their ability to 
glycosylate certain proteins, showed reduction in adhesion and invasion of human intestinal 
epithelial cells in vitro and colonization of the chick gastrointestinal tract (Karlyshev et al, 
2004) (Kakuda & DiRita, 2006). In according to recent studies (Larsen et al, 2004) this 
system might be also involved in the evasion of the immune system.  
Structure of N-linked glycan was clarified by mass spectrometry and NMR spectrometry 
analyses that revealed that this glycan is a heptasaccharide with the following structure: 
GalNAc-a1,4-Gal- NAc-a1,4-(Glcb1,3)GalNAc-a1,4-GalNAc-a1,4-Gal- NAc-a1,3-Bac-b1,N-
Asn, where Bac is bacillosamine, 2,4-diacetamido-2,4,6-trideoxyglucose (Knauer & Lehle, 
1999) 
In contrast to the N-linked system, the genetic locus of the O-linked system is more 
heterogeneous and genetically diverse (Champion et al, 2005); the putative flagellar 
glycosylation locus of C. jejuni NCTC 11168 contains ∼50 genes, among which are the genes 
encoding the flagellin structural proteins FlaA and FlaB. O-linked glycosylation is crucial for 
successful flagellin assembly and motility, therefore influencing adhesion, invasion and 
virulence in vivo  (Thibault et al, 2001). Defects in O‑linked glycosylation result in: loss of 
motility, decrease in the adherence to and invasion of host cells, and decreased virulence in 
ferrets (Guerry et al, 2006). O‑linked glycosylation of flagellin is necessary for the proper 
assembly of the flagellar filament, which has led to the hypothesis that the O‑glycan might 
have a role in the interactions of flagellin subunits with one or many elements of the flagellar 
apparatus.  
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1.6 The outer membrane vesicles (OMVs) 
OMVs have emerged as pathogenic nanoparticles that can travel beyond the mucosa to distant 
locations within the host, with the ultimate goals of causing cellular destruction, promoting 
bacterial survival and facilitating the development of pathogenesis in the host (Pathirana & 
Kaparakis-Liaskos, 2016) (Fig. 1.5). 
OMVs are blebs generated from the outer membrane of the cell envelope of all Gram-
negative species of bacteria studied to date (Amano et al, 2010). They are typically 20-200 nm 
in diameter, and are released only by viable cells during the course of normal metabolism and 
in all cell growth phases in all environmental conditions studied (Bonnington & Kuehn, 
2014). These nanostructures contain outer membrane proteins, phospholipids, 
lipooligosaccharides (LOS), and numerous periplasmic proteins of wide molecular mass range 
(Mashburn-Warren et al, 2008). 
Once the OMVs are free from the bacterium, they appear as small membrane vessels 
including periplasmic constituents and outer membrane components. In the last decade, 
OMVs are increasingly recognized as key determinants for bacterial virulence (Kulp & 
Kuehn, 2010) and play a major role in host-pathogen interactions, including the trafficking 
and eventual release of diverse virulence factors from many pathogenic bacteria (Ellis & 
Kuehn, 2010). Recently, it was reported that the C. jejuni wild type strain 81-176 produces 
OMVs that contain biologically active CDT: during pathogenesis, release of OMVs by C. 
jejuni is a route of this bacterium to deliver all CDT subunits to the surrounding environment, 
infecting host cells and causing the typical cytolethal distending effects in vivo and in vitro 
(Lindmark et al, 2009). Several roles were attributed to OMVs: they may act as delivery 
vehicles for bacterial toxins lacking typical signal sequences (Balsalobre et al, 2006; 
Kouokam et al, 2006), promote cell-cell communication via transit of signaling molecules 
(Mashburn & Whiteley, 2005), and can inhibit phagosome-lysosome fusion during 
macrophage infection (Fernandez-Moreira et al, 2006). OMVs are also potentially rich in 
antigens that serve as initial targets for innate and adaptive immune recognition (Bergman et 
al, 2005). OMVs may also have defensive roles during infection, by sequestering antibiotics 
and antibodies, as well as acting as decoy antigens to divert the attention of the immune 
system away from the invading bacteria (Ellis & Kuehn, 2010) (Chattopadhyay & 
Jaganandham, 2015). Moreover,  Elmi et al. demonstrated that apart from CDT, OMVs 
secreted by C. jejuni delivered also other virulence-associated C. jejuni proteins (Elmi et al, 
2012). 
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Fig. 1.5 Atomic force micrographs of (A) a C. jejuni strain 81-176 cell (Bar: 1 µm) and of (B) 
OMVs on the surface of a C. jejuni cell (Bar: 100 nm). (C) Electron micrograph of OMVs 
isolated from C. jejuni strain 81-176 (arrows indicate OMVs) (Bar: 100 nm) (Lindmark et al, 
2009). 
 
It was hypothesized that OMVs produced by Gram-negative bacteria can invade host cells 
through four different routes. These routes can require clathrin coated pits, formation of 
caveolae, and using of lipid rafts or direct membrane fusion (Fig.1.6).  
Recent research within the field have identified mechanisms whereby OMVs interact with 
host cells to mediate inflammation and immunity have been studied by several authors 
(Pathirana & Kaparakis-Liaskos, 2016). OMVs from different pathogens including H. pylori 
(Ismail et al, 2003) C. jejuni (Elmi et al, 2012) and E. coli (Kaparakis-Liaskos & Ferrero, 
2015) have shown to trigger the production of a range of proinflammatory molecules, such as 
interleukin-8, in human epithelial cells resulting in modulation and control of proliferation (Li 
et al, 2015b), apoptosis, (Mondal et al, 2016) and immune response. 
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Fig. 1.6 O' Donoghue et al. demonstrated that OMVs produced by Gram-negative species 
enter host cells by several different pathways. OMVs entry can be impaired by the use of 
inhibitors against components of these pathways such as chlorpromazine, papain, monensin-
ionophore, monodansylcadaverine,  dynasore, methyl‐β cyclodextrin, filipin and nystatin; 
wortmannin, wiskostatin, cytocholasin D (O'Donoghue & Krachler, 2016).  
 
1.7 C. jejuni-host cell interactions  
Bacterial pathogens, especially those with an intracellular life cycle, have shown to be able to 
manipulate the human host cell to ensure their own survival. Cytoskeletal rearrangements, 
induction of anti-apoptotic pathways and control of the host cell cycle are all used to benefit 
bacterial infection and growth (Siegl & Rudel, 2015) 
C. jejuni infection is a multistep process that includes colonization of the intestinal mucosa 
and interactions with and invasion of the human intestinal epithelial cells (IECs) (Young et 
al., 2007). Bacterial factors such as motility, glycosylation and capsule are involved in C. 
jejuni internalization (Szymanski et al, 2002) (Bacon et al, 2001); mutations in these 
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pathways lead to deficiencies in ability to adhere to and invade host human and animal cells 
(Hendrixson & DiRita, 2004; Morooka et al, 1985; Watson & Galan, 2008). 
C. jejuni entry process appears to utilize the host-cell cytoskeleton as observed in many other 
bacterial pathogens such as Listeria monocytogenes, Shigella flexneri and Salmonella 
typhimurium (Cossart & Sansonetti, 2004). Unlike these reported bacteria, a recent study 
suggested that C. jejuni is internalized into human intestinal epithelial cells through a 
microtubule-dependent, actin-independent fashion.  
Different strategies are adopted by bacteria in order to survive and replicate within host cells. 
As a matter of fact, different behaviours can be adopted by C. jejuni when invade either 
phagocytic or non-phagocytic eukaryotic cells. Therefore, C. jejuni internalization proceed to 
specific routes depending on the intracellular environment. 
Robert O. Watson et al. reported that C. jejuni survives within intestinal epithelial cells by 
deviating from the canonical endocytic pathway; the bacterium showed the ability to avoid its 
delivery to lysosomes, where invading bacteria are commonly killed, shortly after 
internalization (Watson & Galan, 2008). In epithelial cells, C. jejuni is able to construct an 
intracellular niche known as Campylobacter-containing vacuole (CCV). C. jejuni can modify 
the CCV to suit its metabolic needs and survive. CCVs are distinct from lysosomes and are 
functionally separated from the canonical endocytic pathway; indeed, they are not accessible 
to endocytic tracers (Watson & Galan, 2008). It was also hypothesized that C. jejuni 
internalization is caveolin-1 dependent. A caveolin-1-stabilized lipid membrane may be 
required for a proper signaling through tyrosine kinases, which are also required for C. jejuni 
internalization rather than for endocytosis. As a matter of fact, efficient signaling through 
receptor tyrosine kinases requires lipid rafts or caveolae (Helms & Zurzolo, 2004) (Simons & 
Toomre, 2000). In addition, CCVs showed to contain  LAMP-1 (lysosomal-associated 
membrane protein-1), an endocytic marker, that marks the end stage, when late endosomes 
are fused with lysosomes (Eskelinen, 2006). At the final stages of endocytosis, to degrade 
bacteria endolysosomal vesicles are formed in eukaryotic cells (Hamasaki & Yoshimori, 
2010; Huang & Brumell, 2009) 
On the contrary, C. jejuni seems not to be able to deviate this system in professional 
phagocytes like macrophages, which are specialized to engulf and rapidly kill bacteria 
(Kiehlbauch et al, 1985; Wassenaar et al, 1997), but contradictory papers are present in 
literature about this issue. Despite of the phagocytic activity of macrophages, it was supposed 
that C. jejuni was able to infect and utilizes monocytes for its spreading in humans and 
animals (Hickey et al, 2005). Hickey TE et al. showed that C. jejuni 81-176 was capable of 
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extensive replication within human monocytic cell vacuoles and induced apoptotic death by 
means cytolethal distending toxin. Michael A. Jones et al. also confirmed that monocytes and 
macrophages are important cell types with which C. jejuni interacts in mammals (Jones et al, 
2003). These might be relevant in perpetuating the inflammatory disease because it has been 
shown that C. jejuni can persist within peripheral blood monocytes for up 7 days (Kiehlbauch 
et al, 1985). Moreover, monocytic cells could be important contributors to the induction and 
maintenance of gut inflammation because express a range of cell receptors such as CD14 and 
CD11a, which are involved in cell signaling in response to different bacterial pathogen-
associated molecular patterns (Galdiero et al, 2001). 
In addition, previous studies reported that monocytes play an important role in the control of 
immune-related diseases like GBS. Once in circulation, they can migrate into the tissues and 
have the potential to differentiate into macrophages or particular types of dendritic cells.  
Taken together, these data confirm that C. jejuni can survive intracellularly in both intestinal 
cells and monocytes, even though more studies are needed to investigate the relationship 
between C. jejuni and monocytes. Understanding C. jejuni ability to modulate the cellular 
environment is key in understanding its ability to cause disease.  
 
Lipid rafts 
Lipid rafts are self-organized parts of the lipid bilayer of eukaryotic cells, enriched in 
sphingolipids, cholesterol and proteins, that represent sub compartments that serve as 
stabilized platforms for specific biological functions in eukaryotic cells. Hence, the integrity 
of lipid rafts is important for the correct functionality of trafficking, signaling cascades and 
other cellular processes (Michel & Bakovic, 2007). 
Bacteria can cross epithelial barriers via a transcellular route by exploiting lipid rafts. Bacteria 
endocytosed via this route appear to avoid lysosomal fusion (Zaas et al, 2005), hence 
deviating the classical endocytic pathway generally used by cells to kill invading 
microorganisms.   
OMVs have been shown to deliver bacterial virulence factors into host cells by fusion with 
the host cell plasma membrane or via receptor-mediated endocytic pathways (Ellis & Kuehn, 
2010) (Kulp & Kuehn, 2010). Different bacterial pathogens, including E. coli (Kesty et al, 
2004), H. pylori (Kaparakis et al, 2010) and P. aeruginosa (Bomberger et al, 2009), produce 
OMVs that are able to bind lipid rafts. Binding of OMVs to lipid rafts has been reported also 
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for C. jejuni, which seems to be able to deliver its virulence factors by OMVs into human 
IECs (see 1.6). 
In blood cells as well, in particular T cells, lipid rafts can be involved in bacterial invasion; 
depending on the differentiation status of T cells, lipid rafts seclude various protein receptors 
involved in cell signaling, cytoskeleton reorganization, membrane trafficking, and the entry of 
infectious organisms into the cells (Thomas et al, 2004).  
 
The Endoplasmic reticulum 
The ER is a large membrane-bound organelle that ensures intra- and inter- molecular 
disulphide bond formation, protein N-linked glycosylation, Ca
2+
 storage, and lipid 
biosynthesis. These components are subsequently delivered to their destination compartments, 
which include the ER itself, the Golgi apparatus, the plasma membrane, the extracellular 
milieu, or the endocytic and autophagic pathways.  ER functions are highly interconnected 
and perturbation in one directly affects the others (Bettigole & Glimcher, 2015). The ER is 
composed of a series of continuous membranes organized into subdomains that include the 
rough-, smooth- and transitional-ER, and the nuclear envelope. The rough ER, which is 
mainly laminar, is associated with polyribosomes for protein synthesis and Ca
2+
 signaling. 
The smooth ER is primarily composed of tubular structures providing the site of lipid 
biosynthesis, has a main role in Ca
2+
 
 
signaling, and is referred as the chief point of contact 
with other organelles (Park & Blackstone, 2010). For its role in secretory pathways and its 
biosynthetic functions, the ER stands as a nutrient-rich intracellular location that is 
presumably devoid of bactericidal functions, such as antimicrobial peptides or hydrolytic 
enzymes, representing a suitable niche for the intracellular survival, persistence and 
proliferation of intracellular bacterial pathogens. 
ER plays also a crucial role in cellular homeostasis by modulating processing and folding of 
secretory membrane proteins. When protein folding in the ER is compromised or protein 
folding requirements exceeds, unfolded or misfolded proteins accumulate and induce ER 
stress. ER stress leads to the activation of the unfolded protein response (UPR), an 
evolutionary conserved cytoprotective signalling pathway, to restore normal ER functioning 
(Schroder & Kaufman, 2005) (van Schadewijk et al, 2012). 
The UPR can be directly activated by certain secreted bacterial virulence factors, such as pore 
forming toxins (Bischof et al, 2008), subtilase cytotoxin (Wolfson et al, 2008) and cholera 
toxin (Cho et al, 2013) (Table 1.1). These toxins induce UPR by activating UPR mediators 
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directly. Microorganism-mediated UPR modifications therefore tune the quality and the 
magnitude of the immune response. On the contrary, bacteria like Legionella pneumophila 
modulate the cellular environment by suppressing the UPR via multiple mechanisms (Treacy-
Abarca & Mukherjee, 2015). L. pneumophila is a Gram negative intracellular bacteria that can 
survive and replicate within eukaryotic cells; this ability is essential for its virulence. 
 
 
Table 1.1 At present, it has been found that UPR can be directly activated by many secreted 
bacterial virulence factors (Celli & Tsolis, 2015). 
 
Bacterial interactions with the UPR are intricate. Recent findings support that UPR is a key 
component of the crosstalk among ER, intracellular bacteria and their pathogenic activities.  
Bacteria may adapt to live in the ER resulting in UPR subversion that promotes the 
proliferation of intracellular bacterial pathogens; meanwhile, UPR may contribute to 
inflammatory and immune responses against invading bacteria. Modulation of ER functions 
during infection can promote bacterial infection by providing a replicative niche, but at the 
same time the resulting disruption of the secretory pathway can provide a pattern of 
pathogenesis that aids the innate immune system in recognizing intracellular infection and in 
mounting an appropriate defence. However, considering the more rapid evolution of bacterial 
pathogens compared to their hosts, it is likely that bacteria have evolved to modulate the UPR 
to their advantage during infection (Celli & Tsolis, 2015) 
UPR modulates genes required for protein folding, protein degradation, glycosylation, 
lipogenesis, Ca
2+
 signalling and autophagy in order to correct the offending agent that trigger 
the ER stress. Biochemically, UPR is mediated by three ER stress receptors: protein kinase 
RNA-like ER kinase (PERK), inositol-requiring protein-1 (IRE-1) and activating transcription 
factor-6 (ATF6). 
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During steady state, all these ER stress receptors are maintained in an inactive state through 
their association with the ER-chaperone protein GRP78 (BiP). Having BiP higher affinity for 
misfolded proteins than for UPR mediators, under stress conditions, BiP dissociates from 
IRE-1, PERK and ATF6, leading to their activation and initiation of the UPR (Fig.1.7).  
Activation of IRE-1, PERK and ATF6 initiates signalling pathways of the UPR to restore 
homeostasis in the ER, via increasing the production of chaperones to assist in protein 
folding, arresting translation of proteins not involved in resolving ER stress, and degradation 
of misfolded proteins via the ER-associated degradation (ERAD) pathway.  
ERAD is the process by which misfolded or unassembled proteins are destroyed in eukaryotic 
cells. This complex system involves recognition of degradation signals, dislocation of 
proteins across the ER membrane and degradation by the ubiquitin-proteasome system in the 
cytoplasm. 
Dissociation of BiP from PERK leads to autophosphorylation and thereby PERK activation. 
Activated PERK phosphorylates the α subunit of eukaryotic transcriptional initiation factor 
(eIF2α), resulting in the inactivation of eIF2α and translational attenuation by interfering with 
5’-cap assembly (Harding et al, 1999) (Harding et al, 2000), which prevents further 
accumulation of unfolded proteins in the ER (Luchetti et al, 2017). General translational 
inhibition results in an increase in cap-independent translation, facilitating the accumulation 
of the transcription factor ATF4 (Vattem & Wek, 2004). Afterward, ATF4 transcriptionally 
upregulates the transcription factor C/EBP homologous protein (CHOP) (Ma et al, 2002), 
which has been shown to modulate apoptosis in different cellular stress conditions.  
The second arm of the UPR is initiated by ATF6. Dissociation of BiP from ATF6 leads to 
translocation of ATF6 to the Golgi complex where it is cleaved by site-1 and site-2 proteases 
into an active transcription factor. The resulting cytoplasmic fragment liberated from the 
membrane enters the nucleus resulting in transcriptional activation of its target genes 
(Yoshida et al, 2000) (Yoshida et al, 2001), such as BiP, CHOP and X-box binding protein 
(XBP1). In this manner ATF6 indirectly regulates autophagy and apoptosis via XPB1 and 
CHOP (Song et al, 2017). 
IRE1α is a multifunctional protein that possesses kinase and endonuclease activities. 
Dissociation of BiP from the luminal domain of IRE1α leads to its homodimerization and 
autophosphorilation which triggers the excision of 26 base pairs from the XBP1 mRNA, and 
subsequent mRNA relegation causes a translational reading frame shift yielding the highly 
active transcription factor known as XBP1s (Calfon et al, 2002). XBP1s forms a heterodimer 
with pATF6(N) and binds to the enhancer element called the UPR element, resulting in the 
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transcriptional activation of ERAD genes such as HRD1, EDEM and Derlins (Lee et al, 
2003), leading to transcription of ER-chaperone proteins. The splicing of XBP1 mRNA is 
considered to be an ER stress marker. The IRE1α-signalling axis is the most highly conserved 
branch of the UPR, it is present across species from yeast to humans. 
All these three branches work cohesively to correct ER stress but can also lead to apoptosis 
under unresolvable stress conditions. ATF4, XBP1 and ATF6 direct a transcriptional program 
that upregulates chaperones, components of the ERAD pathway, and factors involved in 
autophagy and apoptosis that act to restore cellular homeostasis or, if the ER dysfunction 
cannot be resolved, initiate programmed cell death (Celli & Tsolis, 2015). 
XBP1 and ATF6 support the ER folding capacity by upregulating chaperones, glycosylases, 
ERAD components, intracellular support machinery and protein disulphide isomerases. 
Moreover, Xbp1/IRE1α may limit the influx of proteins into the ER by degrading ER-
localized mRNA. In a parallel branch, PERK stops protein synthesis to allow time for the ER 
to correct existing misfolded proteins, while downstream its target genes induce an 
antioxidant response to oppose ROS production generated by iterative protein folding cycles. 
Temporal and branch-specific UPR control is crucial for determining adaptation versus 
survival (Lin et al, 2007): indeed, depending on the stress conditions either prosurvival IRE1 
or PERK remain activated.  Successful neutralization of the instigating stress results in cell 
survival, whereas the outcome for failure is cell death. 
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Fig. 1.7 UPR mediators are held inactive by BiP protein, but under stress conditions, BiP 
dissociates from these three mediators, leading to their activation (Bettigole & Glimcher, 
2015). 
 
The UPR can be induced in vitro by chemicals such as Thapsigargin and Tunicamycin. 
Thapsigargin blocks the ER Ca
2+
 ATPase pump causing ER Ca
2+
 store depletion, and 
Tunicamycin blocks N-linked glycosylation of proteins. These two chemicals, leading to high 
levels of stressors, rapidly activate all three components of UPR (Rutkowski & Kaufman, 
2004) 
The effective immunity depends on ER homeostatic processes such as Ca
2+
 signalling, 
metabolism of lipids, glycosylation and oxidative protein folding. These same pathways, 
which are required to support the immune system functioning, are modulated by UPR. For 
instance, lipid metabolism has a central role in immune cell function. Membrane fluidity 
regulates lipid rafts formation, which are also crucial in C. jejuni infection, receptor clustering 
and signalling dynamics. IRE1 and PERK can directly induce biosynthesis of fatty acids, 
phospholipids and cholesterol, likely to safeguard intracellular membrane homeostasis.  
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Protein glycosylation has also an important role in the immune system by regulating cell-
trafficking, surface receptors dynamics and apoptosis. 
Autophagy is a key immunological process charged with degrading proteins aggregates, 
damaged organelles and intracellular pathogens (see 2.2). It facilitates antigen processing and 
presentation on both MHC-I and MHC-II, capturing and killing of intracellular microbes, 
efferocytosis, production of type I interferon and cell survival and differentiation. Chemical 
ER stress can induce autophagy via IRE1 and PERK pathways (Ogata et al, 2006); in vivo 
other UPR components may be involved.  
 
2. Mechanisms of cell death  
While philosophers seek the meaning of life, cell biologists are becoming ever more 
interested in the meaning of death (Savill & Fadok, 2000). Early and last papers about cell 
death distinguish three distinct mechanisms of programmed cell death that are named 
apoptosis, autophagy and necrosis (Fuchs & Steller, 2015). 
Apoptotic and autophagic events are going to be described below (see 2.1 and 2.2). Necrosis 
is characterized by organelle and cellular swelling, rupture of the plasma membrane and 
release of the intracellular content (Vanden Berghe et al, 2014). The necroptosis is a non-
apoptotic mode of cell death that is elicited by TNF receptor 1 (TNFR1) when caspases are 
inhibited (Degterev et al, 2005); necroptosis has often been regarded as synonymous with 
regulated necrosis (Galluzzi et al, 2014). 
The functional relationship between apoptosis ('self-killing') and autophagy ('self-eating') is 
intricate in the sense that, under certain circumstances, autophagy constitutes a stress 
adaptation that avoids cell death (and suppresses apoptosis), whereas in other cellular settings, 
it constitutes an alternative cell death pathway. Depending on the upstream signals and the 
different instances, cells activate one or both of these responses; they can combine them or 
switch between the two responses in a mutually exclusive manner (Maiuri et al, 2007). 
 
2.1 Apoptosis  
Previous papers reported that CDT causes cell cycle arrest and cell death in a range of target 
cells (Canonico et al, 2014; Shenker et al, 2001; Svensson et al, 2001), upon cell cycle arrest 
DNA repair occurs and cell apoptosis results. Apoptosis has since been recognized and 
accepted as a distinctive and important mode of “programmed” cell death, which involves the 
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genetically determined elimination of cells. It occurs normally during development and aging 
and as a homeostatic mechanism to maintain cell populations in tissues. It is also thought that 
apoptosis is a defense mechanism such as in immune reactions or when cells are damaged by 
disease or noxious agents (Norbury & Hickson, 2001). Apoptosis marks unwanted cells with 
'eat me' signals that are going to be recognized by phagocytes which mediate their engulfment 
and degradation (Savill & Fadok, 2000). 
In the last decade, many apoptotic cascades have been described with the attempt to 
categorize all signal transduction pathways that lead to cell death, such as intrinsic and 
extrinsic, mitochondrial and death receptor (DR), p53-dependent and -independent, and 
caspase-dependent and -independent pathways in association with initiation, commitment, and 
execution phases (Ashe & Berry, 2003). 
Apoptotic event is a highly conserved process, firstly studied on Caenorhabditis elegans 
(Horvitz, 1999). In biochemical terms, two distinct phases in apoptosis can be recognized, the 
initiation and execution phase. In accord with the source of the triggers, that can be 
extracellular or intracellular, intrinsic and extrinsic mechanisms of initiation can be defined. 
For these reasons, apoptosis can be classified in intrinsic and extrinsic pathways. Intrinsic 
pathway can be triggered by intracellular signals, for example by DNA damage, and involves 
specifically mitochondria; whilst the extrinsic pathway can be triggered by extracellular 
signals, for example, by growth factor withdrawal, steroid hormones, ligation of death 
receptors. Both these apoptotic cell death systems are mediated by molecular pathways that 
culminate in the activation of a family of cysteine proteases, known as the caspases, which 
orchestrate the dismantling and clearance of the dying cell. Activated caspases generate a 
cascade of proteolytic and nucleolytic events that amplify the initial signal (the execution 
phase). However, different studies indicate that a cell that has been treated with an apoptotic 
inducer can also initiate a suicide programme that does not rely on caspase activation (Chipuk 
& Green, 2005); therefore apoptotic cell death can be distinguished in caspase-dependent and 
caspase-independent apoptosis. 
Light and electron microscopy have identified the various morphological changes that 
develops during apoptosis. During the early process it is possible to observe cell shrinkage 
and pyknosis by light microscopy; in this stage, cells are smaller in size, the cytoplasm is 
dense, the organelles are more tightly packed, and the chromatin is condensate.  Then, 
extensive plasma membrane blebbing occurs followed by karyorrhexis and separation of cell 
fragments into apoptotic bodies during a process called “budding.” During this process the 
organelle integrity is still maintained and an intact plasma membrane encloses all the 
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intracellular content. After execution phase, these bodies are subsequently phagocytosed by 
macrophages, parenchymal cells, or neoplastic cells and degraded within phagolysosomes.  
Unlike necrosis, this programmed cell death does not cause inflammatory reactions because 
apoptotic cells are rapidly phagocytosed avoiding the release of the intracellular content and 
anti-inflammatory cytokines are not produced by engulfing cells (Kurosaka et al, 2003). 
Phagocytosis is due to the expression of cell surface markers that result in the early 
phagocytic recognition of apoptotic cells by adjacent cells. This is achieved by the movement 
of the normal inward-facing phosphatidylserine of the cell’s lipid bilayer to expression on the 
outer layers of the plasma membrane (Bratton et al, 1997). 
Although externalization of phosphatidylserine is a well-known recognition ligand for 
phagocytes on the surface of the apoptotic cell, recent studies have shown that also other 
proteins, such as Annexin I and calreticulin, could be as important as phosphatidylserine. 
Annexin V is a recombinant phosphatidylserine-binding protein that interacts strongly and 
specifically with phosphatidylserine residues and is largely used in cytometry, for the 
detection of apoptosis (Arur et al, 2003). 
 
2.1.1 Bcl-2 family proteins 
Bcl-2 family proteins are considered to be key regulators of apoptosis. All family members 
share homology with the archetypal member of the family, B-cell lymphoma-2 protein (Bcl-
2), which contains four Bcl-2 homology domains: BH 1-4. Bcl-2 family proteins can be 
functionally subdivided into anti-apoptotic (Bcl-2, Bcl-XL, Bclw, Mcl-1) and pro-apoptotic 
members. Two subfamilies of pro-apoptotic Bcl-2 family members have been identified: 
‘BH3-only’ family, containing only a catalytic domain BH3 (Bid, Bim, Bik, Bad, Bmf, Hrk, 
Noxa, and PUMA), and ‘multidomain’ family, also named Bax family, containing BH1, BH2, 
and BH3 domains (Bax, Bak e Bok). One of the ‘BH3-only’ protein function is activating the 
multidomain family members Bax and Bak.  
Depending on the prevalence of either pro-apoptotic or anti-apoptotic members, the destiny of 
the cell is decided.  It was demonstrated that Bcl-2 proteins are necessary for the completion 
of apoptotic programs (Wei et al, 2001) (Yin et al, 2002). 
Core members of the Bcl-2 family share structural similarity with the pore-forming domains 
of bacterial toxins, emphasizing the relevance of these proteins to membrane biology 
(reviewed by (Schendel et al, 1998). Several Bcl-2 family proteins insert into intracellular 
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membranes, particularly membranes of mitochondria and endoplasmic reticulum (ER), 
operating as guardians of these organelles. 
Many Bcl-2-family proteins, both anti-apoptotic and pro-apoptotic, have C-terminal 
transmembrane domains that insert in the outer membrane of mitochondria. Pro-apoptotic 
proteins such as Bax and Bak induce mitochondrial outer membrane permeabilization 
(MOMP), causing the release of caspase-activating proteins and other cell death mediators; 
Bax or Bak are necessary for MOMP and for controlling the permeability of mitochondrial 
membranes. Mitochondria induce apoptosis by releasing proteins that participate in caspase 
activation (for example, cytochrome c) and by neutralizing inhibitors of caspases (Reed, 
2002). 
About ER, it was found that overexpression of anti-apoptotic Bcl-2 proteins seem to protect 
cells against cell death induced by ER stress (see The endoplasmic reticulum section), 
whereas pro-apoptotic Bcl-2-family proteins (such as Bax or Bak) are required (Scorrano et 
al, 2003). But how Bcl-2-family proteins regulate ER-initiated cell death mechanisms is 
unclear. 
Bcl-2 family proteins are also present in lysosomes where have a critical role of cell life and 
death mediators. Lysosomes participate to apoptosis and necrosis, and are also critically 
involved in autophagy. Therefore, upon overexpression of either anti-apoptotic or pro-
apoptotic proteins, lysosomes can mediate cell survival or death (Pattingre et al, 2005) 
 
2.1.2 Extrinsic and intrinsic pathway 
Extrinsic pathway is activated by the transduction of the apoptotic signal after the binding of 
death receptors, for example Fas, TNF receptor 1 (TNFR1) and TNF-related apoptosis 
inducing ligand (TRAIL) receptor R1 and R2, to their ligands FasL, TNF and TRAIL. On the 
contrary, the intrinsic pathway of apoptosis is mediated by mitochondria and is regulated by 
the Bcl-2 protein family. In a possible scenario of extrinsic pathway, the binding of Fas ligand 
(FasL) to its receptor Fas leads to the cleavage and activation of pro-caspase 8 to initiator 
caspase 8. This step can be mediated by the adaptor protein Fas-associated death domain 
protein (FADD) and can be inhibited by FADD-like apoptosis regulator (also known as 
FLIP), a catalytically inactive homologue of caspase 8. Subsequently, initiator caspase 8 
cleaves and activates caspase 3 and caspase 7 leading to the degradative phase of apoptosis.  
The intrinsic pathway of apoptosis is regulated by Bcl-2 family proteins (see 2.1.1) ‘BH3-
only’ proteins can either sequester anti-apoptotic proteins, or directly activate the 
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‘multidomain’ proteins, such as BAK and BAX. Once the apoptotic signalling is initiated, 
Bak and Bax induce the release of cytochrome C from the mitochondrion leading to its 
binding to APAF1 and the formation of a complex with pro-caspase 9, known as apoptosome 
that is thought to initiate apoptosis (Rodriguez & Lazebnik, 1999). Activation of caspase 9 in 
the apoptosome in turn induces apoptosis through the activation of caspase 3 and caspase 7.   
An alternative pathway of Fas-induced cell death involves crosstalk between the extrinsic and 
the intrinsic apoptotic pathways. This crosstalk is mediated by the cleavage of Bid that leads 
to the formation of truncated Bid, which interacting with Bak or Bax, is able to modify 
mitochondrial permeability leading to cytochrome C release from mitochondria. Bak or Bax 
expression can also be regulated by p53 (Vousden & Lane, 2007) (Marino et al, 2014) (Fig. 
1.8). 
 
 
Fig. 1.8 Extrinsic and intrinsic apoptotic pathways (Cuda et al, 2016). 
 
2.1.3 pRb, p53 and CD59 
The tumour suppressors pRb (retinoblastoma protein) and p53 are genes which encode for 
products that negatively affect the cell cycle progression thus protecting the cell from the 
accumulation of potentially tumorous mutations. Respectively, to control the cell cycle 
progression, pRb negatively regulates the transcription factor E2F, whereas p53 inhibits the 
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cell growth by up-/down- regulating genes involved in apoptosis, cell cycle, senescence and 
differentiation, DNA repair, transcription and translation as well as cytoskeleton, cell 
adhesion, angiogenesis and migration (Menendez et al, 2009). For these reasons p53 has 
many functions in genomic stability control, apoptosis, metabolism and antioxidant defence 
(Siegl & Rudel, 2015). Apoptosis induction is one of the main tumour suppressor activities of 
p53 (Schmitt et al, 2002). In recent years, numerous bacterial pathogens, such as H. pylori, C. 
trachomatis, S. flexneri and N. gonorrhoeae have been shown to inactivate p53, through 
ubiquitin-proteasome degradation system, to block the protective response of the host cell. 
The degradation of p53 seems to prolong survival of the pathogen’s niche, nevertheless, also 
other ways to modulate p53 were observed in pathogens. Anyway, these evidences support 
the hypothesis that p53 mediates host defence and cell fate during bacterial infection. It was 
also found an association among inflammation, upregulation of p53 levels and CD59 (MIRL) 
(Nalca & Rangnekar, 1998; Sampaziotis et al, 2002) and It was supposed that p53 was a 
direct regulator of the immune response by modulating CD59 levels.  
The GPI-protein CD59 is expressed on the surface of neutrophils, monocytes and erythrocytes 
in order to protect them from the Complement-mediated cell lysis.  
Complement is an important component of innate immunity and modulator of adaptive 
immunity, particularly important for defence against bacterial infections and the efficient 
removal of debris. The membrane attack complex (MAC) is the pore-forming toxin of the 
complement system, a relatively early evolutionary acquisition that confers upon complement 
the capacity to directly kill pathogen, some authors define MAC as a ‘bactericidal missile’ 
(Morgan et al, 2017). The role of CD59 is to inhibit the formation of the MAC. CD59 is also 
involved in the classical endocytic pathway, by facilitating the endocytosis process (Conner & 
Schmid, 2003). For these reasons many pathogens use CD59 as entrance to infect host cells. 
CD59 upregulation might lead to complement inhibition and protection of the bacteria from 
the complement, this could be an optimal expedient for bacteria to prevent the complement 
attack. Recent studies also associated defects in CD59 on blood cells with recurrent GBS 
(Mevorach et al, 2016), suggesting that this molecule might have an important role in 
interaction between bacteria and blood cells and therefore in the onset of GBS. To date, only 
in one paper the relationship between CD59 and C. jejuni is described (Canonico et al, 2014). 
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2.2 Necrosis 
The ability to control/manipulate timing and mode of death in infected host cells plays a 
pivotal role in many microbial infections. Control of cell death by the host can be used to 
manage microbial spread and enhance the induction of immunity; conversely, the 
manipulation of host cell death pathways is exploited by many viral and microbial pathogens 
as part of their life cycle. In contrast to apoptosis, necrosis is marked by rapid loss of plasma 
membrane integrity. Plasma membrane leakage in necrosis is widely thought to occur prior to 
or concomitant with exposure of phosphatidylserines and other ‘eat-me signals’. This early 
rupture of the plasma membrane releases endogenous danger signals or damage-associated 
molecular patterns, which are potent stimulants of inflammation (Butler et al, 2012). A 
necrosis-like form of death has been observed and it demonstrated to allow the release of 
viable bacteria for subsequent re-infection. The necrotic cell death may be an important factor 
in granuloma formation, inflammatory tissue damage and ultimately bacterial transmission. It 
was shown that it can occur through defined biochemical programs and it is negatively 
regulated by caspase activity (Sun & Wang, 2014). 
 
2.3 Autophagy 
Autophagy is a catabolic process involving the degradation of cytoplasmic components, 
protein aggregates and organelles by forming autophagosomes, which are degraded by fusion 
to lysosomes (Mizushima & Komatsu, 2011). Therefore, the vesicles that fuse with lysosomes 
and the sequestered material contained into them is degraded. Monodansylcadaverine (MDC) 
is a specific autophagolysosomes marker typically used to investigate at the molecular level 
the autophagic machinery (Munafo & Colombo, 2001). 
Although in many scenarios autophagy contributes to cell death, it has a protective, pro-
survival function. Some evidences showed that in mice autophagy is an alternative killing 
mechanism which is activated where apoptosis cannot be executed (Lum et al, 2005) 
(Shimizu et al, 2004), other ones indicate that it enable the classic hallmarks of apoptosis, 
such as phosphatidylserine exposure and membrane blebbing, which represent the ‘find-me’ 
and ‘eat me’ signals of the apoptotic process (Qu et al, 2007). 
Autophagy can be induced by several conditions, including starvation, hormone treatment 
(van Sluijters et al, 2000) and stress (Schwartz et al, 1992), and it occurs in several subsequent 
stages. It is involved in cell death and tumour suppression, neurodegeneration, ageing, 
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inflammation, immunity and genome stability. We also know that apart from starvation, 
autophagy is induced by many other perturbations, including hypoxia and metabolic, osmotic 
and oxidative stresses (Farre & Subramani, 2016) 
At first, cytoplasm and various organelles such as endoplasmic reticulum, mitochondria and 
peroxisomes are sequestered by a membrane in order to generate an autophagosome. Nascent 
autophagosomes engender by a structure named phagophore or isolation membrane. In 
mammalian cells, phagophore membranes appear to initiate primarily from the ER in dynamic 
equilibrium with other cytosolic membrane structures, such as the trans-Golgi. Secondly, 
autophagosome fuses with lysosomes and acquires lysosomal membrane proteins and 
enzymes. The sequestered material is finally degraded in vesicles called autophagolysosomes 
or autolysosomes. Material digested during the degradation process is then recycled and 
reabsorbed by the cell. 
Lysosomes are also involved in another degradation process: the lysosomal exocytosis. This 
is defined as a process that a lysosome responds to extracellular stimuli, docks at the interior 
of the cell surface and fuses with the plasma membrane to their contents (Blott & Griffiths, 
2002). Through this process, lysosomes secrete their content within the extracellular space. 
This phenomenon can be detected via translocation of lysosomal membrane proteins, such as 
LAMP-1, on the plasma membrane. In this way, lysosomes fuse with plasma membrane 
through a Ca
2+
 regulated mechanism resulting in the release of the lysosomal content within 
the extracellular space. This process is also important in mechanisms of defence against 
bacterial infections (Roy et al, 2004). 
  
39 
 
Aims and objectives  
The aim of this work was to investigate the effects of C. jejuni virulence factors in human 
cells focusing the attention on cellular pathways that this bacterium might activate or 
deactivate during host cell infection to enhance its invasion and persistence. Among the 
several virulence factors, the CDT was the most investigated. For this purpose, the effects 
induced by three different C. jejuni wild type strains was compared with the effects induced 
by the C. jejuni cdtA mutant strain in three different cell lines: monocytes isolated from 
donor’s blood, tumour myeloid cells (U937) and human intestinal epithelial cells (T84). To 
infect abovementioned cell lines, C. jejuni strains were used in three different forms: as 
bacterial lysates, as OMVs and as whole bacteria. This allowed us to investigate the 
importance of OMVs and whole bacteria during C. jejuni infection. Although it is well known 
that intestinal epithelial cells are typical C. jejuni target cells, much less is known about the 
relationship between C. jejuni and monocytes. This topic was particularly investigated in this 
work since in the last two decades it was assumed a possible critical role of monocytes and 
macrophages in GBS onset.  
The objectives of this work were: 
-Investigating the effects of two wild type strains, C. jejuni ATCC 33291 and C. jejuni ISS 1, 
and a C. jejuni 11168H cdtA mutant strain in human monocytes previously isolated from 
donor’s blood focusing the attention on pro-survival and pro-apoptotic pathways.  
-Investigating the effects of two wild type strains, C. jejuni ATCC 33291 and C. jejuni ISS 1, 
and a C. jejuni 11168H cdtA mutant strain in human tumour myeloid cells (U937), focusing 
the attention on apoptotic and autophagic pathways. 
-Investigating the effects of OMVs previously isolated from C. jejuni 11168H wild type and 
C. jejuni 11168H cdtA mutant strains in U937 cells in order to compare the effects of the 
lysates with the effects of the OMVs in this specific cell line. 
-Investigating the effects of whole cells and OMVs from C. jejuni 11168H wild type and C. 
jejuni 11168H cdtA mutant strain in human intestinal epithelial cells (T84) to study the ER 
stress and UPR activation. 
-The construction of a C. jejuni 11168H cdtA mutant in the GFP strain by using a 
methodology based on the electroporation of a recipient C. jejuni strain with a linear PCR 
fragment carrying an antibiotic resistance cassette and the kanamycin cassette. 
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Materials and Methods 
 
3. Human tumour myeloid cells (U937) and normal monocytes 
3.1 Ethic statement 
PBMCs (peripheral blood mononuclear cells) were isolated from buffy coats of anonymized 
donors obtained from the Transfusion Centre of Urbino Hospital. No specific approval from 
an institutional review board was required for the use of buffy coats for the following reasons: 
(1) no personal patient information was made available; (2) buffy coats could not be used for 
treatment of patients and were waste products for the blood transfusion centre and (3) blood 
donors were verbally informed that parts of the donation that cannot be used for patient 
treatment may be used for scientific research. 
 
3.2 Bacterial strains  
C. jejuni strains Description References 
11168H cdtA mutant 
Isogenic mutant of Cj0079 obtained from 
Campylobacter mutant bank 
http://crf.lshtm.ac.uk/wren_mutants.html 
LSHTM 
mutant bank 
ATCC 33291 
Campylobacter jejuni subsp. jejuni  
(ATCC® 33291™) 
ATCC®, 
U.S.A 
ISS 1 
Campylobacter jejuni subsp. jejuni  
obtained from ‘Istituto Superiore di 
Sanità’ Campylobacter bank. Clinical 
strain isolated from stood specimen of 
patients with gastroenteritis; PCR 
characterized for the presence of the CDT 
virulence genes cdtA, cdtB, cdtC. 
Istituto 
Superiore di 
Sanità, Italy 
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3.3 Growth conditions  
C. jejuni strains were revived from -80 glycerol stocks (see 4.2) by pipetting onto blood agar 
plates containing autoclaved Columbia agar base (Oxoid, U.K) supplemented with 7% 
(vol/vol) horse blood (Oxoid) and Campylobacter Selective Supplement (Oxoid). Strains 
were routinely sub-cultured every 3-4 days up to a maximum of 10 passages. C. jejuni 
cultures were grown in pre-equilibrated Brucella broth (Oxoid) in 50 ml bottles (Duran, 
Germany) with shaking at 120 rpm on a 3005 analogue orbital shaker (GFL, Germany) in 
microaerophilic conditions. 
 
3.4 Cell lines and monocytes isolation 
U937 (human myelomonocytic cell line) cells (Sigma-Aldrich, U.S.A) were grown in RPMI 
(Roswell Park Memorial Institute) 1640 supplemented with 10% heat-inactivated fetal bovine 
serum (FBS), 2 mM glutamine, 25 mM HEPES pH 7.5, and 1% antibiotics and was 
maintained at 37°C in humidified air with 5% CO2. PBMCs were isolated from freshly 
collected buffy-coat preparations of whole human blood from healthy donors. To harvest 
monocytes from the peripheral blood, buffy coats were subjected to a double density gradient 
centrifugation as described below (Menck et al, 2014). 30-35 ml of buffy coat was layered on 
top of the Ficoll-Paque
TM
 Plus solution (GE Healthcare, U.K) into a 50 ml centrifuge tube for 
the first density gradient. The sample was centrifuged at 400 x g without brake for 30 min at 
room temperature (RT) and the white ring of PBMCs which is located between the two 
phases was collected with a serological pipette and was transferred to a 50 ml centrifuge tube. 
The tube was filled with PBS-EDTA (1 mM), up to 40 ml in total, and centrifuged at 300 x g 
for 10 min without brake at RT. The resultant supernatant was aspirated and the pellets were 
washed with 40 ml PBS-EDTA (1 mM). For each donor the resultant pellets, containing 
PBMCs, were polled in 20 ml RPMI-1640 without phenol red + 10% FBS. For the second 
density gradient the iso-osmotic Percoll solution (density: 1.131 g/ml) was prepared as 
described in the protocol (Menck et al, 2014). For each donor 25 ml of the prepared Percoll 
solution was transferred to a 50 ml tube and the PBMC solution previously prepared was 
layered on the top of the Percoll solution. The tubes were centrifuged at 550 x g without brake 
for 30 min at RT. For each gradient the white ring containing monocytes, which is located 
between the two phases, was collected with a serological pipette and transferred to a 50 ml 
centrifuge tube. Monocytes were washed with PBS-EDTA (1 mM) by centrifugation at 400 x 
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g for 10 min without brake at RT. The supernatant was aspirated and pellets were 
resunspended in RPMI 1640 medium supplemented with 10% FBS, 2 mM l-glutamine, 100 
U/ml penicillin and 100 mg/ml streptomycin and incubated in 5% CO2 at 37°C in polylysine-
coated 6-well tissue-culture plates. After 24 hours, non-adherent cells were removed by gentle 
washing and adherent cells remained in culture were used for subsequent assays.  
 
3.5 C. jejuni cell lysate preparation  
C. jejuni ATCC 33291, C. jejuni ISS 1 and C. jejuni 11168H cdtA mutant strains were grown 
in 50 ml Brucella broth (Oxoid) at 37°C in a shaking incubator under microaerophilic 
condition for 48 hours. The bacterial suspensions were adjusted spectrophotometrically to 
approximately 108 bacteria/ml and centrifuged at 4,000 rpm for 10 min. The pellets were 
resunspended in 20 ml of Dulbecco’s modiﬁed eagle medium (D-MEM) (Sigma-Aldrich) and 
lysed by sonication (2 x 30 s bursts with 30 s intervals between each burst) by using a 
sonicator (Sonifier 450, Branson, U.S.A). Cell debris and un-lysed bacterial cells were then 
removed by centrifugation at 4,000 rpm for 10 min. Aliquots of each lysate were sterilized by 
a 0.22 µm membrane ﬁlter (Millipore, Italy) and stored at -20°C before use. 
 
3.6 Detection of cytotoxin activity in C. jejuni lysates 
U937 cells were seeded into 24-well tissue culture plates at a density of 2.6 x 10
5
 cells per 
well for 2 hours prior to the addition of the lysates diluted 1:5, 1:10, 1:50, 1:100 and 1:500 
respectively. The cultures were incubated at 37°C in 5% CO2 atmosphere and examined 
microscopically at 24 hours’ intervals for 4 days to evaluate morphological changes.  
The best acting dilution was the 1:100 which was chosen for all subsequent evaluations. All 
strains were tested in at least three independent experiments. 
 
3.7 Pre-treatment of U937 cells and monocytes with C. jejuni lysates 
U937 cells and monocytes were incubated for 6, 12, 24, 48 and 72 hours with 2 ml media 
enriched with C. jejuni cell lysates (1:100 dilution) from ATCC 33291, ISS 1 and 11168H 
cdtA mutant strains previously prepared (see 3.5). Treated cells were analysed by means of 
flow cytometry and confocal microscopy to evaluate different cellular parameters. For the 
negative control, cells were incubated with media only.  
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3.8 Pre-treatment of U937 cells with C. jejuni OMVs  
U937 cells were incubated for 24, 48 and 72 hours with 2 ml media enriched with OMVs 
isolated from C. jejuni 11168H wild type and 11168H cdtA mutant strains. Approximately 10 
x 10
9
 particles were added to 2 ml media. Treated cells were analysed by means of flow 
cytometry and confocal microscopy to evaluate different cellular parameters. For the negative 
control, cells were incubated with media only. 
 
3.9 Pre-treatment of U937 cells with Rapamycin 
Rapamycin (RM) is an efficient pharmacological inhibitor of mTOR (mammalian target of 
rapamycin) which is able to induce autophagy in mammal cells (Sehgal, 2003). mTOR is a 
complex composed of two entities, m TORC1(mTOR complex 1) and m TORC2 (mTOR 
complex 2). M TORC1 is a downstream target of PI3K (phosphoinositide 3-kinase) and is 
sensitive to the RM (Inoki et al, 2002). mTOR plays an important role in cell growth and 
proliferation (Wullschleger et al, 2006) and its activation was recently associated to intestinal 
inflammation induced by C. jejuni (Sun et al, 2012). U937 cells were pre-treated with RM 
100 nM for 2 hours before the treatment with lysates. 
 
3.10 Nanoparticle Tracking Analysis (NTA) 
Isolated OMVs were diluted at 1:100 in PBS and stored at -20°C for further analysis. NTA 
measurements were performed with a NanoSight LM20 (NanoSight, U.K), equipped with a 
sample chamber with a 640-nm laser and a Viton fluoroelastomer O-ring. The samples were 
injected in the sample chamber with sterile syringes until the liquid reached the tip of the 
nozzle. All measurements were performed at RT. 
 
3.11 Morphological feature evaluation 
To evaluate changes in cell morphology and size both cytometry and confocal microscopy 
were used. In flow cytometry, populations that differ in size and morphology were 
distinguished by using their physical characteristics: forward scatter (FSC, cell size) and side 
scatter (SSC, cell granularity). Although a quantitative analysis was carried out in flow 
cytometry, a qualitative analysis was performed in confocal microscopy.  
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3.12 Flow cytometry and confocal microscopy stainings  
Flow cytometric detection of cell death and flow cytometric absolute count 
Cell death features were evaluated using supravital Propidium Iodide (PI) (Sigma-
Aldrich) that is capable of binding and labeling DNA. No permeabilized cells were incubated 
30 min in the dark with 50µg/ml PI. Cells were washed with PBS and then analysed by flow 
cytometry. Apoptotic and necrotic cells were detected as PI
dim
 and PI
bright
 clusters, 
respectively.  
To investigate programmed cell death features (early and late apoptotic, as well as necrotic 
cells) it was also used a double staining FITC-conjugated Annexin V-PI (AnxV-PI). AnxV 
allows to detect phosphatidylserines exposed on the outer cell membrane following caspase-
activation. AnxV-PI staining was carried out in according to manufacturer's instructions 
(Immunostep, Spain) 
Absolute cell counting was performed by using Dako CytoCount
TM
 beads (Thermo Fisher 
Scientific, U.S.A). 200 µl of sample was carefully dispensed at the bottom of the tube and 50 
µl beads were added. Samples were acquired by using a FACSCanto cytometer (Becton 
Dickinson, BD, U.S.A) within 60 min. Approximately 20,000 cell events were collected. Set-
up and calibration procedures were optimised for the absolute counting protocols (Brando et 
al, 2000). 
 
Nucleic acid staining 
SYBR GREEN I (Thermo Fisher Scientific) is able to stain nucleic acids. The staining with 
this fluorochrome was performed with a final dilution of 1:10,000 (Salucci et al, 2013). 
Samples were analysed by flow cytometry using the appropriate fluorescence channel. 
 
Determination of mitochondrial potential (ΔΨm), mitochondrial mass and mitochondrial 
reactive oxygen species (ROS) 
Mitochondrial features were investigated by TMRE, NAO and MitoSOX stainings. 
Tetramethylrhodamine ethyl ester perchlorate (TMRE) (Sigma-Aldrich) is a ΔΨm-specific 
stain able to selectively enter into mitochondria depending on ΔΨm producing red 
fluorescence. TMRE 40 nM was added to the sample 15 min before the acquisition time. 
Samples were analysed by confocal microscopy and flow cytometry using the appropriate 
fluorescence channel (Canonico et al, 2014).  
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The cardiolipin-sensitive probe Nonyl Acridine Orange (NAO) (Sigma-Aldrich) is able to 
monitor changes in mitochondrial lipids (Luchetti et al, 2012) (Canonico et al, 2016). 
In the present study, this probe was used to measure the mitochondrial mass/number 
independently of mitochondrial membrane potential (ΔΨ). After a 15 min incubation at 37°C 
in the dark with 100nM NAO, samples were acquired by flow cytometry using the 
appropriate fluorescence channels. 
MitoSOX Red (Thermo Fisher Scientific) is a florigenic dye specifically targeted to 
mitochondria in live cells. Oxidation of this probe by superoxide that is contained in 
mitochondria produces a red fluorescence. MitoSOX 5µM was added to the sample 10 min 
before the time of acquisition. Samples were analysed by flow cytometry using the 
appropriate fluorescence channel (Canonico et al, 2016). 
 
Assessment of lysosomal involvement 
To label and trace lysosomes in monocytes and U937 cells the acidotropic dye LysoTracker 
Green (LTG) and LysoTracker Deep Red (LTDR) (Thermo Fisher Scientific) were used. 
LysoTracker probes are fluorescent acidotropic probes for labeling and tracking acidic 
organelles in live cell: it means that the amount of fluorescence obtained from staining with 
LysoTracker is directly related to the volume of lysosome-related organelles in a cell 
(Chazotte, 2011). Cells were cultured at 37°C and resuspended in pre-warmed (37°C) medium 
containing 100 nM LysoTracker (diluted in RPMI). After 45 min incubation green lysosomal 
fluorescence was detected by flow cytometry and confocal microscopy. 
 
ER stress evaluation 
ER-Tracker Green (Thermo Fisher Scientific) is a live-cell stain highly selective for the ER. 
This stain consists of the green-fluorescent BODIPY® FL dye and glibenclamide that binds to 
the sulphonylurea receptors of ATP-sensitive K
+
 channels which are prominent on the ER and 
have a critical role in  ER luminal homeostasis. Indeed, ER K
+
 channels are involved in 
functions such as protein folding, apoptosis, and Ca
2+
 homeostasis (Hogg & Adams, 2001) 
(Ghasemi et al, 2014). 
PBMC were incubated with 100 nM ER-Tracker Green for 30 min at 37°C and subjected to 
flow cytometry and confocal analyses. 
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Intracellular Ca
2+
 levels detection 
To measure intracellular Ca
2+
 levels FURA-2 AM (Thermo Fisher Scientific) was used which 
is known as an intracellular Ca
2+
 indicator, ratiometric and UV light-excitable. After 
treatment with lysates, cells were stained with FURA-2 AM 2µM for 15 minutes at 37°C. 
After incubation time, samples were acquired by flow cytometry using the appropriate 
fluorescence channel. 
 
Surface receptor expression evaluation  
To evaluate CD54 (ICAM-1), CD317, CD59 and CD14 expression fluorochrome-conjugated 
monoclonal antibodies were added to 50 µl of cell pellet. Mouse monoclonal anti-human 
antibodies anti-CD54-PE conjugated (clone D3.6) (Exalpha Biologicals, U.S.A), Alexa 
Fluor® 647 anti-CD317 (BioLegend, U.S.A), anti-CD59-Pe-Cy5 conjugated (BD) and anti-
CD14-PE conjugated (clone M5E2) (BD) were added at dilutions according to manufacturer’s 
instructions. After 15 min incubation at RT, samples were acquired by flow cytometry and/or 
confocal microscopy.  
 
Intracellular detection of Bcl-2, p53 and pRb antigens 
Monocytes were washed in PBS for 10 min at RT, resunspended in 300 µl formaldehyde 
3.7% and incubated at 4°C for 15 min. 2 ml perm/washing buffer was added and cells were 
centrifuged at 1200 rpm for 10 min. Pellets were resunspended in 300 µl Cytoperm reagent 
(Li et al, 2015a). Monoclonal anti-human antibodies Anti-Bcl-2 PE conjugated (clone N46-
467) (BD), Anti-p53 FITC conjugated (clone D0-8) (BioLegend) and Anti-pRb PE 
conjugated (clone MOPC-21) (BD) were added to samples at concentrations according to 
manufacturer’s instructions. Cells were incubated at 4°C for 30 min before being processed 
by flow cytometry and/or confocal microscopy.   
 
Evaluation of intracellular lipids  
To evaluate lipid content and oxidation, three different dyes were used:  Bodipy® 665/676 
(Thermo Fisher Scientific), LipidTOX 
TM
 (Thermo Fisher Scientific) and Nile Red (NR) 
(Sigma-Aldrich) 
Bodipy® 665/676 staining: Bodipy is a fluorescent probe suitable for oxidation studies in 
neutral lipids (Raudsepp et al, 2014). Cells were incubated with the dye at the final 
concentration of 1μg/ml for 30 minutes at 37°C and acquired by flow cytometry. 
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LipidTOX 
TM 
staining: LipidTOX stains neutral lipids and it is commonly used to characterize 
the potentially toxic effects of compounds on lipid metabolism in mammalian cells. Cells 
were incubated with the dye at the final dilution of 1X. 
NR staining: NR is a phenoxazine dye that can be used on viable cells to localize and quantify 
neutral and polar lipids. Polar lipids (i.e., phospholipids) which are mostly present in 
membranes, are stained in red (emission > 590 nm), whereas neutral lipids (esterified 
cholesterol and triglycerides), which are present in lipid droplets, are stained in yellow (570–
590 nm) (Diaz et al, 2008). In this work, NR was prepared at 100μg/ml in dimethylsulfoxide. 
NR was added to the culture medium for 15 min at a final concentration of 1μg/ml in a 
cellular suspension adjusted to 106 cells/ml. After incubation, samples were acquired by flow 
cytometry, collecting at least 10,000 events for each tube. 
 
Autophagic vacuole detection 
Autophagic vacuoles were detected in flow cytometry by monodansylcadaverine (MDC) 
staining, a specific autophagolysosomes marker typically used to investigate the autophagic 
machinery (Vazquez & Colombo, 2009). Cells were incubated with 50µM MDC at 37°C for 
10 minutes.  
 
LAMP-1 surface expression (lysosomal exocytosis assay) 
Cell surface CD107a (LAMP-1), which is found on lysosomes and intracellular lytic granules, 
was measured. LAMP-1 surface expression was used as a marker of lysosomal exocytosis 
(Andrews, 2017). CD107a-PeCy5 antibody (clone H4A3, BioLegend) was added to 50μl of 
cellular suspension at the concentration indicated in the manufacturer’s instructions. Cells 
were incubated for 1 hour at RT and acquired by flow cytometry. To evaluate the lysosomal 
exocytosis, in many cell types LAMP-1 values are associated to cytosolic Ca
2+
 content 
(Ivanov et al, 2004).  
 
Cytometric investigations 
Cytometric experiments were carried out with a FACSCanto II flow cytometer (BD) equipped 
with an argon laser (Blue, Ex 488 nm), a helium-neon laser (Red, Ex 633 nm) and a solid 
state diode laser (Violet, Ex 405 nm). Analyses were performed with FACSDiva
TM
 software 
(BD); approximately 10,000 cell events were acquired for each sample. 
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3.13 Trypan blue viability test 
This test was used to determine the number of viable cells present in the cell suspension. 
Monocytes or U937 cells in suspension were 1:1 diluted in 0.4% Trypan Blue solution 
(Sigma-Aldrich). 10 µl of the cell solution prepared was used to fill the haemocytometer 
chamber (Naubauer chamber). After 1-2 min incubation cells were counted under Nikon 
Eclipse TS100 fluorescence microscope (Nikon corporation, Italy) applying the following 
formula. Cells were visually examined to determine whether cells took up or excluded dye: 
viable cells typically show a clear cytoplasm (unstained) whereas nonviable cells show a blue 
cytoplasm (stained) (Strober, 2001). 
 
                          
               
                 
                      
 
3.14 Confocal microscopy analyses 
Confocal microscopy analyses were applied by a Leica TCS SP5 II confocal microscope 
(Leica Microsystem, Germany) with 488, 543 and 633 nm illuminations and oil-immersed 
objectives. For confocal live imaging, cells were grown on MatTek glass bottom chambers 
(MatTek Corporation, Slovak Republic). The images were further processed and analysed in 
ImageJ software (NIH, U.K). 
 
3.15 Statistical analyses  
Data are shown as mean ± standard deviation (SD) of at least three independent experiments. 
Analyses of variance (ANOVA) approaches were used to compare values among more than 
two different experimental groups for data that met the normality assumption. One-way 
ANOVA or two-way ANOVA were followed by a Bonferroni post-hoc test. The means of 
two groups were compared by using t test. P values less than 0.05 were considered 
statistically significant. All statistical analyses were done using GraphPad Prism 5.0 
(GraphPad software, U.S.A). 
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4. Human intestinal cell model and molecular work 
4.1 Bacterial strains, plasmids and primers 
Table 1. Bacterial strains used in this study: 
C. jejuni strains Description References 
11168H 
A hypermotile derivative of the original 
sequence strain NCTC 11168 that shows higher 
levels of caecal colonisation in a chick 
colonisation model 
(Jones et al, 2004; 
Karlyshev et al, 
2002) 
11168H cdtA 
mutant 
Isogenic mutant of Cj0079 obtained from 
Campylobacter mutant bank 
http://crf.lshtm.ac.uk/wren_mutants.html 
LSHTM mutant bank 
11168H cdtB 
mutant 
Isogenic mutant of Cj0078 obtained from 
Campylobacter mutant bank 
http://crf.lshtm.ac.uk/wren_mutants.html  
 
LSHTM mutant bank 
11168H GFP 
Hypermotile derivative of the original sequence 
strain NCTC 11168 containing  GFP with a 
porA promoter  
(Jervis et al, 2015) 
 
Table 2. E. coli strains used in this study:  
E. coli strains Description Reference 
E. coli XL-2  
Blue MRF 
competent cells 
Agilent,  
U.S.A 
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Table 3. Plasmids used in this study: 
Plasmids Description Reference 
pGEM-T 
Easy 
PCR cloning vector, ampicillin resistant Promega, U.K 
pGEM-cdtA 
pGEM-T Easy vector containing Cj0079 CDS fragment 
(0.7 kb) 
This study 
pGEM-cdtA-
Km
R
 
pGEM-T Easy containing Cj0079 with a 1.4 kb Km
R
 
inserted at position 411 of the Cj0079 nucleotide 
sequence 
This study 
 
Table 4. Primers used in this study: 
Primer Name Sequence 
cdtA-F TGGAGAATTTGAAGATACTG 
cdtA-R TCTCCTTGGCGATATAAAG 
cdtA-IPCR-F GGGAGATCTATCGATAGCAAAGGATTTG 
cdtA-IPCR-R GGGAGATCTAATCCAATTTCCTTGTGC 
Km
R
 forward-out TGGGTTTCAAGCATTAGTCCATGCAAG 
Km
R
 reverse-out GTGGTATGACATTGCCTTCTGCG 
SP6 universal primer ATTTAGGTGACACTATAG 
T7 universal primer TAATACGACTCACTATAGGG 
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XBP1-F ACACGCTTGGGGATGAATGC 
XBP1-R CCATGGGAAGATGTTCTGGG 
Spliced XBP1-F TGCTGAGTCCGCAGCAGGTG 
Spliced XBP1-R GCTGGCAGGCTCTGGGGAAG 
GAPDH-F GGATGATGTTCTGGAGAGCC 
GAPDH-R CATCACCATCTTCCAGGAGC 
 
4.2 Growth conditions and storage 
C. jejuni strains were revived from -80°C glycerol stocks by pipetting onto blood agar plates 
containing autoclaved Columbia agar base (Oxoid) supplemented with 7% (vol/vol) horse 
blood (TCS Microbiology, U.K) and Campylobacter Selective Supplement (Oxoid). 
Depending on the different applications, appropriate concentrations of antibiotics were added 
to the medium as follows: ampicillin (100 μg/ml), kanamycin (50 μg/ml), and 
chloramphenicol for E. coli (50 μg/ml) or C. jejuni growth (10 μg/ml). In detail, plates for C. 
jejuni cdtA and cdtB mutant strains were supplemented with kanamycin, plates for C. jejuni 
11168H GFP strain growth were supplemented with chloramphenicol and plates for C. jejuni 
11168H cdtA mutant GFP strain growth were supplemented with kanamycin and 
chloramphenicol. 
Bacteria were restreaked every 2-3 days with passages being no more than 10 to preserve 
bacteria viability.  
C. jejuni strains were grown for 24 hours prior to use in all subsequent experiments (unless 
otherwise stated). C. jejuni were grown in a variable anaerobe chamber (VAIN) (Don Whitley 
Scientific, U.K) under microaerobic conditions at 37°C containing 85% N2, 10% CO2, and 
5% O2. 
To prepare 15 blood agar plates, 400 ml of Columbia agar base (400 ml of distilled water was 
added to 15.6 g of Columbia agar base in powder), one vial of Campylobacter selective 
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supplement (Skirrow, Oxoid) and 28 ml of horse blood (7%). Kanamycin blood agar plates 
contained 50 µg/ml
 
kanamycin. 
C. jejuni overnight cultures were prepared by adding an adequate bacterial suspension to 10 
ml of Brucella broth in a 30 ml flask (Thermo Fisher Scientific, U.S.A) (preincubated under 
the same growth conditions for 24 hours). Subsequently flasks were incubated for 24 hours 
(or for the desired experimental time) at 37°C under microaerobic conditions on a shaker (75 
rpm). 
E. coli cells were revived from -80°C glycerol stocks and plated onto Luria-Bertani (LB) agar 
plates and were incubated at 37°C under aerobic conditions (Sonyo, Canada). LB plates with 
E. coli grown overnight were sealed with Parafilm M (Sigma-Aldrich) and stored at 4°C for a 
maximum of 2-3 weeks. Overnight cultures of E. coli were prepared by selecting a single 
colony, picked up with a small inoculation loop (1 µl) and added to 10 ml LB broth in a 30 ml 
universal. Cultures were grown at 37°C for 16-18 hours under aerobic conditions into a 
shaking incubator at 200 rpm (Weiss Gallenkamp, U.K).  
To prepare 10 LB agar plates, 250 ml of distilled water was added to 9.25 g LB agar (Oxoid) 
in powder. LB/ampicillin/IPTG/X-Gal plates (8-10 plates) were prepared by adding 250 µl 
ampicillin (100 mg/ml), 40 µl IPTG (Isopropyl β-D-1-thiogalactopyranoside) (1 pmol/μl) and 
500 µl 2% (wt/vol) X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) to 250 ml of 
LB agar.    
Bacteria glycerol stocks were created for long-term storage of C. jejuni and E. coli strains of 
interest. Glycerol stocks were prepared for C. jejuni (from an overnight plate) and E. coli 
(from an overnight liquid culture) cells using 10% (vol/vol) glycerol, 10% (vol/vol) foetal calf 
serum (FCS) (Sigma-Aldrich) and 80% (vol/vol) Mueller-Hinton broth mixture (C. jejuni) or 
15% (vol/vol) glycerol in LB broth (E. coli). Next, 500 μl aliquots were snap-frozen using dry 
ice in 100% (vol/vol) ethanol and stored in a -80°C freezer (New Brunswick Scientific, U.K).    
 
4.3 Preparation of a specific OD600 C. jejuni suspension 
50 ml of Brucella broth were preincubated in a 300 ml flask at 37°C and placed into a 
microaerobic chamber for 24 hours. C. jejuni, grown on blood agar plates for 24 hours, were 
collected using a sterile inoculation loop and resunspended in 1 ml PBS into a 1.5 ml 
microcentrifuge tube. 100 μl of this suspension was resunspended in 900 μl Brucella broth in 
a sterile 1.5 ml microcentrifuge tube. This diluted suspension was vortexed and transferred to 
a 1 ml spectrophotometer cuvette (Thermo Fisher Scientific) and the OD600 recorded using a 
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spectrophotometer (cell density meter CO8000, WPA, U.K). 1 ml of an appropriate blank was 
used before recording.  
In summary, the defined volume of the original C. jejuni suspension was added to 50 ml of 
equilibrated Brucella broth to produce an initial inoculum with an OD600 of 0.1 was calculated 
as follows: 
 
                               
                                      
                                                  
 
  
   
                    
            
 
                                                                
 
4.4 DNA Purification 
C. jejuni genomes were purified using the Pure Link Genomic DNA kit (Invitrogen, U.S.A). 
This method consisted of four steps: 
Gram negative bacteria lysate preparation: Cells were harvested using an inoculation loop 
(approximately 2 x 10
9
 cells), resunspended in 1 ml PBS and centrifuged for 2 minutes at 
13,000 rpm. The pellet was resunspended in 180 µl of digestion buffer and 20 µl of proteinase 
K to lyse the cells. After 90 minutes of incubation at 55°C, 20 µl of RNase A were added and 
the lysate was incubated at room temperature for 2 minutes. 200 µl of Lysis/Binding buffer 
was added and vortexed to obtain a homogenous solution. Finally, 200 µl of 97-100% ethanol 
was added to the lysate and mixed well by vortexing for 5 seconds.  
DNA binding: The prepared lysate (~640 μl) was added to a spin column, placed into a 
collection tube and centrifuged at 10,000 x g for 1 minute at room temperature. Subsequently 
the collection tube was discarded and the spin column was then placed into a clean one. 
DNA washing: The DNA was washed with 500 µl of Wash buffer 1 and centrifuged at 
10,000 x g for 1 minute. The DNA was then washed with 500 µl Wash buffer 2 and 
centrifuged at maximum speed.  
DNA eluting: The spin column was placed into a 1.5 ml microcentrifuge tube and 50 µl 
Milli-Q water were added. After 1-minute incubation, the column was subjected to 
centrifugation at maximum speed. This procedure was repeated for a second time. After this 
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step the purified DNA was obtained and stored at -20°C. The concentration and the purity of 
the resultant sample was checked using a NanoDrop 1000 Spectrophotometer (Thermo 
Fischer Scientific, U.S.A). 
4.5 Purified DNA Quantitation 
Genomic DNA was quantitated using a NanoDrop 1000 Spectrophotometer (Thermo Fischer 
Scientific). 1.5 µl sample was pipetted onto the end of a fiber optic cable (the receiving fiber). 
A second fiber optic cable (the source fiber) was then brought into contact with the liquid 
sample causing the liquid to bridge the gap between the fiber optic ends. A pulsed xenon flash 
lamp provided the light source and a spectrometer utilizing a linear CCD array was used to 
analyse the light after passing through the sample and the ng/µl was recorded. 
 
4.6 Polymerase Chain Reaction Technique 
A typical PCR consists of a series of 25-30 repeated temperature changes, called ‘cycles’, 
with each cycle consisting of three discrete temperature steps:  
 Denaturation step: The reaction starts with a 2-minute initial denaturation step at 
95°C. This step causes the DNA melting of the DNA template by disrupting the 
hydrogen bonds between complementary bases, yielding single-stranded DNA 
molecules. 
 Annealing step: Typically, 30 seconds to 1 minute. To optimize the annealing 
conditions, the annealing temperature (Ta) is usually set to 5°C below the calculated 
melting temperature of the primers (Appendix 1). 
 Extension/elongation step: This reaction is typically performed at the optimal 
temperature for Taq DNA polymerase (72-74°C) for 5 minutes. In this step the DNA 
polymerase synthesizes a new DNA strand complementary to the DNA template 
strand by adding dNTPs. 
Each reaction tube contained the following volumes/concentrations: 
Component Volumes Final concentration 
PCR Master Mix 25 µl 1X 
DNA 1 µl < 250 ng 
Forward primer 0.075 µl 0.1-1.0 µM 
Reverse primer 0.075 µl 0.1-1.0 µM 
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For typical PCR reactions, the template should be present at 10 to 1000 copies per reaction. 
Before initiating the PCR reaction, DNA must be isolated (see 4.4). To prevent pipetting 
errors, the PCR MyTaq mix format was used. The PCR MyTaq mix is a premixed ready-to-
use solution, containing Taq DNA polymerase, dNTPs, and MgCl2 and reaction buffers at 
optimal concentrations for efficient amplification of DNA templates by PCR.  
PCR mix was set up as follows:  
 
MyTaq mix (Bioline, U.K) 25 μl 
Forward primers 0.075 μl 
Reverse primers 0.075 μl 
DNA 1 μl 
 
PCR products were analysed on a 0.7% TAE-agarose-ethidium bromide gel electrophoresis as 
described in 4.7. 
 
4.7 Tris-Acetate-EDTA agarose ethidium bromide gel electrophoresis 
In order to prepare the 0.7% agarose gel (Bioline, U.K), 1.05 g of agarose powder was mixed 
with 150 ml of electrophoresis buffer (Tris-acetate-EDTA, TAE 1X). The contents were 
mixed, heated and poured into a casting tray containing a sample comb. Once the gel had 
solidified, the comb was removed and the electrophoresis buffer was poured into the 
electrophoresis chamber followed by addition of 10-12 µl of sample loaded into appropriate 
wells. Once the ethidium bromide was added into the buffer (final concentration 0.5 µg/ml). 
An adequate migration (120V, 500mA) was performed and the gel was viewed on (Consort 
EV, Sigma-Aldrich) an ultraviolet Trans-illuminator was used to identify and scan DNA 
bands (Bio Imaging System, Syngene, U.K).   
 
4.8 Purification of PCR products 
QIAquick PCR Purification Kit (Qiagen, Germany) was used to purify and remove impurities 
(such as primers, nucleotides, enzymes etc.) from DNA samples of size 100 bp to 10 kb. 
Initially, 5 volume buffer PB was added to 1 volume of PCR reaction and the mixture was 
placed in a column. To wash, 750 µl buffer PE were added to the column and twice 
centrifuged. The column was placed into a clean 1.5 ml microcentrifuge tube and to elute 
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DNA, 30 µl of Milli-Q water were added. After centrifugation, the resultant sample contained 
the purified DNA.   
4.9 Ligation and transformation stages 
The plasmid was introduced into bacterial cells, specifically E. coli cells, using a standard 
heat-shock transformation. This method, called ‘transformation’, allows the introduction of 
foreign DNA into competent cells. To clone PCR products (which have been previously 
cleaned) the pGEM-T-Easy Vector was used (Promega) which is a "TA" cloning vector that 
has "A" & "T" overhangs. Taq polymerase leaves an extra "T" or "A" at the end of the 
amplified DNA in the PCR reaction, so the PCR product ligates readily into the vector.  
The ligation reaction was set up as described with the reactions described below and 
incubated for 1 hour at room temperature after mixing. Alternatively, if the maximum number 
of transformants is required, the ligation should be incubated overnight at 4°C. 
 
Reagent 
Standard 
Reaction 
Positive 
control 
Background 
Control 
2X Rapid Ligation buffer 5 µl 5 µl 5 µl 
pGEM-T Easy Vector (50 ng) 1 µl 1 µl 1 µl 
PCR product X µl - - 
Control Insert DNA  - 2 µl - 
T4 DNA Ligase 1 µl 1 µl 1 µl 
Deionized water to a final volume of 10 µl 10 µl 10 µl 
 
Following this procedure, 50 µl of thawed competent cells were added to 2 µl of the ligation 
mix and incubated on ice for 20 minutes. The reaction was heat-shocked for 45-50 seconds at 
exactly 42°C and incubated on ice for 2 minutes. After adding 950 μl room temperature SOC 
medium (Sigma-Aldrich), the reaction was incubated for 1.5 hours at 37°C with shaking 
(~150/200 rpm). Approximately 200 μl of each transformation culture were plated onto 
LB/ampicillin/IPTG/X-Gal plates previously prepared (see 4.2), using an L-shaped cell 
spreader.  
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The pGEM-T-Easy vector used was able to encode the β-galactosidase gene across the 
multiple cloning site allowing of making a “blue/white screening”, a rapid technique used to 
detect successful ligation and transformation. Colonies with the insert should appear white, 
whereas colonies without the insert should appear blue. Only cells that contained the plasmid 
were able to grow and form colonies. This screening allowed us to identify E. coli cells that 
have the desired form of plasmid DNA within them. After an overnight incubation in 5% CO2 
at 37°C, blue and white colonies were grown in the LB/ampicillin/IPTG/X-Gal plates. White 
single colonies transformants were selected and picked up using a 1 µl loop, plated in LB/amp 
plates and overnight incubated in 5% CO2 at 37°C.  Plates with resultant colonies were stored 
at 4°C. 
 
4.10 PCR from boiled/lysed bacteria colonies  
To check the success of the transformation step, single colonies of E. coli were picked up and 
resuspended in 100 µl sterilized Milli-Q water, lysed through boiling (95°C on the PCR 
block) and cleaned by centrifugation (13,000 rpm/5 minutes). Then, 1 µl of each sample was 
subjected to vector primer PCR (VPPCR), and insert specific primers PCR (ISPCR), using 
primers previously used for the amplification of the CDS of interest (cdtA gene) to test for 
positive transformants. 
 
The VPPCR reaction was set up as follows: 
Forward T7 primer (100 pmol/µl) 0.075 µl 
Reverse SP6 primer (100 pmol/µl) 0.075 µl 
Boiled supernatant 1 µl 
VPPCR pre mix to 25 µl 
 
Standard PCR programs were performed (see 4.6) and the resultant electrophoretic gel was 
analyzed to confirm the presence of the interested insert into the correct gene. After checking, 
exclusively E. coli colonies which contained the right insert into the required location could 
be streaked for the next step. Therefore, selected colonies were plated in fresh LB/amp agar 
plates allowing glycerol stock preparation and the Miniprep production. 
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4.11 Overnight culture preparation 
The overnight incubated liquid bacteria cultures were essential for the preparation of the 
bacterial glycerol stock (see 4.2) and the Miniprep production. These were prepared as 
follows: single colonies, grown into LB/amp agar plates, were selected using a 1 µl loop and 
resunspended in 10 ml of LB Broth enriched with ampicillin (0.1%) using 30 ml tubes. After 
inoculation, the cultures were pre-incubated overnight into a shaking incubator. 
 
4.12 Isolation of plasmid DNA: QIAprep Miniprep production  
To purify the plasmid DNA, QIAprep Miniprep Kit (Qiagen) was used. This procedure is 
based on three basic steps: the preparation and cleaning of bacteria lysate under alkaline 
conditions, the adsorption of the DNA onto the QIAprep silica membrane and the washing 
and the elution of the plasmid DNA. The following procedure was applied: overnight E. coli 
cultures in 10 ml LB medium were lysed, cleared by centrifugation and applied to the 
QIAprep module where plasmid DNA adsorbed to the silica membrane and eluted in a 
microcentrifuge tube. After centrifugation, the pellet was resunspended with 250 µl of buffer 
P1 and transferred to a 1.5 ml microcentrifuge tube. To perform the wash step, 250 µl P2 
buffer and 350 µl N3 buffer were added to the tube, then the reaction was immediately mixed 
by inverting the tube 4-5 times. The mixture was centrifuged for 10 minutes at 13,000 g in a 
table top centrifuge and pipetted in a clean spin column. Then, the tube was centrifuged for 
30-60 seconds, discarded and twice washed, firstly adding 500 µl buffer PB, secondly adding 
750 µl of buffer PE. Finally, the tube was discarded, centrifuged at maximum speed and the 
column was placed into a clean 1.5 ml microcentrifuge tube. To elute the DNA, a small 
volume of Milli-Q water (30 µl) was added to the centre of the column and centrifuged. 
Purified DNA was quantitated using a NanoDrop 1000 Spectrophotometer and the sample 
purity was checked (see 4.5). Purified samples were stored at -20°C. 
 
4.13 Restriction endonuclease digestion 
Standard restriction digests were prepared using a final volume of 20 μl. 0.5-1.0 μg plasmid 
DNA was digested with 10 U of the appropriate restriction endonuclease and buffer. 
Reactions were prepared into 1.5 ml microcentrifuge tubes and incubated at the appropriate 
temperature and time duration recommended by the manufacturer. Lastly digests were 
purified using the QIAquick PCR Purification kit (Qiagen) (see 4.8). 
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4.14 Inverse PCR mutagenesis 
Inverse PCR mutagenesis (IPCRM) was performed when the CDS to be mutated did not 
contain a BamHI, BclI or BglII restriction site. As illustrated in the following figure, IPCRM 
primers were designed by selecting 15-20 nucleotides in the centre of the CDS to be mutated 
with an interspacing region of 10-15 nucleotides.  
 
 
 
 
 
 
 
ATGCAAAAAATTATAGTTTTTATTTTATGTTGTTTTATGACTTTTTTTCTTTATGCATGT
TCTTCTAAATTTGAAAATGTAAATCCTTTGGGGCGTTCATTTGGAGAATTTGAAGATACT
GATCCTTTAAAACTAGGACTTGAACCTACTTTTCCTACCAATCAAGAAATTCCAAGTTTA
ATTAGCGGTGCTGATTTAGTACCTATTACTCCTATTACCCCACCTTTAACTAGAACAAGC
AATAGTGCCAACAATAATGCAGCAAATGGGATCAATCCTCGCTTTAAAGACGAAGCTTTT
AATGATGTTTTAATTTTTGAAAATCGCCCTGCGGTTTCTGATTTTTTAACCATTTTAGGC
CCTAGCGGAGCAGCTTTAACGGTTTGGGCTTTAGCACAAGGAAATTGGATTTGGGGCTAT
ACTTTAATCGATAGCAAAGGATTTGGCGATGCTAGAGTTTGGCAACTTTTGCTTTATCCT
AATGATTTTGCAATGATTAAAAATGCCAAAACCAATACTTGTCTTAATGCTTATGGTAAT
GGAATTGTCCATTATCCTTGTGATGCAAGCAATCACGCACAAATGTGGAAACTTATCCCT
ATGAGCAATACAGCGGTTCAAATTAAAAATTTAGGAAATGGAAAATGCATACAAGCACCT
ATTACAAATCTTTATGGTGATTTTCACAAGGTTTTTAAAATTTTTACCGTAGAGTGTGCA
AAAAAAGATAATTTTGATCAACAATGGTTTTTAACTACTCCGCCTTTTACCGCAAAACCT
TTATATCGCCAAGGAGAGGTACGATGA 
cdtA-IPCRM-F= 5’ GGGAGATCTATCGATAGCAAAGGATTTG 3’ 
cdtA-IPCRM-R= 5’ GGGAGATCTAATCCAATTTCCTTGTGC 3’ 
Fig. 4.1 IPCRM primers designed for cdtA sequence. To allow the functionality of the BglII 
restriction site the IPCRM primers have to contain three guanine residues at the 5’ -end 
followed by the BglII complementary sequence –AGATCT. 
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The IPCRM reaction was prepared by mixing the following reagents: 
 
buffer 1 (10X) 10 μl 
AccuPrime Taq DNA high fidelity polymerase* (5 U/μl) (Invitrogen) 0.4 μl 
DNTPs in buffer 1 concentration  400 μM 
Milli-Q water 89.6 μl 
 
IPCRM reaction was set up as follows: 
 
IPCRM Pre-mix 98.4 μl 
DNA (0.1-10 ng) 1.0 μl 
IPCRM primers 0.6 μl 
 
IPCRM reaction steps: 
 Step 1: 94°C for 2 minutes 
 Step 2: Denature at 94°C for 1 minute 
 Step 3: Anneal at 45°C for 1 minute 
 Step 4: Extension at 72°C for X minutes (X = size of plasmid in kb x 1.5 minutes) 
 Step 5: 72°C for 7 minutes 
Steps 2-4 were repeated 40 times 
 
The amplified IPCRM product was analysed on an electrophoretic gel (see 4.7) and purified 
using the QIAquick PCR Purification kit (Qiagen) (see 4.8). 
 
4.15 DNA sequencing 
Sequencing of plasmid DNA was performed using ABI Prism Terminator Ready Reaction 
Mix (Applied Biosystems, U.K). Sequencing reactions were also performed on genomic DNA 
using similar concentrations as for plasmid DNA. 
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ABI Reaction Mix 8 μl 
Plasmid or genomic DNA (200-500 ng) 1 μl 
Forward or reverse CDS specific primer (1 pmol/μl) 4 μl 
Sterilised Milli-Q water to 20 μl 
 
PCR cycle: 
 Step 1: Denature at 96°C for 10 seconds 
 Step 2: Anneal at 50°C for 5 seconds 
 Step 3: Extension at 60°C for 4 minutes 
Steps 1-3 were repeated 25 times 
 
Sequencing reactions were performed on a GeneAmp 9600 thermal cycler (Perkin-Elmer, 
U.K). The entire sequencing reaction was then transferred to a 1.5 ml microcentrifuge tube 
containing 80 μl 75% (vol/vol) isopropanol. The sample was briefly vortexed and incubated at 
-20°C for 1 hour. The sample was then centrifuged at 13,000 rpm for 30 minutes and the 
supernatant discarded. 400 μl of 75% (vol/vol) isopropanol was added to the pellet and briefly 
vortexed before centrifuging at 13,000 rpm for 5 minutes. The supernatant was removed and 
the pellet was dried at room temperature for approximately 20 minutes. 10 μl HiDi solution 
(Applied Biosystems) was applied to the pellet and the reaction mixture sequenced using the 
LSHTM ITD Faculty facilities. Analysis of sequence data was performed using Chromas 
v1.61 software (Technelysium Pty. Ltd).  
 
4.16 Transformation of C. jejuni by Electroporation 
For electroporation, cells were grown to mid-log phase, washed extensively to eliminate all 
salts and mixed with the DNA to be transformed. In detail, bacteria cells were collected from 
24 hour grown plates and resunspended in 10 ml cold EBF buffer into a 30 ml universal.  
EBF buffer was prepared as follows:  
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100% (vol/vol) Glycerol 15 ml 
10% (wt/vol) Sucrose 10 ml 
Sterilised Milli-Q water to 100 ml  
 
The tube was centrifuged and the pellet was resunspended in 1 ml cold EBF. The content was 
transferred into a 1.5 ml microcentrifuge tube and centrifuged at 4°C in a cold room for 2 
minutes at 13,000 x g. Subsequently, the pellet was resunspended in 250 µl cold EBF. 5 µl of 
DNA of interest were mixed to 50 µl cell suspension; the resulting reaction was incubated for 
5-10 minutes on ice and occasionally resunspended by flicking. All following reactions were 
conducted at 4°C on ice. 60 µl sample were transferred into a Gene Pulser Electroporation 
cuvette (Bio-Rad, U.K). The cuvette was put in a micro-electroporation chamber of a Gene 
Pulser Xcell™ Electroporation System (Bio-Rad) and pulsed to 200 Ω. The Gene Pulser was 
set at 25 µFD and 2.5 kV. After pulsing, 100 µl rich medium (SOC medium) were added to 
electroporated cells and the whole volume was plated into a blood agar plate.  
Electroporated cells grew up in blood agar plates for 48 hours in microaerobic conditions. 
After 48 hours, bacterial cells were harvested using a sterile inoculation loop and 
resunspended in 800 µl Brucella broth. 200-400 µl aliquots were pipetted in blood agar plates 
enriched with chloramphenicol (10 µl/ml) and kanamycin (50 µg/ml) antibiotics.  The 
bacterial solution was spread using a sterile spreader and plates were incubated for up 5-7 
days at 37°C under microaerobic conditions. Resultant colonies were restreaked in fresh 
blood agar plates enriched with chloramphenicol and kanamycin. Colonies were subsequently 
used to prepare the glycerol stock (see 4.2). 
 
4.17 Construction of a C. jejuni 11168H cdtA GFP mutant strain 
Mutagenesis strategy 
The methodology used in this study is based on electroporation of a recipient C. jejuni strain 
with a linear PCR fragment carrying an antibiotic resistance cassette and the kanamycin 
cassette. The process consists of three main stages: construction of a PI construct (Plasmid + 
Insert), construction of a PIK (Plasmid Insert Kanamycin cassette) construct and 
transformation by electroporation (see 4.16). 
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 Stage 1 - PI production 
After designing primers for the CDS of interest (Appendix 1) the CDS/CDS fragment was 
amplified using PCR (see 4.6) and purified using a QIAquick PCR Purification Kit (4.8). The 
next step was to insert the DNA, the PCR product, into a plasmid or cloning vector, pGEM-T 
Easy vector, so that the DNA fragment could be propagated. The ligation was followed by 
transformation into E. coli XL-2 cells (see 4.9). The plasmid DNA was isolated and positive 
transformants, checked by PCR (see 4.10). 
 
Stage 2 - PIK production 
The aim of the second stage was to incorporate a Km
R
 cassette into the CDS of interest. The 
Km
R
 cassette (aphA-3 (Trieu-Cuot et al, 1985)) was obtained from pJMK30 (van Vliet et al, 
1998) following a BglII restriction digest. The C. jejuni CDS to be mutated was analysed for 
the presence of a single BamHI, BclI or BglII site within the sequence using NEBcutter v2.0 
(http://tools.neb.com/NEBcutter2/index.php). The unique restriction site should ideally be 
located near the centre of the amplified CDS/CDS fragment to improve efficiency of 
recombination. 
To allow insertion of the Km
R
 cassette, 2 μg plasmid DNA containing the cloned CDS of 
interest was digested with approximately 20 units’ restriction enzyme (BamHI, BclI or BglII) 
(see 4.13). The digest was purified using the QIAquick PCR Purification kit (see 4.8) and 
sample concentration was recorded using a NanoDrop ND-1000 spectrophotometer. The 
following ligation reaction was then set up: 
 
Plasmid DNA digested with unique restriction enzyme (≈ 250 ng/μl) 2 μl 
Km
R
 cassette digested with BglII (≈ 20 ng/μl) 5 μl 
10X Ligase buffer 1 μl 
T4 DNA Ligase (3 Weiss units/μl) 2 μl 
 
The reaction was incubated overnight at 4°C. Transformation of the reaction mixture into XL-
2 cells was performed as previously described (see 4.10). Transformants were selected and 
plated on LB/ampicillin/kanamycin plates and incubated overnight at 37°C. Resultant 
colonies were restreaked onto LB/ampicillin/kanamycin plates and checked for the insertion 
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of a Km
R
 cassette by carrying out an orientation specific primer PCR and an ISPCR, using the 
original primers used for amplification of the CDS of interest to test positive transformants. 
To check the orientation of the Km
R
 cassette and the success of the transformation step, a 
PCR from boiled/lysed bacteria single colonies was carried out. To transform this E. coli, 
single colonies were selected from the respective plates, resunspended in Milli-Q water, lysed 
through boiling and purified. Next, 1 µl of each sample was subjected to VPPCR using vector 
specific primers and orientation specific primer PCR (kanamycin forward out and cdtA gene 
specific forward primers) (Appendix 2). After an adequate migration, DNA bands were 
scanned and analyzed. Exclusively E. coli colonies which showed to have the kanamycin 
cassette into the PI were plated in fresh LB/ampicillin plates and overnight incubated. Only 
positive transformants colonies grown on LB/amp plates were used for PIK glycerol stock 
preparation and Miniprep production (see 4.12). 
 
4.18 Isolation of C. jejuni OMVs 
The OMV isolation process consisted of three stages: 
Stage 1: 50 ml of Brucella Broth were preincubated, for 24 hours before inoculation, with 
shaking at 75 rpm in the VAIN. 
Stage 2: C. jejuni from a 24 hour grown blood agar plate was resunspended in 1ml Brucella 
broth and used to inoculate 50 ml pre-equilibrated Brucella broth to an OD600 of 0.1; PBS was 
used as blank for spectrophotometer determination. 
Stage 3: C. jejuni cultures were grown for 18 hours to mid-log phase (overnight) and the 
OD600 was re-checked using Brucella broth as blank. Samples were centrifuged at 4000 x g 
for 30 minutes at 4°C and the resulting supernatant was filtered through a 0.22 μm membrane 
(Millipore, U.K). Subsequently, filtrate was centrifuged at 4000 x g for 30 minutes at 4°C 
using an Ultra-4 centrifugal filter unit (Millipore) with a nominal 10 kDa cut-off to 
concentrate the filtrate to 2 ml volume. 
The concentrated filtrate was transferred into a new glass centrifuge tube. The weight was 
checked (7.0 g per tube) and ultra-centrifuged at 45,000 x g for 3 hours at 4°C using a 
Beckman Optima™ TL 100 ultracentrifuge (Beckman Coulter, U.K). The centrifuged tube 
was discarded and the resulting OMVs pellet was carefully resunspended with 200 µl of PBS 
and stored at -20°C. All isolation steps were carried out at 4°C (on ice) to preserve OMVs 
stability. Approximately 100 µg of OMVs by protein content was isolated from 50 ml of 
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culture supernatant (Elmi et al, 2016). At the end, the resulting sample can be processed for 
the quantitation of total proteins. 
 
4.19 Quantitation of total proteins by bicinchoninic acid assay (BCA)  
Quantitation of total proteins isolated from 50 ml of culture supernatant, was determined by 
BCA assay (Thermo Fisher Scientific). This method combines the well-known reduction of 
Cu
+2
 to Cu
+1
 by protein in an alkaline medium (the Biuret reaction) with the highly sensitive 
and selective colorimetric detection of the cuprous cation (Cu
+1
) using a unique reagent 
containing bicinchoninic acid (Smith et al, 1985)The chelation of two molecules of BCA with 
one cuprous ion causes the peculiar purple-coloured reaction of this assay. We can obtain the 
resultant BCA/complex, readable at 562 nm to the spectrophotometer, following the 
following Pierce BCA Protein Assay Kit protocol. 
Before starting the Standard protocol, the preparation of diluted albumin standards (BSA) and 
working reagent was required. BSA standards were prepared as described in the following 
table: 
 
Vials Volume of diluent (µl) Volume and Source BSA 
(µl) 
Final BSA 
concentration (µg/ml) 
A 0 300 of stock solution 2000 
B 125 375 of stock solution 1500 
C 325 325 of stock solution 1000 
D 175 175 of vial B dilution 750 
E 325 325 of vial C dilution 500 
F 325 325 of vial E dilution 250 
G 325 325 of vial F dilution 125 
H 400 100 of vial G dilution 25 
I 400 0 0 
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The BCA working reagent (WR) was prepared as described in the following formula: 
(# standards + # unknowns) x (# replicates) x (volume of WR per sample) = 
 
 Total volume of WR required 
 
Having 6 unknown/samples and 2 replicates, the resulting formula was: 
 
(9 standards + 6 unknowns) x (2 replicates) x (200 µl) = 6000 µl WR required 
 
Having calculated the WR volume required, WR was prepared by mixing 50 parts of BCA 
Reagent A with 1 part of BCA Reagent B (50: 1, Reagent A: B); in this specific case 120 µl 
Reagent B was combined with 6000 µl Reagent A. 
The microplate procedure was performed using a sample to WR ratio equal to 1: 20 (as a 
consequence, the working range of the assay was limited to 125-2000 µg/ml). For this reason, 
10 µl of each sample were pipetted into the microplate wells and 200 µl WR were added to 
each. Then the plate was put on a plate shaker for 30 seconds to mix the solutions and was 
incubated on the dark at 37°C for 30 minutes. After this incubation period, the plate was 
cooled to room temperature and the absorbance at 562 nm was measured on a plate reader 
(Spectra Max M3, Molecular Devices, U.K) by using the SoftMax Pro 5 software (Molecular 
Devices). 
To determine the protein concentration of each sample it was used a standard curve prepared 
by plotting the average blank-corrected 562 nm measurement for each BSA standard vs. its 
concentration in µg/ml. The blank correction was done subtracting the average 562 nm 
absorbance measurement of the blank standard replicates from the 562 nm measurements of 
all other individual standard and sample replicates. The resulting standard curve is necessary 
to calculate the concentration value (µg/ml) for each sample.  
 
4.20 Pre-treatment of T84 intestinal Eukaryotic cells with C. jejuni whole cells and 
OMVs 
T84 cells (1 x 10
5
 per well) were two times washed with DMEM/F-12 (Gibco™, Thermo 
Fisher Scientific) at 37°C and then incubated for 4, 6, 16, 20 hours with 1 ml media enriched 
with OMVs previously isolated or C. jejuni whole cells (OD600: 0.1) from bacteria strains. For 
the positive control, cells were incubated with Thapsigargin (25 µM) (Cell Signaling 
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Technology, U.S.A). Thapsigargin is well known as an endoplasmic reticulum Ca
2+
 pump 
inhibitor because of the rapid interaction with SERCA enzymes (Ca
2+
-ATPase family) 
(Rutkowski & Kaufman, 2004). 
 
4.21 CHOP and BIP proteins detection by SDS-PAGE and Western blotting 
Proteins contained into lysates were separated by SDS-PAGE (NuPage Novex Bis-Tris 4 – 
12%; Invitrogen). For Western blots, separated proteins contained into the pre-run 
polyacrylamide gel were blotted and transferred onto nitrocellulose membranes (iBlot2, 
Thermo Fisher Scientific) using the iBlot 2 Dry Blotting System (Thermo Fisher Scientific). 
The membrane was blocked with PBS 1X supplemented with 2% (wt/vol) non-fat dried milk 
and incubated overnight at 4°C. The membrane was incubated with primary mouse anti-
CHOP (Sigma-Aldrich) or primary mouse anti-BiP (Sigma-Aldrich) antibodies respectively 
(1: 2500 dilution in PBS 1X supplemented with 0.1% (vol/vol) Tween-20 and 2% (wt/vol) 
non-fat dried milk) for 1 hour at room temperature with shaking (35 rpm/min speed, Platform 
Shaker STR6, Stuart Scientific, U.K). After incubation, the membranes were rinsed four times 
with PBS 1X supplemented with 0.1% (vol/vol) Tween-20 and were incubated for 1 hour at 
room temperature with infrared fluorescence – conjugated secondary antibodies (goat anti-
rabbit IR800) (Sigma-Aldrich) a 1: 10,000 dilution of blocking buffer. Before visualization, 
membranes were washed 4 times with PBS supplemented with 0.1% (vol/vol) Tween -20 and 
once with PBS 1X. The blots were visualized and scanned with an Infrared Imager (Odyssey 
CLx Imaging System, LI-COR Biosciences, U.K) and analysed using the Image Studio 
Software (LI-COR Biosciences). 
 
4.22 Total RNA isolation  
After preincubation with OMVs and C. jejuni whole cells (see 4.20), total mRNA was 
isolated from T84 cell lysates using the PureLink RNA Mini Kit (Thermo Fisher Scientific). 
T84 cell lysis and RNA extraction were performed in three passages: lysis, homogenization 
and RNA Purification. 
The growth medium was removed from the cells and 0.6 ml Lysis Buffer were added to the 
wells. Lysis buffer used in this passage contained 1% 2-mercaptoethanol (10 µl 2-
mercaptoethanol for every 1 ml Lysis buffer). By pipetting cells were disrupted and the 
reaction was transferred into 1.5 µl microcentrifuge tubes. Tubes were vortexed until the cell 
pellet was dispersed and the cells appeared completely lysed. During the second passage, 
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lysates were transferred into clean tubes and homogenized using a Precellys
R
 tissue 
homogenizer (Precellys, U.K) for three times. After each homogenization cycle, tubes were 
chilled 5 minutes in ice. Subsequently binding, washing and elution of RNA were performed 
as follows: one volume of 70% ethanol was added to each volume of cell homogenate and the 
reaction was vortexed to disperse any visible precipitate. 700 µl of the sample were 
transferred to the spin cartridge (with the collection tube) and centrifuged at 12,000 x g for 15 
seconds, then the flow-through was discarded. This step was repeated until the entire sample 
had been processed. To wash the sample, 700 µl wash buffer 1 were added to the spin 
cartridge and centrifuged at 12,000 x g for 15 seconds at room temperature; the flow-through 
was discarded and the spin cartridge was placed into a new collection tube. For the second 
washing 500 µl wash buffer 2 (previously enriched with ethanol 100%) was added to the tube 
that was centrifuged at 12,000 g for 15 second, for 2 minutes. This passage was repeated two 
times. 
In order to dry the membrane with attached the RNA, the spin cartridge was centrifuged at 
12,000 x g for 2 minutes. The collection tube was discarded and the spin cartridge was 
inserted into a recovery tube; 40 µl RNAse free water was added to the centre of the spin 
cartridge and incubated for 1 minute. A final centrifugation of the spin cartridge (2 minutes) 
allowed the RNA to elute from the membrane into the recovery tube. The quality and the 
quantity of our RNA was determined by using a NanoDrop spectrophotometer with UV 
absorbance at 260 nm (see 4.5). RNA samples that were not immediately used were stored at -
80°C. 
To assure highly pure RNA without genomic DNA contamination, after RNA purification a 
DNase treatment was performed (Turbo DNA-Free Kit). 
In detail, 4 µl TURBO DNase buffer 10X were added to the tube containing purified RNA 
and an incubation for 45 minutes at 37°C followed. 4 µl inactivation reagent were added to 
the reaction and the tube was incubated for 5 minutes at room temperature, mixing 
occasionally by flicking. Followed a centrifugation at 10,000 x g for 15 minutes. 30 µl 
supernatant were transferred into a new clean tube. Samples were immediately used or stored 
at -80°C for a long term storage. 
  
69 
 
4.23 cDNA synthesis  
The first-strand cDNA synthesis from purified total RNA was performed with SuperScript III 
First-Strand Synthesis System for RT-PCR (Thermo Fisher Scientific). The following 
protocol was used for positive and negative RT control reaction preparation: 
Total RNA was diluted to 100 pg/µl with DEPC-treated water and RNA/primer mixtures was 
prepared in sterile 0.5 ml tubes as described below (total volume, 10 µl): 
 
Component +RT control -RT control 
Diluted total RNA (100 pg/µl) 1 µl 1 µl 
Oligo (dT)20 1 µl 1 µl 
10 mM dNTPs mix 1 µl 1 µl 
DEPC-treated water 7 µl 7 µl 
 
Samples were incubated at 65°C for 5 minutes, then placed on ice for at least 1 minute. The 
contents were collected by a brief centrifugation and the following components were added: 
 
Component +RT control -RT control 
10X RT buffer 2 µl 2 µl 
25 mM MgCl2 4 µl 4 µl 
0,1 M DTT 2 µl 2 µl 
RNaseOUT (40 U/ µl) 1 µl 1 µl 
SuperScript III RT (200 U/ µl) 1 µl - 
DEPC-treated water  - 1 µl 
 
Tubes were gently mixed, collected by brief centrifugation and put into the PCR block and the 
following programme was performed: 
 Step 1: 25°C, for 10 minutes 
 Step 2: 50°C, for 50 minutes 
 Step 3: 85°C, for 5 minutes 
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Tubes were briefly centrifuged to collect the reactions. 1 µl of RNase H was added to each 
tube and incubated for 20 minutes at 37°C in order to remove the RNA template from the 
cDNA: RNA hybrid molecules by digestion with RNase after first-strain synthesis. 
 
4.24 Reverse Transcription PCR (RT-PCR)  
Once synthesised the cDNA from mRNA, the RT-PCR reaction was set up as follows: 
 
XBP1 forward + reverse primers (FR) 1 µl 
cDNA 2 µl 
PCR master mix 50 µl 
 
Reagents were added in succession and gently mixed by pipetting. Tubes were put into the 
PCR block and the following programme was performed: 
 Step 1: 95°C, for 3 minutes 
 Step 2: Denaturation at 95°C, for 15 seconds 
 Step 3: Annealing at 50°C, for 20 seconds 
 Step 4: Extension at 72°C, for 30 seconds 
Steps 2-3 were repeated 35 times 
To view the samples, an agarose gel was run as described in section 4.7, but with the 
following modifications. The gel was prepared by mixing TAE 1X (150 ml) with 3.3% 
(wt/vol) agarose (2.2 g) and 3.3% (wt/vol) Sea Plaque agarose (2.2 g). 20 µl of the PCR 
reaction was analysed on the agarose gel previously prepared and after an adequate migration, 
an ultraviolet trans-illuminator was used to identify and scan DNA bands (Syngene).   
Hs_GAPDH_1_SG QuantiTect
R 
Primer Assay (Qiagen) was used as loading control for RT-
PCR samples.  For each tube, the RT-PCR of GAPDH was set up as follows:  
 
Hs GAPDH 1 SG 1 µl 
cDNA 1 µl 
PCR master mix 20 µl 
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Samples amplified with GAPDH primers were loaded into a 0.7% agarose gel. After an 
adequate migration the resulting gel was analysed (see 4.7). 
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Results 
 
5. Monocytes from donor’s human blood 
 
PCR analyses of C. jejuni strains. 
Before lysate preparation and OMV isolation, it was verified the cdtA gene presence or 
absence in C. jejuni wild type and cdtA mutant strains respectively. The resulting 
electrophoresis confirmed the wild type nature of C. jejuni ATCC 33291, C. jejuni ISS 1 (Fig. 
5.1), and C. jejuni 11168H (Fig.5.2), and the presence of the cdtA gene mutation in the C. 
jejuni 11168H cdtA mutant strain (Fig. 5.2). 
 
 
Fig. 5.1 Electrophoresis from genomic DNA purified by two clones of the C. jejuni ATCC 
33291 wild type strain (W1 and W2) and two clones of the C. jejuni ISS 1 wild type strain 
(IS1 and IS2). C. jejuni genomes were purified using the PureLink Genomic DNA kit, 
amplified by PCR and analysed on TAE-agarose-ethidium bromide gel electrophoresis. The 
ntc shows the negative control. Quality of isolated genomic DNA was controlled by standard 
16S rDNA. These results confirmed the presence of the cdtA gene in all investigated clones. 
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Fig.5.2 Electrophoresis from genomic DNA purified by C. jejuni 11168H wild type strain 
(lane 3) and two clones of the C. jejuni 11168H cdtA mutant strain (lanes 4 and 5). C. jejuni 
genomes of wild type and cdtA mutant strains were purified using the PureLink Genomic 
DNA kit, amplified by PCR and analysed on TAE-agarose-ethidium bromide gel 
electrophoresis. The lane 2 shows the negative control. These results confirmed the presence 
of the cdtA gene mutation in the C. jejuni 11168H cdtA mutant strain. 
 
Morphological features, cell death and absolute count 
It has been widely shown how CDT intoxication induces cellular distension/enlargement in 
target cells (Dixon et al, 2015). Forward light scatter parameter (FSC) was used as an 
indicator of cell size in cytometry; these data were taken together with microscopy analyses of 
morphologic appearance. 
We compared FSC values of untreated control cells with FSC values of cells that were treated 
with lysates previously prepared. All treatments induced a moderate increase in FSC values 
and cell enlargement after 24 hours (Fig. 5.3A). At 48 hours, as predicted, cells preincubated 
with lysates from the wild type strains showed the typical distension induced by the CDT, 
whereas cells preincubated with the C. jejuni 11168H cdtA mutant lysate revealed a 
significant reduction in FSC values, also due to the apoptotic shrinkage that occurred in these 
last (see data on Propidium iodide positivity) 
The PI (Propidium iodide) supravital labelling allowed us to detect and discriminate necrotic 
and apoptotic cells (Fig. 5.3C). PI results demonstrated that lysates caused a significant 
increase in PI positive cells (apoptotic cells) overall. Of note, from 24 hours onwards, both 
lysates from the wild type strains acted as death-inducers, but in two different ways. To 
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deeply monitor the phenomenon of cell death, we performed cell count by using Trypan blue 
viability test and absolute counting beads in cytometry (see 3.13 and 3.12). Microscopy 
visualization of this cellular rarefaction and total cell count are shown in Fig. 5.3B and 5.3D 
respectively. Reduction in cell number was particularly evident in monocytes preincubated 
with the C. jejuni ATCC 33291 lysate.  
 
 
Fig. 5.3 Morphological features and cell death rate. (A) Trends of FSC values for each 
treatment during the time course from T0 to 48 hours. FSC values were converted to arbitrary 
units (A.U.) setting control (T0) as 100. Each value is expressed as a mean ± SD (Results 
from n ≥ 3 independent experiments). Two-way ANOVA with Bonferroni’s multiple 
comparison test revealed *P<0.05 MUT vs control (T0) at 48 hours, *P<0.05 ISS 1 vs 
respective 24 hours, at 48 hours. The trend during the time course was determined to be 
significant (***P < 0.001). (B) Bright field images of monocytes after 24 hours preincubation 
with C. jejuni ATCC 33291 lysate (b), C. jejuni ISS 1 lysate (c) and C. jejuni 11168H cdtA 
mutant lysate (d), compared to the untreated control cells (a). (C) Trends of percentage of PI 
positive cells for each experimental condition during the time course from T0 to 48 hours. 
Each value was expressed as a mean ± SD (Results from n ≥ 3 independent experiments). (D) 
Absolute counts of viable and dead cells after 48 hours preincubation with lysates, compared 
to untreated control cells. Results from a representative experiment.  
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Mitochondrial and lysosomal alterations 
Perturbations of mitochondrial transmembrane potential resulted after preincubation with 
lysates (Fig. 5.6A and Fig.5.7A). TMRE MFI (mean fluorescence intensity) gradually 
decreased in monocytes infected with the C. jejuni ATCC 33291 lysate during the time course 
(from 3 to 48 hours). At 48 hours, these last showed the lowest TMRE value, compared with 
other experimental conditions, in which a decrease in TMRE MFI was followed by a return to 
the original/control values (T0).  
Cardiolipin (CL) is an easily oxidizable phospholipid present in mitochondria. To investigate 
mitochondrial status, we also evaluated cardiolipin content by Nonyl Acridine Orange (NAO) 
staining. As shown in Fig. 5.7B, non-significant variations in cardiolipin content occurred in 
monocytes preincubated with the lysates. At the same time, by using the MitoSOX staining, 
we detected a dramatic increase in mitochondrial ROS from 24 hours onwards in all 
experimental conditions, compared to the control (T0) (Fig. 5.7C).  
In order to investigate whether C jejuni lysates altered host lysosome integrity during 
infection, cells were stained with Lyso Tracker Green: a lysosomotropic dye that emits 
fluorescence when accumulate in acidic compartments, such as lysosomes. As shown in Fig. 
5.6B and 5.7D, in terms of amount of LTG-accumulating lysosomes, C. jejuni lysates induced 
in monocytes a reduction at 12 hours followed by a significant increase at 24-48 hours, 
specifically in cells preincubated with the C. jejuni ISS 1 lysate.  
These findings are consistent with PI results that showed that the mortality rate was low at 12 
hours and pronounced at 24-48 hours. These data also demonstrated that, if monocytes 
initially reduced their lysosomal compartments in size, number and functionality, 
subsequently they increased them in late phases of the infection.  
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Fig. 5.6 (A) Single confocal optical sections of TMRE (mitochondria), with the relative bright 
field (BF) images, of CTRL cells and monocytes infected with C. jejuni ATCC 33291 lysate 
for 12, 24 and 48 hours. (B) Single confocal optical sections of LTG (lysosomes) with the 
relative BF images for CTRL cells, and cells infected with ATCC 33291, ISS 1 and 11168H 
cdtA mutant lysates for 12 hours.   
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Fig. 5.7 (A) Trends of TMRE MFI for each treatment during the time course from T0 to 48 
hours. Mean values were converted to A.U. setting control (T0) as 100. Each value is 
expressed as a mean ± SD (Results from n ≥ 3 independent experiments). Two-way ANOVA 
with Bonferroni’s multiple comparison test revealed: *P<0.05 ISS1 vs control (T0) at 24 
hours, **P<0.001 MUT vs control (T0) at 24 hours, ***P<0.001 ATCC 33291 vs control (T0) 
at 48 hours. The trend during the time course was determined to be significant (***P < 
0.001).  
(B) Trends of NAO MFI for each experimental condition during the time course from T0 to 
48 hours. Mean values were converted to A.U. setting control (T0) as 100. Each value is 
expressed as a mean ± SD (Results from n ≥ 3 independent experiments). 
(C) Trends of MitoSOX MFI for each treatment during the time course from T0 to 48 hours. 
Mean values were converted to A.U. setting control (T0) as 100. Each value is expressed as a 
mean ± SD (Results from n ≥ 3 independent experiments) Two-way ANOVA with 
Bonferroni’s multiple comparison test revealed: ***P < 0.001 ATCC 33291 vs control (T0) at 
24 and 48 hours, ***P < 0.001 MUT vs control (T0) at 24 hours, ***P < 0.001 ISS 1 vs 
control (T0) at 24 hours, *P < 0.05 ISS 1 vs control (T0) at 48 hours, ***P < 0.001 ATCC 
33291 and ISS 1 vs MUT at 24 hours.  
(D) Trends of LTG MFI for each treatment during the time course from T0 to 48 hours. Mean 
values were converted to A.U. setting control (T0) as 100. Each value is expressed as a mean 
± SD (Results from n ≥ 3 independent experiments). Two-way ANOVA with Bonferroni’s 
multiple comparison test revealed: *P < 0.05 MUT vs control (T0) at 48 hours, **P < 0.01 
ISS 1 vs control (T0) at 48 hours. The trend during the time course was determined to be 
significant (***P < 0.001). 
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p53 and Bcl-2 detection 
Our results revealed a decrease in p53 content in monocytes preincubated with the wild type 
lysates for 12 hours. This status remained stable until 24 hours, then p53 intracellular content 
increased, reaching initial physiological levels (Fig. 5.8A). These fluctuations reflected the 
balance between growth arrest and apoptosis mechanisms (Siegl & Rudel, 2015). Apoptosis 
was accompanied by morphological changes, including nucleus condensation, apoptotic blebs 
formation and appearance of cytoplasmic vacuoles and granulation (Fig 5.8C). 
The apoptotic threshold of a cell was determined by a ratio of pro-apoptotic and anti-apoptotic 
signals, and apoptosis occurred when pro-apoptotic signals outweighed the counteracting anti-
apoptotic factors (Verbeke et al, 2006). 
Anti-apoptotic Bcl-2 family proteins are known to influence the apoptotic threshold. Our 
findings revealed the following scenario for Bcl-2 (Fig. 5.8B): from T0 to 12 hours a drop in 
Bcl-2 intracellular levels was observed, in particular in monocytes preincubated with the C. 
jejuni ATCC 33291 lysate; at 24 hours Bcl-2 values of all experimental conditions were very 
similar. 
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Fig. 5.8 p53 and Bcl-2 protein levels and morphologic features of cell death. (A) Graphs 
showing p53 intracellular content for each experimental condition during the time course 
from T0 to 48 hours. Mean values were converted to A.U. setting control (T0) as 100. Each 
value is expressed as a mean ± SD (Results from n ≥ 3 independent experiments). Two-way 
ANOVA with Bonferroni’s multiple comparison test revealed: *P<0.05 ISS1 vs control (T0) 
and **P<0.01 ATCC vs control (T0) at 12 hours, *P <0.05 ATCC and ISS1 vs control (T0) at 
24 hours, **P<0.01 MUT vs control (T0) at 24 hours.  
(B) Graphs showing Bcl-2 intracellular content for each experimental condition during the 
time course from T0 to 48 hours. Mean values were converted to A.U. setting control (T0) as 
100. Each value is expressed as a mean ± SD (Results from n ≥ 3 independent experiments). 
Two-way ANOVA with Bonferroni’s multiple comparison test revealed: **P<0.01 ATCC vs 
control (T0) at 12 hours. 
(C) Bright field images of monocytes after 24 hours preincubation with C. jejuni ATCC 
33291, ISS1 and 11168H cdtA mutant lysates, compared to untreated control cells (CTRL). In 
infected cells it is possible to appreciate apoptotic blebs (black arrows), condensed nuclei 
(arrowhead), cytoplasmic vacuoles (asterisks) and a diffuse granulation (in particular in 
ATCC 33291 and ISS 1). 
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ER stress and modulation of intracellular Ca
2+
 levels 
ER stress might be both a trigger and consequence of chronic inflammation. Monocytes were 
stained with ER-Tracker Green and Fura-2 AM in order to investigate ER stress and 
intracellular Ca
2+
 level perturbations. ER-Tracker Green dye is a cell-permeant, live-cell stain 
that is highly selective for the ER. It stains ER membranes and it is known to be a ER stress 
marker in both cytometry and microscopy (Conn, 2011). Our data showed that ER stress 
occurred after 12-24 hours of treatment (Fig. 5.9A), especially in monocytes infected with the 
C. jejuni ATCC 33291 lysate. Moreover, the lysate from the cdtA mutant strain caused more 
ER modifications then the ISS 1 wild type strain; we supposed that ER stress is not an effect 
associated to the CDT, but it is due to other C. jejuni virulence factors. 
In addition, FURA-2 AM results showed an increase in intracellular Ca
2+
 content in 
monocytes preincubated for 48 hours with the C. jejuni ATCC 33291 lysate compared with 
other experimental conditions (data not statistically significant) (Fig. 5.9B).  
 
 
Fig. 5.9 (A) Graph showing ER-Tracker Green MFI for each experimental condition during 
the time course from T0 to 48 hours. Mean values were converted to A.U. setting control (T0) 
as 100. Each value is expressed as a mean ± SD (Results from n ≥ 3 independent 
experiments). Two-way ANOVA with Bonferroni’s multiple comparison test revealed: 
***P<0.001 ATCC 33291 vs control (T0) at 12 and 24 hours, *P<0.05 ATCC 33291 vs 
control (T0) at 48h, **P<0.01 ISS 1 vs control (T0) at 48 hours, ***P<0.001 ATCC 33291 vs 
ISS 1 at 12 hours and **P<0.01 at 24 hours, **P<0.01 ATCC 33291 vs MUT at 24 hours. (B) 
Fold of increase in intracellular Ca
2+
 content, measured by means of FURA-2 AM, referred to 
control samples after 48 hours preincubation. Each value is expressed as a fold of increase ± 
SD (Results from n ≥ 3 independent experiments). 
 
81 
 
Surface CD59 expression 
CD59 expression was studied in monocytes in order to investigate if MAC complex was 
involved in cell response triggered by C. jejuni lysates. It was found that from 24 to 48 hours 
in infected monocytes an upregulation of CD59 surface expression occurred: it was 
particularly evident in cells preincubated with the C. jejuni ISS 1 lysate, followed by 
monocytes preincubated with the mutant strain lysate (Fig.5.10). This condition, being CD59 
a critical complement regulator in protecting human cells from MAC formation and MAC-
induced phenomena, seems to predispose monocytes to survive. In fact, it is known that CD59 
over-expression may assist malignant cells to escape immunologic surveillance and 
complement-mediated cytolysis (Verbeke et al, 2006). 
 
 
Fig.5.10 Bar graph of CD59 expression for each experimental condition after 24 and 48 hours 
of treatment. Mean values were converted to A.U. setting control (T0) as 100. Each value is 
expressed as a mean ± SD (Results from n ≥ 3 independent experiments). 
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Surface LAMP-1 expression: lysosomal exocytosis 
Infected and uninfected cells were also analysed for the presence of lysosomal protein LAMP-
1 at cell surface. Being cells specialized to phagocytose, monocytes typically express low 
levels of surface LAMP-1 (CD107a). It was observed an increase in LAMP-1 expression 
principally in monocytes preincubated with the wild type lysates from T0 to 24 hours (Fig. 
5.11A). Increasing the exposition time (48 hours), it was worth to note that a downregulation 
of LAMP-1 to hypo-physiologic levels occurred. Our data on lysosomal exocytosis, suggested 
that lysosomes, in the first infection stages, may “dump” indigested materials, reducing their 
accumulation within lysosomes, whereas at 48 hours a drop in exocytotic activity it was 
registered. These findings have to be coupled with LTG results: in fact, the decrease in 
lysosomes size and number was not due to the exocytosis activation. On the contrary at 48 
hours, when LTG fluorescence peaked, LAMP-1 strongly decreased. This process might have 
an important role in secretion and plasma membrane repair since lysosomes play a key role in 
resealing the membrane to prevent cell death (McNeil, 2002). 
 
 
Fig.5.11 (A) Graph showing lysosomal exocytosis for each experimental condition during the 
time course from T0 to 48 hours. Mean values were converted to A.U. setting control (T0) as 
100. Each value is expressed as a mean ± SD (Results from n ≥ 3 independent experiments). 
(B) Trends of LTG MFI for each treatment during the time course from T0 to 48 hours 
(described in Fig. 5.7). 
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CD14 and ICAM-1 (CD54) variations  
In infected monocytes, an early decrease in CD14 expression (T0-12 hours) was followed by 
an important increase in CD14 expression after 24 hours of treatment (Fig. 5.12).  
Increased ICAM-1 expression induced by various pathogens was shown to mediate cell-to-
cell adhesion in inflamed tissues (Tamai et al, 2005). As showed in Fig. 5.13A, an increase in 
ICAM-1 expression was detectable in monocytes particularly at 3 and 48 hours. Furthermore, 
confocal pictures revealed a variation in surface ICAM-1 distribution: a ‘punctuate’ 
organization with a loss of ‘cap’ distribution occurred confirming that a reshaping of the 
plasma membrane arose because of the infection (Fig. 5.13B).  
 
 
Fig. 5.12 CD14 expression. (A) Graph showing CD14 expression in monocytes preincubated 
with lysates. Mean values were converted to A.U. setting control (T0) as 100. Each value is 
expressed as a mean ± SD (Results from n ≥ 3 independent experiments). Two-way ANOVA 
with Bonferroni’s multiple comparison test revealed: *P < 0.05 MUT and ATCC 33291 vs 
control (T0) at 24 hours, *P<0.05 MUT and ATCC 33291 vs respective 24 hours, at 3 hours; 
*P<0.05 MUT, ATCC 33291 and ISS 1 vs respective 24 hours, at 12 hours. The trend during 
the time course was determined to be significant (***P < 0.001). (B) Confocal images of 
CD14-PE with the relative bright field images from monocyte control cells and monocytes 
preincubated with the C. jejuni ATCC 33291 lysate for 24 hours. Bars: 10µm. 
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Fig. 5.13 ICAM-1 expression. (A) Graph showing ICAM-1 expression Mean values were 
converted to A.U. setting control (T0) as 100. Each value was expressed as a mean ± SD 
(Results from n ≥ 3 independent experiments). Two-way ANOVA with Bonferroni’s multiple 
comparison test revealed: ***P<0.001 ISS 1 vs control (T0) at 3, 24 and 48 hours, 
***P<0.001 ATCC 33291 vs control (T0) at 3 hours, *P<0.05 ISS 1 and ATCC 33291 vs 
respective 12 hours, at 3 hours. The trend during the time course was determined to be 
significant (*P < 0.05). (B) Confocal images of CD54-PE with the relative bright field images 
from monocyte control cells and monocytes preincubated with ISS 1 lysate after 48 hours of 
treatment. Bars: 10µm. 
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Discussion 
Our results highlight that the cellular distension, typically induced by CDT, is mainly 
appreciable in monocytes preincubated with lysates from the wild type strains, particularly 
after 48 hours. During the time course, cell death increased, qualifying C. jejuni ATCC 33291 
lysate as the best cell death-inducer, followed by C. jejuni ISS 1 lysate. Taking PI results 
together with other cell death parameters, we can say that it is very likely that a reduction in 
PI positive cells at 48 hours in monocytes treated with the C. jejuni ATCC 33291 strain is not 
due to a greater cell viability of these cells but to a greater DNA damage, that does not allow 
the binding between PI dye and DNA. This finding was also confirmed by absolute cell count 
at 48 hours.  
In order to evaluate mitochondrial mass and morphology, as well as the involvement of 
mitochondria in the apoptotic pathway, cells were stained with TMRE and NAO, two 
mitochondria-speciﬁc ﬂuorochromes. The collapse of the mitochondrial transmembrane 
potential leads to the opening of the mitochondrial permeability transition pores, the release of 
cytochrome c into the cytosol and the activation of the apoptotic cascade. Depending on the 
specific apoptotic stage in which cells are, mitochondrial transmembrane potential can 
increase or decrease: more polarized mitochondria (i.e. hyperpolarized, where the interior is 
more negative) will accumulate more cationic dye, whereas depolarized mitochondria (where 
the interior is less negative) accumulate less dye because of an extremely collapsed 
mitochondrial status (Hüttemann et al, 2012). The C. jejuni strain that induced the most 
relevant mitochondrial alterations was the ATCC 33291, confirming that this strain favours an 
intrinsic apoptotic pathway  
In addition, an increase in the content of reactive oxygen species occurred in monocytes 
preincubated with lysates, probably in a CDT independent manner, as demonstrated by 
MitoSOX result, which are consistent with TMRE results. 
We found mitochondria and lysosomes differently targeted by the different strains in 
monocytes. Indeed, whereas C. jejuni ATCC 33291 wild type strain showed to induce an 
intrinsic apoptotic pathway, characterized by the induction of mitochondria alterations, the C. 
jejuni ISS 1 wild type strain mostly induced lysosomal alterations, therefore an extrinsic 
apoptotic pathway. Furthermore, although at 48 hours host acidic compartments/lysosomes 
started to respond differently to the different lysates, from 3 to 12 hours the trend is the same 
for all experimental conditions: a significant decrease in LTG fluorescence indicates that a 
86 
 
neutralization of host acidic compartments occurred in infected cells in response to C. jejuni 
virulence factors contained within the lysates.  
Changes in lysosomal acidic compartments, ER and p53 expression occurred together from 
T0 to 24 hours. 
The p53 tumour suppressor responds to certain cellular stresses by inducing transcriptional 
programs that can lead to growth arrest or apoptosis. P53-dependent growth arrest and 
apoptosis are usually caused by stimuli that trigger DNA damage (Amaral et al, 2010).  
In this investigation, lysates from the wild type strains induced an important decrease in p53 
intracellular content from T0 to 12 hours; this effect is not shown in cells preincubated with 
the mutant strain. This finding underlines that this specific effect is mainly due to the CDT. 
Different authors have demonstrated that the degradation of p53 prolongs pathogen survival 
(Zaika et al, 2015). However, p53 levels increase after 48 hours. This increase might be also 
associated to data about lysosomal compartments and lysosomal exocytosis at the same time 
point. Our findings also revealed a strong decrease in Bcl-2 content specifically after 12 hours 
in monocytes treated with the ATCC 33291 lysate: this pro-apoptotic response is consistent 
with the deep mitochondria alterations induced by this strain that has been already described.  
Overall, lysates induced ER stress in monocytes compared to the untreated control cells. Of 
note, an important stress was induced by the C. jejuni ATCC 33291 strain. Surprisingly, the 
lysate from the cdtA mutant strain caused more ER alterations then the ISS 1 wild type strain; 
inducing us to suppose that ER stress is not associated to the CDT, but it is due to other C. 
jejuni virulence factors. ER data are consistent with the increase in cytosolic Ca
2+
 content 
induced by lysates.  
CD59 is an 18-kDa cell surface protein that inhibits the formation of the MAC, the pore-
forming toxin of the complement system that cells activate in order to kill pathogens. The 
marked increase of CD59 expression observed in monocytes treated with lysates could 
promote the pro-inflammatory/non-lytic role of MAC, resulting in protection of the 
bacterium/virulence factors from the complement attack. CD59 revealed to be as a general 
infection marker in monocytes. The maximum increase of CD59 is registered at 48 hours for 
ISS 1 and 11168H cdtA mutant lysates, whereas cells treated with the C. jejuni ATCC 33291 
lysate showed a reduction at this time point: this is consistent with the presence of an 
apoptotic rate. Upregulation of CD59 in monocytes preincubated with the mutant strain 
suggested that CDT is not implicated in processes described above. 
Although monocytes express basal lysosomal exocytosis processes because of their 
phagocytic nature, LAMP-1 upregulation was caused by lysates used in our investigations. 
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However, our findings suggested that virulence factors contained in lysates are able to 
activate lysosomal exocytosis in monocytes in a CDT-dependent manner. 
The CD14 involvement in host defence against viral and bacterial infections has been 
investigated in several experimental models. It was reported that CD14 is upregulated by 
bacterial LPS and contribute to CD14-mediated phagocytosis of Gram-negative bacteria 
(Grunwald et al, 1996). In this work there were not found particular differences in CD14 
expression between cells preincubated with the wild type and mutant strains, on the contrary 
variations between uninfected and infected cells and variations in CD14 expression during the 
time course were statistically significative.  
ICAM-1 mobility is of general importance for immune responses that require firm adhesion 
(Comrie et al, 2015). Adhesion molecules, such as ICAM-1, direct immune cells to the 
inflammation site by the process of rolling, activation, adhesion, and transmigration (Ley et 
al, 2007). Altered ICAM-1 mobility perturbs inter-cellular adhesion. In this work, ICAM-1 
expression showed marked fluctuations from T0 to 48 hours, peaking after 3 hours of 
treatment and dropping at 12 hours, with a subsequent increase at 48 hours. Being this 
behaviour mainly evident in cells preincubated with the lysates from the wild type strains, it is 
possible to affirm that CDT is involved in these modifications. 
 
Even though some statistically significant results were achieved by this part of the project, a 
better method has to be optimized to study the effects of C. jejuni virulence factors in 
monocytes isolated from donors, and to better investigate the behaviour that different C. jejuni 
strains can explicate and the CDT role. This model has some limitations: the great biologic 
variability of primary myeloid cells from different donors, the moderate recovery obtainable 
from each separation procedure (monocytes represent 3-7% of total white blood cells, 
monocytes absolute count is 1.5 x10
8
 to 7.0 x10
8
/l blood in healthy human adults) and the 
differentiation to macrophages that begins when monocytes stably adhere. In addition, 
because of the high mortality rate that occurred in monocyte cultures after 48 hours, no 
investigations were carried out after this time point. 
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6. U937 cell model: U937 cells preincubated with C. jejuni lysates 
 
Subdivision of U937 cells sub-populations 
To better investigate the effects of the CDT contained within lysates and OMVs isolated from 
the C. jejuni wild type and mutant strains (see 7. Chapter 3) in U937 cells, cytometric 
analyses were conducted not only on total U937 cells, but also focusing the attention on 
different U937 sub-populations. Sub-populations were established depending on the 
morphological parameters and considering that the presence of enlarged cells after the 
treatment was due to the effects caused by the CDT. Therefore, in U937 cells, all investigated 
parameters were studied in: -total U937 cells, -distended cells, -viable/non-apoptotic cells and 
-dead cells (Fig 6.1). Particular attention was given to ‘distended cells’ because they were 
certainly affected by the CDT. In chapter 5 it was not possible to classify monocytes in these 
sub-populations because of the reduced number of available cells in the samples. 
 
 
Fig. 6.1 U937 sub-populations were established depending on the morphological parameters: 
red gate shows dead cells, yellow gate shows distended cells, blue gate shows viable cells. It 
was established that total cells were the summary of red, yellow and blue gates. In pink are 
debris excluded by the analysis. Dot plots in the picture show CTRL untreated cells and cells 
treated with the C. jejuni ATCC 33291 lysate for 72 hours. 
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Morphological features, cell death and absolute count 
As previously observed in monocytes, morphologic appearance was studied by microscopic 
and cytometric investigations. Also in U937 cells, C. jejuni wild type lysates caused the 
typical CDT dependent-cellular distension compared to untreated control cells and cells 
treated with the mutant strain lysate. Trypan blue viability test and absolute counting beads 
were used for cell counting (see 3.13 and 3.12), revealing that lysates from the wild type 
strains caused reduction in cell number in U937 cells (data not shown). In addition, AnxV-PI 
double staining revealed that AnxV-PI positive cells, that represent the apoptotic cells, were 
particularly present in U937 cells preincubated with the C. jejuni ATCC 33291 lysate (Fig. 
6.2 and 6.3). 
 
 
Fig. 6.2 Histograms of percentage of AnxV-PI positive cells calculated after 72 hours from 
lysate administration in total cells. Each value is expressed as a mean ± SD (Results from n ≥ 
3 independent experiments). One-way ANOVA with Bonferroni’s multiple comparison test 
revealed: ***P<0.001 CTRL vs ATCC 33291, ***P<0.001 ATCC 33291 vs ISS 1, 
***P<0.001 ATCC 33291 vs MUT. 
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Fig. 6.3 Density plots of PI vs AnxV MFI of all experimental conditions. Q1 shows PI 
positive cells, Q4 shows AnxV positive cells, Q2 shows AnxV-PI positive cells, Q3 shows 
AnxV-PI negative cells and debris. 
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Evaluation of cellular division  
Efficiency of CDT in G2-M blocking was investigated by means of CFSE labelling. Results 
at 48 hours showed that C. jejuni ATCC 33291 lysate exerted maximally this blocking-effect, 
whereas lysate from the C. jejuni ISS 1 strain was less active, showing percentages of 
undivided cells slightly higher than cells treated with the lysate from the mutant strain. In fact, 
as shown in Fig 6.4, a big amount of ATCC 33291 infected cells do not enter in mitosis at 48 
hours. Of note, this approach not only confirmed data from literature, but also suggested that 
lysates from different wild type strains can show different effects in U937 cells. 
Efficiency of CDT in G2-M blocking was calculated at 72 hours (Fig. 6.5). Histograms 
regarding 1°, 2° and 3° divisions indicated that CDT effects on DNA, not only persist after 72 
hours from lysate administration, but also became more evident, particularly for the C. jejuni 
ATCC 33291 lysate. 
 
 
Fig. 6.4 (A) Histogram of undivided cells calculated in cytometry via CFSE staining at 48 
hours. Paired t test (two-tailed P value) revealed: ***P<0.0001 CTRL vs ATCC 33291, 
**P<0.001 CTRL vs ISS 1, **P<0.001 ATCC 33291 vs MUT. (B) Histogram of divided cells 
calculated in cytometry via CFSE staining at 48 hours. Paired t test (two-tailed P value) 
revealed: ***P<0.0001 CTRL vs ATCC 33291, *P<0.05 CTRL vs ISS 1, **P<0.001 CTRL 
vs MUT, **P<0.001 ATCC 33291 vs MUT 
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Fig. 6.5 Histograms of cells in 1°, 2° and 3° division calculated in cytometry via CFSE 
staining at 72 hours (A) Paired t test (two-tailed P value) revealed: *P<0.05 MUT vs ATCC 
33291; (B) **P<0.001 CTRL vs ATCC 33291, **P<0.001 CTRL vs MUT, *P<0.05 CTRL vs 
ISS 1, *P<0.05 MUT vs ATCC 33291; (C) ***P<0.0001 CTRL vs ATCC 33291, **P<0.001 
MUT vs ATCC 33291, *P<0.05 CTRL vs ISS 1. 
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Mitochondrial alterations 
Microscopy and cytometric TMRE results reported interesting mitochondrial membrane 
potential perturbations after treatments (Fig. 6.6 and 6.7). Significative changes in TMRE 
MFI occurred after 72 hours in cells preincubated with the wild type strains; in particular, the 
C. jejuni ATCC 33291 lysate caused a major increase in TMRE MFI in both total and 
distended U937 cells. Lysates altered mitochondria both functionally and structurally: indeed, 
confocal pictures highlighted the presence of ‘fragmented’ mitochondria in infected cells, 
compared to uninfected control cells, where mitochondrial morphology remained unaltered 
(Fig. 6.6). 
 
 
Fig. 6.6 Single confocal optical sections of TMRE MFI of uninfected cells and infected U937 
cells at 72 hours.  
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Fig. 6.7 Histograms of percentage of TMRE positive cells calculated after 24, 48 and 72 
hours from lysate administration in total cells (tot) and distended cells (dist). Each value was 
converted to A.U. setting control as 100. Each value is expressed as a mean ± SD (Results 
from n ≥ 3 independent experiments). One-way ANOVA with Bonferroni’s multiple 
comparison test revealed: **P<0.01 CTRL vs ATCC 33291 at 72 hours (total cells), *P<0.05 
CTRL vs ISS 1 at 72 hours (total cells), *P<0.05 CTRL vs ATCC 33291 at 72 hours 
(distended cells). 
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Lysosomal alterations 
Lysosomal involvement in both apoptotic and survival pathways was monitored by staining 
U937 cells with LysoTracker Deep Red (LTDR). As shown in Fig. 6.8, C. jejuni lysates from 
the wild type strains (in particular ATCC 33291) induced a decrease in amount of LTDR-
accumulating lysosomes in U937 cells after 6 hours, followed by a significant increase in 
amount of LTDR-accumulating lysosomes after 72 hours. 
 
 
Fig. 6.8 Histograms of percentage of LTDR positive cells calculated after 6, 48 and 72 hours 
from lysate administration in total cells. Each value was converted to A.U. setting control as 
100. Each value was expressed as a mean ± SD (Results from n ≥ 3 independent 
experiments). One-way ANOVA with Bonferroni’s multiple comparison test revealed: 
**P<0.01 CTRL vs ATCC 33291, ISS1 and MUT at 6 hours; ***P<0.001 CTRL vs ATCC 
33291 at 72 hours, *P<0.05 CTRL vs ATCC 33291 at 72 hours, *P<0.05 CTRL vs ISS 1 at 
72 hours. 
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Autophagic vacuole detection 
Monodansylcadaverine (MDC) staining, a specific autophagolysosome marker, was used to 
investigate the involvement of the autophagic machinery in infected U937 cells. 
Specially after 72 hours of treatment, MDC MFI increased in U937 cells infected with the C. 
jejuni ATCC 33291 lysate (Fig. 6.9 and 6.10). These results are consistent with LTDR data at 
72 hours  that show a significant lysosomal destabilization in cells preincubated with this 
same lysate. 
  
 
 
Fig. 6.9 Histogram of percentage of MDC positive cells calculated after 72 hours from lysate 
administration in total cells. Each value was converted to A.U. setting control as 100. Each 
value is expressed as a mean ± SD (Results from n ≥ 3 independent experiments). Paired t test 
(two-tailed P value) revealed: **P<0.01 CTRL vs ATCC 33291 at 72 hours. 
. 
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Fig. 6.10 Density plot of MDC (Am Cyan) vs FSC values of CTRL (A) cells and cells 
preincubated with the C. jejuni ATCC 33291 lysate (B). In red are shown MDC positive cells, 
in grey are shown MDC negative cells and debris that were not included in the analysis. 
 
 
ER stress evaluation 
At first, in order to investigate ER stress induced by lysates, U937 cells were stained with ER-
Tracker and analysed in both cytometry and confocal microscopy. Results reported in Fig 
6.11 showed that ER stress occurred in U937 cells after 24 hours; afterwards, at 48 and 72 
hours, ER modifications were so much intricate that we were not able to define a specific 
trend. In addition, having observed significant variations in ER MFI at 24 hours in cells 
preincubated with the C. jejuni ATCC 33291 lysate, CHOP protein was quantified by 
Western blotting at 24 hours. As shown in Fig. 6.12, Western blotting of CHOP protein 
confirmed that C. jejuni lysates induced ER stress after 24 hours in U937 cells. 
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Fig. 6.11 Histograms of ER Tracker MFI estimated in cells at 24, 48 and 72 hours. Each value 
was converted to A.U. setting control as 100. Each value is expressed as a mean ± SD 
(Results from n ≥ 3 independent experiments). Paired t test (two-tailed P value) revealed: 
*P<0.05 CTRL vs ATCC 33291 at 24 hours. 
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Fig. 6.12 Quantification of CHOP protein in U937 cells after 24 hours from lysate 
administration. Welch’s unpaired t test revealed: **P=0.004 CTRL vs ATCC 33291, 
*P=0.043 CTRL vs MUT. 
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Content of intracellular Ca
2+
 
Fura 2-AM was used to study variations in content of intracellular Ca
2+
. Both in viable and 
total cells it was observed a significative increase in intracellular Ca
2+ 
content after the 
treatment with the C. jejuni ATCC 33291 lysate for 48 hours (Fig. 6.13). According to the 
literature, since Ca
2+
 content alterations characterize mostly the earliest phases of the cell 
death process, they are particularly evident in viable cells, unlike in distended or dead cells. 
 
 
Fig. 6.13 Histograms of FURA 2-AM MFI estimated in total (tot) and viable U937 cells at 24 
and 48 hours. Each value was converted to A.U. setting control as 100. Each value was 
expressed as a mean ± SD (Results from n ≥ 3 independent experiments). One-way ANOVA 
with Bonferroni’s multiple comparison test revealed: *P<0.05 CTRL vs ATCC 33291 at 48 
hours in total and viable cells. 
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Bcl-2 and pRb detection 
Being U937 cells p53 mutant, to investigate the apoptotic pathway Bcl-2 and pRb proteins 
were investigated. Preliminary data showed an overexpression of Bcl-2 and pRb in cells 
preincubated with the wild type lysates, in particular the C. jejuni ATCC 33291 lysate, 
compared to the control. Changes in Bcl-2 (Fig. 6.14) and pRb (Fig. 6.15 and 6.16) 
expression were particularly evident in distended cells; as shown in the histograms below, 
expression of these two proteins was compared in total and distended cells.   
 
 
Fig. 6.14 Histogram of Bcl-2 intracellular content in total (tot) and distended (dist) U937 cells 
at 72 hours. Each value was converted to A.U. setting control as 100. 
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Fig. 6.15 Histogram of pRb intracellular content in U937 cells at 72 hours. Each value was 
converted to A.U. setting control as 100. 
 
 
Fig. 6.16 Single confocal optical sections pRb MFI of untreated cells and U937 cells 
preincubated with the C. jejuni ATCC 33291 lysate for 72 hours. 
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Evaluation of intracellular lipid content 
To investigate intracellular lipid modifications in U937 cells, LipidTOX and Bodipy 
fluorescent dyes were used. In Fig. 6.17, cytometric results show peculiar staining of both 
treated and untreated cells after 24, 48 and 72 hours of preincubation with lysates. Notably 
after 72 hours, important changes in intracellular content of neutral lipids occurred in cells 
preincubated with the C. jejuni ISS 1 lysate. On the contrary, a greater accumulation of 
peroxidised lipids resulted in U937 cells preincubated for 72 hours with the C. jejuni ATCC 
33291 lysate (Fig. 6.18).  
 
 
Fig. 6.17 Histograms of percentage of LipidTOX positive cells was calculated after 24, 48 
and 72 hours from lysate administration in total cells (tot) and distended cells (dist). Each 
value was converted to A.U. setting control as 100. Each value is expressed as a mean ± SD 
(Results from n ≥ 3 independent experiments). One-way ANOVA with Bonferroni’s multiple 
comparison test revealed: *P<0.05 CTRL vs ISS 1 at 24 hours (total cells), **P<0.01 CTRL 
vs ISS 1 at 72 hours (total cells), *P<0.05 CTRL vs ISS 1 at 72 hours (distended cells). 
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Fig. 6.18 Histogram of percentage of Bodipy positive cells calculated after 72 hours from 
lysate administration in total cells. Each value was converted to A.U. setting control as 100. 
Each value is expressed as a mean ± SD (Results from n ≥ 3 independent experiments). One-
way ANOVA with Bonferroni’s multiple comparison test revealed:  *P<0.05 CTRL vs ATCC 
33291 at 24 hours. 
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Autophagy associated to mTOR signaling activation 
Activation of autophagy correlated to mTOR signaling involvement, was studied by 
investigating the effects of RM in U937 cells uninfected or infected with the respective 
lysates. For the investigated parameters, data from cells preincubated with lysates and RM 
together were compared to data from cells preincubated only with lysates: basically a ratio 
between these values was done (RM/without RM).  
mTOR blockade caused by RM resulted in a different response of U937 cells to the lysates.  
As shown in Fig. 6.19, important differences were reported between uninfected and infected 
cells (with lysates) and untreated and treated cells (with RM).  
In detail, ratios about ER tracker values reduced in infected cells compared with uninfected 
cells, demonstrating that the effect of the lysates on host ER was stronger than the effect of 
the RM. As already affirmed in other chapters, no differences were observed between wild 
type and mutant strains confirming that CDT might not have a critical role in structural ER 
modifications and ER stress. 
In addition, by using LTDR staining, we observed that in U937 cells preincubated with the 
wild type lysates, lysosomes responded in the same manner, compared with CTRL and cells 
MUT, which in turn have a similar trend as well (Fig. 6.19 and 6.20). 
U937 cells were also stained with MDC, a specific autophagolysosome marker. Whereas 
control cells and cells preincubated with the lysate from the mutant strain showed the same 
trend, cells preincubated with the wild type strains showed two different opposite behaviours: 
the ratio is low in ATCC 33291-infected cells and particularly high in ISS 1-infected cells.  
Preliminary data, not shown here, demonstrated the involvement of lipids, stained with 
LipidTOX and Bodipy, in mTOR mediated autophagy triggered by C. jejuni wild type lysates. 
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Fig. 6.19 For investigated parameters, ER (by ER Tracker staining, in green), autophagic 
vacuoles (by MDC staining, in orange) and lysosomes (by LTDR staining, in blue), a ratio 
between RM/without RM was carried out for each experimental condition at 72 hours. Each 
value was converted to A.U. setting untreated cells, that were not treated with RM, as 1; 
therefore, values higher or lower than 1 have to be interpreted as modulated or not modulated 
by RM. Basically, where the effect of the lysate was stronger than the effect of RM the ratio 
resulted lower then 1, on the contrary, where the effect of the lysate was weaker than the 
effect of RM the ratio resulted higher than 1. 
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Fig. 6.20 Single confocal optical sections of ER Tracker MFI (in green) and LTDR MFI (in 
pink) of untreated U937 cells (CTRL) and U937 cells preincubated with lysates after 72 hours 
of treatment with and without RM. Where present, co-localization is shown in white.  Lower 
pictures show U937 cells pre-treated with RM for 2 hours before lysate administration. Bars: 
10 µm. 
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CD14 and ICAM-1 (CD54) variations  
CD14 variations during the time course were detected in U937 cells preincubated with lysates 
(data not shown), although they were not statistically significative. On the contrary, as shown 
in Fig 6.21 ICAM-1 expression was upregulated particularly after 72 hours preincubation 
with the C. jejuni ATCC 33291 lysate. 
 
 
Fig. 6.21 Histograms of percentage of ICAM-1 positive cells calculated after 24, 48 and 72 
hours from lysate administration in total cells (tot) and distended cells (dist). Each value was 
converted to A.U. setting CTRL as 100. Each value is expressed as a mean ± SD (Results 
from n ≥ 3 independent experiments). One-way ANOVA with Bonferroni’s multiple 
comparison test revealed: *P<0.05 CTRL vs MUT at 24 hours, ***P<0.001 CTRL vs ATCC 
33291 at 72 hours, ***P<0.001 ATCC 33291 vs MUT at 72 hours. 
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Discussion 
Although in U937 cells infected with respective lysates the same investigations that were 
described in the previous chapters were carried out, in this part of the work it was focused the 
attention not only on total cells, but also on different sub-populations. 
Modifications induced by lysates were present mostly in total and distended cells. Distended 
cells represented the most interesting sub-population because in these cells the CDT certainly 
acted: they represent the intermediate state between infected and dead cells. In these cells the 
CDT can act and persist, enhancing the infection spreading. Results about viable/non-
apoptotic cells and dead cells were reported only when significant variations were observed. 
As it was already demonstrated, C. jejuni lysates were able to induce morphologic changes, 
cell cycle arrest, therefore reduction in cell number, and apoptosis in U937 cells in a CDT 
dependent manner. 
Moreover, as demonstrated by CHOP and ER Tracker results, after 24 hours’ infection, ER 
stress occurred in U937 cells through a CDT-independent manner. The CDT might not have a 
critical role in ER stress induction, because the mutant strain showed to induce an increase in 
CHOP protein. This protein is generally activated in different cellular stress conditions and it 
is shown to modulate the apoptotic pathway.  
At the same time point, alterations in adhesion molecules (ICAM-1) resulted in U937 cell 
surface, leading to inter-cellular adhesion perturbation; this phenomenon in vivo is essential 
for rolling, activation, adhesion, and transmigration of immune cells. 
As predicted, ER stress was followed by an increase in Ca
2+
 intracellular content at 48 hours’ 
post-infection, that lead to the apoptotic cascade activation by the cell.  
Although pRb and Bcl-2 data are preliminary, it is possible to affirm that lysates from the 
wild type strains were also able to induce an anti-apoptotic (pro-survival) response in U937 
cells (at 72 hours), unlike it was observed in monocytes (at 12 hours): it might be probably 
due to the different response of the changed cell line or the different time point of analysis.    
pRb results are consistent with CFSE results confirming an occurred cell cycle arrest. pRb has 
been reported to cause growth arrest and inhibit apoptosis (Haupt et al, 1995). Upregulation of 
pRb by C. jejuni wild type strains might represent a helpful expedient that this bacterium 
activates to persist in host cells and to contrast the programmed cell death. 
TMRE was used to monitor mitochondrial transmembrane potential and mitochondrial 
function. As previously mentioned, depending on the specific apoptotic stage in which cells 
are, TMRE MFI can increase or decrease. The C. jejuni strain that induced the most relevant 
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mitochondrial alterations was the ATCC 33291, confirming that this strain favours an 
intrinsic apoptotic pathway. 
In addition, we observed that in both monocytes and U937 cells, lysosomes respond to the 
lysates by following the same trend: if in monocytes a decrease in LysoTracker MFI at 12 
hours was followed by an increase at 24-48 hours, in U937 we observed a decrease in 
LysoTracker MFI at 6 hours that was followed by an important increase at 72 hours. This 
behaviour is evident in cells preincubated with the C. jejuni ATCC 332921 lysate. These 
findings might suggest that C. jejuni triggers in myeloid cells a first pro-survival response, 
followed by a pro-apoptotic or pro-autophagic response. LTDR results are consistent with 
MDC results, confirming that, after 72 hours of treatment, U937 cells respond to stimuli by 
activating the autophagic machinery, in which lysosomes are largely involved. Activation of 
autophagy was also proven by investigations carried out in U937 cells pre-treated with RM.  
It is known that RM is an efficient inhibitor of mTOR that can induce autophagy in mammal 
cells. mTOR blockade caused by RM resulted in a different response of U937 cells to the 
lysates, inducing us to suppose that C. jejuni induces some modifications in U937 cells 
involving mTOR activation. 
RM is able to trigger the autophagic flux, trying to re-establish the main stages of 
autophagolysosomes formation and fusion, when they are altered. Our findings showed that in 
uninfected cells, RM structurally and functionally alter ER membranes (tubules and sheets) 
and cause an increase in acidic compartments/ lysosomes. Nevertheless, many differences 
were found between uninfected and infected cells. 
RM results showed that, as predicted, ER is involved in autophagic processes induced by C. 
jejuni, in a CDT independent manner. On the contrary, LTDR data showed that lysosomes are 
differently recruited by wild type and mutant strains: that means that C. jejuni recruits 
lysosomes in the autophagic pathway in a CDT dependent manner, in particular for the ATCC 
33291 strain.  
Interesting findings were found for the C. jejuni ISS 1 strain. This strain showed an 
interesting behaviour because it is not particularly able to cause cell death and/or autophagy in 
U937 cells, as demonstrated by AnxV-PI, CFSE and MDC results. In addition, an increment 
of autophagolysosomes occurred only after RM treatment, demonstrating that the lysate is not 
particularly able to induce these mechanisms.  Nevertheless, lysosomes are recruited and ER 
modifications resulted in these cells. It is very likely that this behaviour is due to an 
alternative route that this specific strain utilizes. It was already reported that the CDT 
(Medina-Kauwe, 2007) as well as whole C jejuni cells (Watson & Galan, 2008), can deviate 
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the classical endocytic pathway to evade the intracellular barriers that cells utilize against 
pathogens. It is very likely that the C. jejuni ISS 1 wild type strain utilize this same expedient 
to avoid host defences and persist undisturbed within host cells. On the contrary, the C. jejuni 
ATCC 33291 strain does not have this ability since U937 cells respond to this strain by 
strongly activating both apoptotic and autophagic pathways.  
Moreover, at 72 hours’ post-infection, Bodipy-LipidTOX findings demonstrated that also 
lipid peroxidation and alterations in intracellular lipid content are caused by C. jejuni in a 
CDT-dependent manner. It is very likely that modifications in peroxidised lipids, that occur in 
ATCC 33291 infected cells, are a consequence of the activation of the autophagic pathway, 
whereas modifications in neutral lipid content, that occur in ISS 1 infected cells, are due to the 
formation of endosomes that allow CDT entrance and persistence.  
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7. U937 cell model: U937 cells preincubated with C. jejuni OMVs 
 
NTA and cytometric evaluations of OMVs 
Integrity and size of the OMVs were investigated by using cytometric and NanoSight 
analyses (Fig.7.1). Cytometric analyses were carried out by using Nile Red and SYBR Green 
stainings; membrane integrity and the potential presence of nucleic acids within OMVs were 
evaluated. Performed investigations confirmed that OMVs used in subsequent assays were 
intact and with an average size of 100-120 nm. Nile Red analyses also confirmed that OMVs 
produced by the wild type strain and its mutant were different in size and membrane content 
(Fig. 7.2 and 7.3). Moreover, SYBR Green analyses revealed an important presence of 
nucleic acids in OMVs isolated from the C. jejuni cdtA mutant, as recently mentioned by O’ 
Donoghue and Krachler (O'Donoghue & Krachler, 2016). The meaning of this finding will be 
investigated in the future. 
 
Morphological features, cell death and Ca
2+
 intracellular content 
Morphologic appearance of uninfected and infected cells was investigated in both cytometry 
and confocal microscopy; FSC and SSC cytometric parameters were used as indicators of cell 
size and complexity. Morphological features are appreciable in all confocal pictures below. 
FSC values of untreated control cells were compared with FSC values of cells treated with 
OMVs previously isolated. All treatments induced a moderate increase in FSC values and cell 
enlargement already at 24 hours. Confocal microscopy also showed that U937 cells 
preincubated with the wild type OMVs (WT) showed the typical apoptotic shrinkage. These 
findings were confirmed by cytometric AnxV-PI results that revealed the presence of a high 
percentage of AnxV-PI positive cells (apoptotic cells) in these last (Fig. 7.4). 
Moreover, FURA-2 AM analyses revealed an important increase in intracellular Ca
2+
 content 
in cells preincubated with the OMVs from the wild type strain, compared with the mutant 
(MUT) and untreated control cells (CTRL) (Fig. 7.4). 
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Fig. 7.1 To verify integrity and size of vesicles from C. jejuni 11168H wild type (A) and C. 
jejuni 11168H cdtA mutant strains (B), NTA measurements were performed by using a 
NanoSight LM20 (NanoSight, U.K). 
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Fig. 7.2 Cytometric analyses of OMVs previously isolated from the C. jejuni 11168H wild 
type strain and stained with Nile Red (FL2/PE). P1 shows beads used for the absolute count; 
P2, P3, and P4 are gates drawn around different sized OMVs: P2 are the biggest ones, 
whereas P3 are the aggregated vesicles: adhesion and aggregation can develop in these kind 
of samples. 
 
 
Fig. 7.3 Cytometric analyses of OMVs previously isolated from the C. jejuni 11168H cdtA 
mutant strain and stained with Nile Red. Violet, blue and green histograms are related to P4, 
P3 and P2 gates, respectively. 
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Fig. 7.4 (A) Histogram of AnxV-PI positive event percentage in U937 total cells after 72 
hours of treatment with OMVs isolated from the wild type and mutant strains. (B) Trends of 
FURA2-AM MFI in total cells for each experimental condition during the time course. 
 
 
CD14 and ICAM-1 variations 
Specifically, after 72 hours of treatment, U937 cells preincubated with OMVs from the wild 
type strain, compared with untreated control cells and the counterpart preincubated with 
OMVs from the mutant strain, showed an important increase in CD14 and ICAM-1 
expression. As shown in Fig. 7.5 and 7.6, these findings were confirmed by both cytometric 
and microscopy analyses. 
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Fig. 7.5 (A) Single confocal optical sections of CD14-FITC MFI of control and U937 cells 
preincubated for 48 and 72 hours with C. jejuni OMVs. Bars: 10µm. (B) Trends and CD14-
FITC MFI in total cells for each experimental condition during the time course. 
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Fig. 7.6 Single confocal optical sections of ICAM-1 MFI of control and U937 cells 
preincubated for 72 hours with OMVs. (B) Statistical histogram of ICAM-1 MFI in total cells 
after 72 hours of treatment. Bars: 10µm. 
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Mitochondrial, ER and lipid raft alterations 
Although mitochondrial alterations were appreciable principally in cytometry, ER and lipid 
raft alterations were evident both in cytometry and confocal microscopy after 48 and 72 hours 
of treatment (Fig. 7.7, 7.8, 7.9, 7.10).  
Mitochondrial transmembrane potential, which is considered an important parameter of 
mitochondrial function, and it is frequently used as an indicator of cell death, was mesured by 
TMRE staining. A TMRE MFI increase was observed in U937 cells after 48 hours of 
preincubation with OMVs, confirming that mitochondrial transmembrane alterations 
occurred, that inevitably might have led to the activation of the apoptotic process (Fig. 
7.10A). 
Moreover, an overall increase in CD317 MFI, which was used as lipid rafts marker, was 
observed after 48 and 72 hours of preincubation with OMVs in all experimental conditions in 
both cytometry (Fig. 7.10B ) and confocal mycroscopy (Fig. 7.7 and 7.8).  
ER-Tracker Green data also showed ER alterations after 24-48 hours of treatment with both 
OMVs from the wild type and mutant strains. Therefore, it was possible to affirm that CDT 
might not be the only player involved in these modifications (Fig. 7.9). 
 
Lysosomal alterations 
Lysosomal compartments were detected in cytometry and confocal microscopy by 
LysoTracker Deep Red (LTDR) staining; in this way lysosomal involvement in both apoptotic 
and survival pathways was monitored. As shown in Fig. 7.11, wild type OMVs induced a 
significant increase in amount of LTDR-accumulating lysosomes in U937 cells after 48 and 
72 hours of treatment compared to untreated control cells. 
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Fig.7.7 Single confocal optical sections of TMRE, CD317 and ER Tracker of untreated and 
treated U937 cells after 48 hours of preincubation with OMVs from wild type and mutant 
strains. Bars: 10µm. 
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Fig. 7.8 Single confocal optical sections of TMRE, CD317 and ER Tracker of untreated and 
treated U937 cells after 72 hours of preincubation with OMVs from wild type and mutant 
strains. Bars:10µm. 
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Fig. 7.9 (A) Cytometric histograms showing ER Tracker MFI in untreated control cells 
(CTRL), and cells preincubated with OMVs from wild type (WT)  and mutant (MUT) strains 
for 48 hours. (B) Trends of ER Tracker MFI in distended for each experimental condition 
during the time course.  
 
 
Fig. 7.10 (A) Trends of TMRE MFI in total cells for each experimental condition during the 
time course. (B) Trends of CD317 MFI in total cells for each experimental condition during 
the time course. 
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Fig. 7.11 (A) Single confocal optical sections of LTDR MFI of control and treated U937 cells 
after 72 hours . (B) Trends of LTDR MFI in total cells for each experimental condition during 
the time course. Bars: 10µm. 
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Evaluation of the intracellular lipid content 
To characterize lipid accumulation in U937 cells,  fluorescent dyes LipidTOX and Bodipy 
were used. In Fig.7.12 and 7.13, cytometric and microscopy results show respectively the 
peculiar staining of both treated and untreated cells. Of note, after 72 hours preincubation 
with OMVs from the wild type strain, U937 cells showed a great accumulation of peroxidised 
lipids, although minimal variations in neutral lipid content occurred. More investigations will 
be necessary to better elucidate the role of C. jejuni cdtA mutant OMVs, therefore the role of 
the CDT in these processes. 
 
 
Fig. 7.12 Trends of Bodipy (A) and LipidTOX (B) MFI in total cells for each experimental 
condition during the time course. 
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Fig. 7.13 Single confocal optical sections of LipidTOX (in green) and Bodipy (in red) MFI 
(merged) of control and treated U937 cells after 48 and 72 hours of treatment. Bars: 10 µm. 
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Autophagic vacuole detection 
MDC staining was used to investigate autophagolysosome formation in U937 cells infected 
with C. jejuni OMVs. As shown in Fig. 7.14, cytometric results revealed an important 
presence of autophagolysosomes in U937 cells infected with OMVs from the wild type strain, 
already at 48 hours . 
 
 
Fig. 7.14 Trend of MDC MFI in total cells for each experimental condition during the time 
course. 
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Discussion 
Although more replicates are needed, preliminary data obtained from U937 cells preincubated 
with OMVs isolated from C. jejuni 11168H wild type and cdtA mutant strains confirm results 
previously obtained with lysates.  
AnxV-PI and MDC stainings were used as indicators of cell death and autophagy 
respectively. In this part of the work, wild type OMVs, compared with OMVs from the 
mutant strain, induced apoptosis and autophagy in U937 cells via a CDT dependent 
mechanism, likely much more strongly than lysates (see previous chapter). Moreover, having 
the treatment induced perturbations in both mitochondrial and lysosomal functions, it is very 
likely that the apoptotic response involves both intrinsic and extrinsic apoptotic pathways. 
Infected cells also showed significant alterations in lipid rafts and intracellular lipid content; 
this confirm the strong relationship between C. jejuni infection and lipids in human cells, 
already demonstrated in literature. Of note, whereas CD317 data demonstrated the evident 
involvement of lipid rafts in OMV-mediated C. jejuni infection, Bodipy-LipidTOX findings 
proved the lipid peroxidation caused by C. jejuni via CDT. The critical role of the CDT in this 
process is demonstrated by data from cells infected with OMVs from the mutant strain.  
It is well known that Ca
2+
 metabolism and ER are strongly interconnected. The elevated levels 
of intracellular Ca
2+
 in cells preincubated with OMVs from the wild type strain demonstrated 
that a significant release of Ca
2+
 from ER stores occurred in these cells. ER and Ca
2+
 results, 
taken together, demonstrate that C. jejuni OMVs, from both wild type and mutant strains, are 
able to induce ER stress, although Ca
2+
 modifications are mostly induced by the wild type 
strain. These findings reveal that, while ER can be targeted by different C. jejuni virulence 
factors, ER Ca
2+
 storage can be altered only by a stronger player as the CDT.  
It was already established that in human monocytes, CD14 is upregulated by bacterial LPS 
and contribute to CD14-mediated phagocytosis of Gram-negative bacteria (Grunwald et al, 
1996). In this work, wild type OMVs induced CD14 upregulation on U937 surface.  
In addition, as predicted, ICAM-1 modifications occurred in U937 cells after the treatment, 
suggesting that C. jejuni OMVs use ICAM-1 as a binding target through which cellular 
infection is initiated; from this same molecule host response against the pathogen is triggered. 
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8. Human intestinal cell model 
 
C. jejuni induces ER stress response in T84 cells 
ER stress response in T84 cells preincubated with C. jejuni whole cells was investigated by 
monitoring the splicing of XBP1 mRNA by RT-PCR, and CHOP protein by Western blotting 
at 6, 12 and 24 hours’ post-infection. In this chapter not only the C. jejuni cdtA mutant strain 
was used but also the C. jejuni cdtB mutant strain, as preliminary study concerning the role of 
the B subunit. Specifically, after 24 hours of infection, a significant increase in the spliced 
form of XBP1 was revealed in cells preincubated with the wild type 11168H strain (Fig. 8.1). 
After 6 (not shown) and 12 hours, differences were less significative (Fig. 8.2). Investigations 
of the effect of C. jejuni CDT mutants (cdtA and cdtB) resulted in less induction of XBP1 
mRNA splicing at 24 hours (Fig. 8.3). 
 
 
Fig. 8.1 (A) T84 cells were either uninfected or infected with MOI 100:1 C. jejuni wild type 
11168H strain. The level of spliced XBP1 mRNA was determined after 24 hours by RT–PCR 
with normalisation to GAPDH. XBP1 spliced and unspliced mRNA species were resolved by 
high-density agarose gel. (B) Quantification of XBP1 spliced band intensities from 
independent results was determined by densitometric analysis. Percentage of 
Splicing = spliced/total×100. Bars are combined mean. Positive control was Thapsigargin. 
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Fig. 8.2 T84 cells were either uninfected or infected with MOI 100:1 C. jejuni wild type 
11168H strain. The level of spliced XBP1 mRNA was determined after 12 hours by RT–PCR 
with normalisation to GAPDH. XBP1 spliced and unspliced mRNA species were resolved by 
high-density agarose gel. Positive control was Thapsigargin. 
 
 
Fig. 8.3 (A) T84 cells were either uninfected or infected with C. jejuni wild type 11168H 
strain, cdtA and cdtB mutants at an MOI 100:1. The level of XBP1s mRNA was determined 
after 24 hours by RT-PCR with normalisation to GAPDH. XBP1 spliced and unspliced 
mRNA species were resolved by high-density agarose gel. (B) Quantification of XBP1 
spliced band intensities from independent results was determined by densitometric analysis. 
Percentage of Splicing = spliced/total×100. Bars are combined mean. Positive control was 
Thapsigargin. 
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Preliminary data gained by Western blotting showed a mild increase in CHOP protein (data 
not shown) in infected cells compared with uninfected cells after 24 hours. According to these 
data, C. jejuni seemed to induce the UPR by inducing XBP1 mRNA splicing in T84 cells in 
vitro. C. jejuni CDT mutant results suggested a putative role of the CDT in these processes. 
 
C. jejuni OMVs induce ER stress response in T84 cells 
ER stress response in T84 cells preincubated with OMVs from C. jejuni was investigated by 
monitoring the splicing of XBP1 mRNA by RT-PCR, and CHOP protein by Western blotting 
at 6, 12 and 24 hours’ post-infection. As previously observed in T84 preincubated with whole 
C. jejuni cells, after 24 hours of infection, a significant increase in the spliced form of XBP1 
was revealed in infected cells (Fig. 8.4) compared with uninfected cells. Surprisingly, 
investigations of the effect of C. jejuni CDT mutants (cdtA and cdtB) resulted in more 
induction of XBP1 mRNA splicing at 24 hours compared with the wild type strain. After 6 
and 12 hours, differences were less significative (not shown). Data gained by Western blotting 
showed an important increase in CHOP protein in cells infected with OMVs compared with 
uninfected cells after 6 hours (Fig. 8.5). According to these data, C. jejuni OMVs seemed to 
induce the UPR by inducing XBP1 mRNA splicing in T84 cells in vitro as well as CHOP 
protein upregulation. According to C. jejuni CDT mutant results, more studies are needed to 
better investigate the putative role of the CDT in OMV-mediated infection. 
 
 
Fig. 8.4 T84 cells were co-cultured with OMVs isolated from C. jejuni 11168H wild-type 
strain, cdtA or cdtB mutants. The level of spliced XBP1 mRNA was determined after 24 hours 
by RT–PCR with normalisation to GAPDH. XBP1 spliced and unspliced mRNA species were 
resolved by high-density agarose gel. Positive control was Thapsigargin. 
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Fig. 8.5 Infrared fluorescent Western blot for detection of CHOP protein. T84 cells were pre-
incubated for 6 hours with OMVs from C. jejuni 11168H wild-type strain at different 
concentrations. Positive control was Thapsigargin. 
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Discussion 
Findings reported in this chapter are important in understanding the relationship among C. 
jejuni, ER and UPR. IECs showed to detect C. jejuni infection as a form of ER stress and 
subsequently they attempt to activate UPR presumably to support protein folding and 
eventually induce apoptosis. Splicing of XBP1 and induction of CHOP are key hallmarks of 
the UPR, and both OMVs and whole C. jejuni cells showed to induce the UPR. On the 
contrary, CDT might not have an important role in ER stress induction and UPR activation (as 
already affirmed in the previous chapters).  
A. Kaser et al. (Kaser et al, 2008) reported that XBP1 is a key element of IBD (inflammatory 
bowel disease) pathogenesis. XBP1 deletion in IECS resulted in spontaneous enteritis and 
overactive responses of the IECs to the IBD inducers; this suggested that intestinal 
inflammation can originate from XBP1 abnormalities in IECs, thus linking cell-specific ER 
stress to the induction of organ specific inflammation. As described previously (see 
Introduction), IBD is a post infectious disease strictly associated to C. jejuni. Taken together 
these data show that XBP1 may represent the joining link between C. jejuni and IBD. Better 
investigating the relationship among IBD, C. jejuni and XBP1/UPR might be an interesting 
future intention. 
Recent papers have shown that UPR can be activated by two complementary processes: the 
first one involves the binding of BiP to the luminal domains of the three sensors IRE1, ATF6 
and PERK, the other one involves the direct binding of unfolded proteins to the stress-sensing 
luminal domain (Volmer et al, 2013). Perturbation of lipid composition also activates the 
UPR. In mammals altered lipid composition leads to ER Ca
2+
 depletion (Fu et al, 2011; Li et 
al, 2004) , that promote ER stress and UPR activation. A recent study reported that the 
luminal stress-domain of yeast IRE1 was able to be induced by lipid perturbation (Promlek et 
al, 2011). 
Considering the importance of lipid rafts in C. jejuni infection and lipid modifications caused 
by C. jejuni (as observed in the previous chapters) future studies may better elucidate if UPR 
activation in IECs by C. jejuni is BiP or lipid dependent.  
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9. Construction of C. jejuni 11168H GFP mutant strain 
As previously described (Methods 4.17), the CDS/CDS fragment was amplified using 
designed primers, purified and propagated into the pGEM-T Easy vector. Ligation and 
transformation into E. coli XL-2 cells followed, and transformants were checked by PCR 
(Fig. 9.1). 
In the second stage the Km
R
 cassette was incorporated into the CDS of interest: ligation and 
transformation into XL-2 cells were performed and the resultant colonies were checked for 
the insertion of a Km
R
 cassette by carrying out an orientation specific primer PCR and an 
ISPCR to test positive transformants (Fig. 9.2). To check the orientation of the Km
R
 cassette, 
bacteria single colonies were boiled/lysed and subjected to VPPCR using vector specific 
primers and orientation specific primer PCR (Fig. 9.3). The putative construct was finally 
confirmed using sequencing (Fig. 9.4). 
Once obtained the putative construct, C. jejuni cells were grown to mid-log phase and mixed 
with the DNA to be transformed by electroporation. Resultant colonies grew up and the 
effective green fluorescence emitted by bacteria was verified by confocal microscopy (Fig. 
9.5). 
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Fig. 9.1 Electrophoresis from plasmid DNA using cdtA gene (lanes 2-5) and SP6 + T7 pGEM 
vector primers (lanes 8-10). Colony PCR was performed (Methods 4.10) and positive clones 
were selected. Lanes 1 and 7 represent positive controls; lanes 6 and 11 represent negative 
controls. 
 
 
 
Fig. 9.2 (A) Electrophoresis from purified plasmid DNA (lanes 1 and 2) (B) Electrophoresis 
from purified plasmid DNA (lane 1) using IMPCR primers. Colony PCR was performed 
(Methods 4.10) and positive clones were selected. Lanes 3 and 4 represent positive and 
negative controls respectively. 
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Fig. 9.3 Electrophoresis from purified plasmid DNA using SP6+T7 pGEM vector primers 
(lanes 1-9 represent clones) and GS-F/KmR orientation specific primers (lanes a-l represent 
clones). Colony PCR was performed (Methods 4.10) and positive clones were selected. Lane 
10 represents the positive control; lanes 11 and m represent negative controls. 
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Km
R
 cassette 
 
CNNTCTATAGATATATTGATAAGCGCGCTGCCTATGCCTTGCCCCCTGAAATCCTTACATA
CGGCGATATCTTCTTATAAGCGTACCGGTTCCAATTTTTTCGCAGTTTAACTTTTCCGACG
CATTTATCGTCTTGGTAGTAAAGATATATTATATATTATCTTATCAGTATTGTCAATATAT
TCAAGGCAATCTGCCTCCTCATCCTCTTCATCCTCTTCGTCTTGGTAGCTTTTTAAATATG
GCGCTTCATAGAGTAATTCTGTAAAGGTCCAATTCTCGTTTTCATACCTCGGTATAATCTT
ACCTATCACCTCAAATGGTTCGCTGGGTTTATCGATGATAAGCTGTCAAACATGAGAATTC
GAGCTCGGTACCCGGGGATCTAATCCAATTTCCTTGTGCTAAAGCCCAAACCGTTAAAGCT
GCTCCGCTAGGGCCTAGAATGGTTAAAAAATCAGAAACCGCAGGGCGATTTTCAAAAATTA
AAACATCATTAAAAGCTTCGTCTTTAAAGCGAGGATTGATCCCATTTGCTGCATTATTGTT
GGCACTATTGCTTGTTCTAGTTAAAGGTGGGGTAATAGGAGTAATAGGTACTAAATCAGCA
CCGCTAATTAAACTTGGAATTTCTTGATTGGTAGGAAAAGTAGGTTCAAGTCCTAGTTTTA
AAGGATCAGTATCTTCAAATTCTCCAAATCACTAGTGAATTCGCGGCCGCCTGCAGGTCGA
CCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGAGTATTCTATAGTGTCACCTA
AATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAA
TTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAG
CTAACTCACATTNATTTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAANCTGTCNNG
CCAGCTGCATTANNANCNGCNANGNNNNNGGGANAGGNGNTTGCGNATTGGGNCGCTCNTC
NNTTCNCGCNTCACTGANTCNNNNNNCTNNGNCNNNNGNNTGNNNNNNNNGNNTCANNTCN
NTNANGGNNGNNNNNNNGTNNTNNNNANNNGNNNNNNCNGAANAANNTGNNNNANCAANNN 
cdtA gene 
 
NNNNACTTTTCCTACCNATCAAGAAATTCCAAGTTTAATTAGCGGTGCTGATTTAGTACCT
ATTACTCCTATTACCCCACCTTTAACTAGAACAAGCAATAGTGCCAACAATAATGCAGCAA
ATGGGATCAATCCTCGCTTTAAAGACGAAGCTTTTAATGATGTTTTAATTTTTGAAAATCG
CCCTGCGGTTTCTGATTTTTTAACCATTCTAGGCCCTAGCGGAGCAGCTTTAACGGTTTGG
GCTTTAGCACAAGGAAATTGGATTAGATCCCCGGGTACCGAGCTCGAATTCTCATGTTTGA
CAGCTTATCATCGATAAACCCAGCGAACCATTTGAGGTGATAGGTAAGATTATACCGAGGT
ATGAAAACGAGAATTGGACCTTTACAGAATTACTCTATGAAGCGCCATATTTAAAAAGCTA
CCAAGACGAAGAGGATGAAGAGGATGAGGAGGCAGATTGCCTTGAATATATTGACAATACT
GATAAGATAATATATAATATATCTTTACTACCAAGACGATAAATGCGTCGGAAAAGTTAAA
CTGCGAAAAAATTGGAACCGGTACGCTTATATAGAAGATATCGCCGTATGTAAGGATTTCA
GGGGGCAAGGCATANGCAGCGCGCTTATCAATATATCTATTAAAANGGGCAAAGCATAAAA
ACTTGCATGGANNANTGCTTTGAAACCCAGGANATAAACCTTATAGCTTGAAAATTCTATC
NTAANNTGTGGATTCAAAATCCGGCTCCCN 
 
Fig. 9.4 Sequencing verification of Km
R
 cassette and cdtA gene. 
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Fig. 9.5 Visualisation of C. jejuni cdtA mutant with fluorescence confocal microscopy at 2 
hours. T84 cells were grown on round coverslips in 24 well plates overnight. Live bacteria 
(OD600 0.1) were added and co-incubated for 2 hours. Cells were fixed with 
paraformaldehyde, washed with PBS, stained and mounted. Cells were immunostained with 
anti-WGA (Red) to indicate membranes with DAPI (Blue) to indicate nuclei, with C. jejuni 
cdtA mutants GFP (Green). 
 
 
Discussion 
The C. jejuni cdtA GFP mutant strain realized in this part of the work could be extensively 
used in future investigations finalized to study the intimate relationship of C. jejuni with 
intracellular compartments contained in human cells, in particular the ER, and the role of the 
CDT. Only the mutant for the cdtA gene was made because of the complexity of the 
construction process; in the future, realization of C. jejuni cdtB and cdtC mutant strains might 
be conducted. 
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Conclusions 
 
Role of the CDT in C. jejuni infection 
The usage of C. jejuni cdt mutant strains allowed us to investigate the role of the CDT in C. 
jejuni infection mechanisms. Although some modifications seem to be CDT independent, 
such as ER stress, CD14 and CD59 surface expression; many of the investigated mechanisms 
are certainly CDT dependent. Of note, cell response to CDT seems time dependent: if in 
monocytes we observed important modifications at 24-48 hours, in U937 cells important 
modifications are evident at 48-72 hours. The fact that CDT provokes some modifications in 
host cells after long time lapses (from 24 to 72 hours) might be essential for the onset of post 
infectious sequelae such as the GBS. To better study the role of the CDT and the single cdt 
subunits, in the future it could be interesting to investigate the effects of all C. jejuni cdt 
mutant strains (cdtA, cdtB and cdtC) in all above-mentioned cell lines, as well as the 
complements of the respective cdtA, cdtB and cdtC mutants could be made to understand the 
structural and functional properties of these proteins. 
 
Myeloid cells can respond to C. jejuni infection by activating programmed cell death 
Human cells can respond to the CDT by activating apoptosis in order to kill the pathogen, and 
avoid a possible bacterial spreading. If in normal cells pro-apoptotic and anti-apoptotic signals 
are constantly on balance, in infected cells an imbalance between these signals arises, as 
demonstrated by Bcl-2, p53 and pRb findings. In this work, from 6 to 72 hours, we gradually 
observed which mechanisms are activated by the human cell to die or survive to the C. jejuni 
infection.  
Mitochondria and lysosomes are differently targeted by different C. jejuni strains, 
demonstrating that cells activate different programmed cell death pathways, classical intrinsic 
or mitochondria-lysosome crosstalk, depending on the specific strain. Although mitochondrial 
modifications caused by C. jejuni CDT are certainly associated to an activation of an intrinsic 
apoptotic pathway, recruitment of lysosomes can be associated to the activation of both the 
extrinsic apoptotic pathway and the autophagic pathway, two different pathways that 
meanwhile are strictly interconnected. 
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C. jejuni can activate the endocytic pathway, the autophagic pathway and the secretory 
pathway  
Particularly interesting is the relationship between C. jejuni and lysosomes; we provided 
evidences about how much these organelles are important for C. jejuni infection. LAMP-1 
upregulation, lysosomal destabilization, mTOR involvement and autophagy activation 
occurred in our cell models suggesting that C. jejuni is particularly able to activate the 
endocytic pathway, the secretory pathway and the autophagic pathway.  
The primary functions of the endocytic pathway are degrading and recycling internalized 
materials and redundant cellular component by using a specialized arsenal of hydrolases and 
proteases enclosed in membrane bound organelles. Lysosomal proteases can initiate apoptotic 
signaling by amplifying the apoptotic pathways initiated in/by other cellular components. At 
the same time, the endocytic system assists the autophagic system in counteracting apoptotic 
stimuli (Repnik et al, 2013) (Hafner Česen et al, 2012). 
Endocytosis has a central role in the uptake of nutrients from extracellular environment and  
recycling of the plasma membrane and its components, allowing the degradation of 
potentially harmful molecules, by connecting the transport of degradation-destined cargo from 
the early recycling circuit to the degradative system (Huotari & Helenius, 2011). 
 
Fig. 10 Schematic representation of endocytic, autophagic and secretory pathways. C. jejuni 
showed to activate all these routes. (Repnik et al, 2013) 
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Components that should be degraded are transported to the late endosome (LE), that 
represents the ‘stomach’ of the cell, through multivescicular bodies (MVB) or endosome 
carrier vesicles (ECVs) (Fig. 10). Enzymes used by LE for degradation process come from 
the trans-Golgi network (TGN). Lysosomes bud off the LE in a process known as lysosome 
re-formation (Bright et al. 1997). It has recently been shown that lysosome re-formation 
depends on mTOR activation, which in turn depends on monomeric metabolites, which are 
produced during lysosomal degradation (Yu et al, 2010). 
LAMP molecules are integral membrane lysosomal proteins that are found in both LEs and 
lysosomes. They seem to be involved in vesicle trafficking along microtubules and serve as 
receptors for chaperone-mediated autophagy (Patel & Cuervo, 2015). Indeed, there are 
three different forms of autophagy: Macro-autophagy, chaperone-mediated autophagy and 
micro-autophagy (Boya et al, 2013). Although additional investigations are needed, our 
findings demonstrate that C. jejuni might activate more than one type of autophagy. 
Although lysosomal exocytosis/secretory pathway was studied only in monocytes cells, 
interesting data were collected. C. jejuni virulence factors demonstrated to induce lysosomal 
exocytosis in monocytes.  
The ER is a continuous membrane organelle that consists of a nuclear envelope and a 
peripheral network of tubules and sheets. It also serves as a principal site for protein synthesis 
and folding, protein glycosylation, Ca
2+ 
storage and signaling, sterol biosynthesis, and drug 
metabolism. Thus, the ER is sensitive to alterations in Ca
2+
 homeostasis and accumulation of 
misfolded proteins. Depletion of Ca
2+
, inhibition of glycosylation, exposure to toxins or 
reactive oxygen species, and/or the accumulation of misfolded proteins in the ER lead to ER 
stress, and sustained ER stress eventually results in cell death (Rao et al, 2004). In a branch of 
the UPR, the ER transmembrane kinase/endonuclease IRE1α and β initiate a novel UPR-
mediated mRNA splicing mechanism that leads to the formation of the spliced XBP1 
formation. Spliced XBP1 plays an important role in phospholipid synthesis in the ER 
membranes. These phospholipids allow ER biogenesis and expansion of ER membranes 
under stress conditions (Sriburi et al, 2004) (Sriburi et al, 2007). ER expansion, through the 
UPR-mediated activation of lipid biosynthesis, has been reported to alleviate stress. 
Different techniques and very different approaches were used in this work to investigate ER 
stress (Conn, 2011). Experiments with the C. jejuni cdtA and cdtB mutant strains showed ER 
modifications are CDT independent. Both results from myeloid cells and intestinal cells 
confirm this hypothesis; as well as both ER Tracker results and molecular investigations 
showed that C. jejuni is able to induce ER expansion and ER stress, but not statistically 
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significant differences were observed between mutant and wild type strains used in this 
project. Of note, this work also provides the first evidence that C. jejuni induces UPR in 
human intestinal cells and U937 cells. Although we proved that C. jejuni cause ER stress and 
CHOP activation, more investigations are needed to elucidate the relationship among C. 
jejuni, UPR and monocytes in humans. ER findings are consistent with Ca
2+
 data: in cells 
preincubated with OMVs, we observed that Ca
2+
 depletion is mostly induced by the wild type 
strain, suggesting that ER Ca
2+
 storage can be altered only by a stronger player as the CDT. 
This is only one of the numerous proves that CDT represent a complex and astute system that 
C. jejuni explicate to infect host cells.  
ER stress and UPR activation can also lead to autophagy activation, such as alterations in 
lipid metabolism, as demonstrated by Bodipy and LipidTOX findings. ER stress, caused by 
various stimuli, affects lipid metabolism through modulating the expression levels of key 
enzymes involved in lipid synthesis or modification (Han & Kaufman, 2016) 
Our results showed alterations in lipid content and an increase in peroxidised lipids in U937 
preincubated with C. jejuni lysates and OMVs. It is likely that lipid content modification after 
48-72 hours is a consequence of spliced XBP1 and UPR activation (Gardner & Walter, 2011). 
As demonstrated by MDC results and pre-treatment with RM, C. jejuni induce the autophagic 
processes in myeloid cells, with an important involvement of mTOR, ER and lysosomes. 
mTOR signaling modulates autophagic responses involved in bacterial killing and clearance 
(Gutierrez et al, 2004) and it is shown to be involved in host response to C. jejuni infection. 
Sun et al.  demonstrated that intestinal inflammation induced by C. jejuni is correlated with 
PI3K/mTOR signaling activation, which can regulate the innate immune host response (Sun 
et al, 2012). Factors involved in mTOR signaling might be therapeutic targets for 
campylobacteriosis.  
 
Myeloid cells and GBS onset 
ICAM-1 is a ligand for β2 integrin particularly expressed on monocytes which participate in 
leucocyte-leucocyte, leucocyte-endothelial and leucocyte-epithelial cell interactions by 
mediating leucocyte rolling, firm adhesion and subsequent extravasation (Springer, 1994) 
(Hubbard & Rothlein, 2000). ICAM-1 upregulation enhances antigen presentation and 
inflammatory response activation, allowing the generation and maintenance of the host 
response. It was also shown that ICAM-1 mobility can be altered by OMVs produced by 
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Gram negative bacteria such as E. coli (Kim et al, 2013). Moreover, a recent paper reported a 
significant association between polymorphisms of ICAM-1 and the GBS (Kharwar et al, 
2017), suggesting that ICAM-1 could have a possible role in GBS development, also 
representing a possible genetic marker to GBS susceptibility. In this study we demonstrated 
that C. jejuni activate the inflammatory response by upregulating ICAM-1 expression in a 
CDT- independent manner, this means that other virulence factors produced by the C. jejuni 
are involved in this process.  
The GPI-protein CD59 is expressed on the surface of several blood cells in order to protect 
them from the complement-mediated cell lysis. Nevertheless, the complement is an important 
component of innate immunity as well as a modulator of the adaptive immunity, with a 
central role in contrasting bacterial infections and removing debris. The critical role of MAC 
in immune defence is to kill a subset of Gram-negative bacteria, in particular cocci of the 
phyla Neisseria, Moraxella and Haemophilus, that are inefficiently eliminated by 
opsonophagocytosis (Morgan et al, 2017). In this thesis there is evidence that C. jejuni 
virulence factors induce CD59 expression, suggesting that C. jejuni might interact with CD59 
in order to inhibit cell lysis and persist in host cells. This might allow the infection spreading 
that could lead to the onset of post-infectious sequelae such as the GBS. At present, there are 
no evidences that C. jejuni interact with CD59 in order to infect host cells and lead to GBS. 
More studies are certainly necessary to better elucidate this topic. 
All those modifications, such as autophagy activation and/or pRb upregulation, that are 
caused by the bacterium and are finalized to host cell survival and bacterium persistence, have 
to be considered potentially important for GBS onset. Upregulation of pRb by C. jejuni might 
represent a helpful expedient that this bacterium could activate in order to contrast the 
programmed cell death that cells activate in response to bacterial infection. 
 
CDT internalization 
Although more investigations about lipid rafts are necessary, interesting data were reported 
about CDT internalization in this work. As demonstrated in U937 cells preincubated with the 
C. jejuni ISS 1 wild type lysate, it is very likely that the CDT produced by this wild type 
strain is internalized by an alternative route that deviates the classical endocytic pathway, 
unlike the C. jejuni ATCC 33291 strain. Some pathogens utilize alternative routes to enter 
host cells that may evade the intracellular barriers encountered by the typical clathrin-
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mediated endocytic pathway. In the last 15 years, different authors hypothesized a novel 
model system through which all CDTs are trafficked in a retrograde manner from the cell 
membrane to the Golgi, and from the Golgi to the ER, in reverse of classical secretion, to 
translocate to cytosolic targets and nucleus. This mechanism facilitates the entry of pathogens 
and potential delivery agents (Medina-Kauwe, 2007). The actuation of this expedient is 
essential for C. jejuni persistence within host cells. 
 
Importance of OMVs in C. jejuni infection 
In this work, it was also studied the importance of OMVs in C. jejuni infection. In U937 cells, 
we compared the effect of C. jejuni lysates with OMVs and it was found that in all 
investigated parameters the effect of the OMVs were more pronounced than lysates, in 
particular the effects induced by the wild type strain. These findings suggest that, if on the one 
hand virulence factors contained in C. jejuni lysates can cause many modifications and cell 
death in monocytes/myeloid cells, without the involvement of the viable bacterium and 
OMVs, on the other hand some modifications such as alteration of Ca
2+
 content, intracellular 
lipid content, ICAM-1 expression and CD14 expression are enhanced by the action of the 
OMVs. 
 
In conclusion, this work represents a novel approach to investigate the mechanisms that C. 
jejuni uses to cause disease. So far, cytometry, here successfully applied, has been a technique 
poorly applied in microbiological investigations as well as in C. jejuni studies. Moreover, we 
tried to better understand the relationship among monocytes, C. jejuni and Guillain-Barré 
syndrome; unfortunately, only a few papers focused the attention on this topic in the last 
decade. The ability of C. jejuni to survive within intestinal cells and monocytes, unlike what 
happens within macrophages, might have a critical role in GBS outset.     
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Appendices 
Appendix 1-Primer design 
Oligonucleotide primers were designed manually by selecting 15-25 nucleotides, with 
consideration of melting temperature and GC content. Sequences were checked for the 
presence of self-dimers and hairpins using the web program IDT SciTools-OligoAnalyzer 3.0 
(https://www.idtdna.com/calc/analyzer).  
 
cdtA sequence:  
 
 
ATGCAAAAAATTATAGTTTTTATTTTATGTTGTTTTATGACTTTTTTTCTTTATGCATGT
TCTTCTAAATTTGAAAATGTAAATCCTTTGGGGCGTTCATTTGGAGAATTTGAAGATACT
GATCCTTTAAAACTAGGACTTGAACCTACTTTTCCTACCAATCAAGAAATTCCAAGTTTA
ATTAGCGGTGCTGATTTAGTACCTATTACTCCTATTACCCCACCTTTAACTAGAACAAGC
AATAGTGCCAACAATAATGCAGCAAATGGGATCAATCCTCGCTTTAAAGACGAAGCTTTT
AATGATGTTTTAATTTTTGAAAATCGCCCTGCGGTTTCTGATTTTTTAACCATTTTAGGC
CCTAGCGGAGCAGCTTTAACGGTTTGGGCTTTAGCACAAGGAAATTGGATTTGGGGCTAT
ACTTTAATCGATAGCAAAGGATTTGGCGATGCTAGAGTTTGGCAACTTTTGCTTTATCCT
AATGATTTTGCAATGATTAAAAATGCCAAAACCAATACTTGTCTTAATGCTTATGGTAAT
GGAATTGTCCATTATCCTTGTGATGCAAGCAATCACGCACAAATGTGGAAACTTATCCCT
ATGAGCAATACAGCGGTTCAAATTAAAAATTTAGGAAATGGAAAATGCATACAAGCACCT
ATTACAAATCTTTATGGTGATTTTCACAAGGTTTTTAAAATTTTTACCGTAGAGTGTGCA
AAAAAAGATAATTTTGATCAACAATGGTTTTTAACTACTCCGCCTTTTACCGCAAAACCT
TTATATCGCCAAGGAGAGGTACGATGA 
cdtA-F= 5’ TGGAGAATTTGAAGATACTG 3’ 
cdtA-R= 5’ TCTCCTTGGCGATATAAAG 3’ 
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cdtB sequence: 
  
ATGAAAAAAATTATATGTTTATTTTTATCTTTTAACCTTGCTTTTGCAAATTTAGAAAAT
TTTAATGTTGGCACTTGGAATTTGCAAGGCTCATCCGCAGCCACAGAAAGCAAATGGAGT
GTTAGTGTAAGACAACTTGTAAGTGGAGCAAACCCCTTAGATATCTTAATGATACAAGAA
GCAGGAACTTTACCAAGAACAGCCACTCCAACAGGACGCCATGTGCAACAAGGTGGAACA
CCTATTGATGAATATGAGTGGAATTTAGGAACTCTTTCAAGGCCTGATAGGGTTTTTATT
TATTATTCTCGCGTTGATGTAGGAGCTAATCGTGTAAATTTAGCTATAGTTTCAAGAATG
CAAGCTGAAGAAGTGATTGTTTTACCTCCACCTACTACAGTTTCAAGACCCATTATAGGA
ATTCGCAATGGAAATGATGCTTTTTTCAATATCCATGCTTTAGCTAATGGAGGAACAGAT
GTAGGAGCAATTATCACAGCTGTAGATGCACATTTTGCAAATATGCCTCAAGTTAACTGG
ATGATAGCAGGGGATTTTAACCGTGATCCTTCTACTATAACAAGTACAGTGGATAGAGAA
TTAGCAAATAGAATTAGAGTGGTTTTTCCAACTAGCGCAACTCAAGCAAGCGGAGGGACT
CTTGATTATGCAATTACAGGAAATTCAAATAGACAACAAACCTATACTCCACCGCTTTTA
GCTGCGATTTTAATGCTTGCAAGTTTAAGATCTCATATAGTTTCAGATCATTTTCCAGTA
AATTTTAGAAAATTTTAG 
 
cdtB-F= 5’ TAATGTTGGCACTTGG 3’ 
cdtB-R= 5’ AAGCGGTGGAGTATAGG 3’ 
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Appendix 2- Different orientations of the Km
R
 cassette 
Correct orientation: 
 
 
 
Reverse orientation: 
 
 
 
 
 
     
                   
   
 
 
 
 
  
GSF + KFO = Fa + .38 
kb 
GSR + KRO = Ra + .17 
kb 
GSF + KRO = Fa + .17 kb 
GSR + KFO = Ra + .38 kb 
GSF = Gene Specific Forward 
GSR = Gene Specific Reverse 
KFO = Km
R
 forward-out 
KRO = Km
R
 reverse-out 
FA = Forward gene size 
 
RA = Reverse gene size 
Gene Insert 
Km
R 
cassette 
Oligonucleotide Primer 
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